{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:12:01Z","timestamp":1793661121621,"version":"4.5.1"},"reference-count":766,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Tehran University of Medical Sciences","award":["49992"],"award-info":[{"award-number":["49992"]}],"id":[{"id":"https:\/\/ror.org\/01c4pz451","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-024-01810-w","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T05:15:45Z","timestamp":1730092545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Cancer Trends in Inborn Errors of Immunity: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"45","author":[{"given":"Saba","family":"Fekrvand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Hamidi","family":"Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmeh Nameh Goshay","family":"Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboube","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helia","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Almasi-Hashiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Saeedi-Boroujeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mohtashami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadehsadat","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh","family":"Khanmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Ahangarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiarash","family":"Saleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Hassanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"issue":"1","key":"1810_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1710-1492-7-S1-S11","volume":"7","author":"C McCusker","year":"2011","unstructured":"McCusker C, Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol. 2011;7(1):1\u20138.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"1810_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12026-014-8498-z","volume":"60","author":"V Modell","year":"2014","unstructured":"Modell V, et al. Global overview of primary immunodeficiencies: a report from Jeffrey modell centers worldwide focused on diagnosis, treatment, and discovery. Immunol Res. 2014;60(1):132\u201344.","journal-title":"Immunol Res"},{"key":"1810_CR3","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.3389\/fimmu.2018.03146","volume":"9","author":"W Al-Herz","year":"2019","unstructured":"Al-Herz W, et al. Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population. Front Immunol. 2019;9:3146.","journal-title":"Front Immunol"},{"issue":"7","key":"1810_CR4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","volume":"42","author":"SG Tangye","year":"2022","unstructured":"Tangye SG, et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2022;42(7):1473\u2013507.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1810_CR5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jaci.2011.02.047","volume":"127","author":"N Rezaei","year":"2011","unstructured":"Rezaei N, et al. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol. 2011;127(6):1329-1341.e2.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1810_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5114\/ceji.2017.72825","volume":"42","author":"S Bazregari","year":"2017","unstructured":"Bazregari S, et al. Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency. Cent-Eur J Immunol. 2017;42(4):336.","journal-title":"Cent-Eur J Immunol"},{"key":"1810_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fimmu.2016.00365","volume":"7","author":"E Mortaz","year":"2016","unstructured":"Mortaz E, et al. Cancers related to immunodeficiencies: update and perspectives. Front Immunol. 2016;7:365.","journal-title":"Front Immunol"},{"issue":"1","key":"1810_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2017.06.009","volume":"141","author":"F Hauck","year":"2018","unstructured":"Hauck F, et al. Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders. J Allergy Clin Immunol. 2018;141(1):59-68.e4.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1810_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ajh.21903","volume":"86","author":"RS Shapiro","year":"2011","unstructured":"Shapiro RS. Malignancies in the setting of primary immunodeficiency: implications for hematologists\/oncologists. Am J Hematol. 2011;86(1):48\u201355.","journal-title":"Am J Hematol"},{"key":"1810_CR10","doi-asserted-by":"publisher","first-page":"720025","DOI":"10.3389\/fimmu.2021.720025","volume":"12","author":"H Abolhassani","year":"2021","unstructured":"Abolhassani H, et al. Hallmarks of cancers: primary antibody deficiency versus other inborn errors of immunity. Front Immunol. 2021;12:720025.","journal-title":"Front Immunol"},{"issue":"4","key":"1810_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/biology10040313","volume":"10","author":"A Tiri","year":"2021","unstructured":"Tiri A, et al. Inborn errors of immunity and cancer. Biology. 2021;10(4):313.","journal-title":"Biology"},{"key":"1810_CR12","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.3389\/fimmu.2018.03136","volume":"9","author":"OA Haas","year":"2019","unstructured":"Haas OA. Primary immunodeficiency and cancer predisposition revisited: embedding two closely related concepts into an integrative conceptual framework. Front Immunol. 2019;9:3136.","journal-title":"Front Immunol"},{"issue":"6","key":"1810_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/ACI.0000000000000863","volume":"22","author":"Y Wang","year":"2022","unstructured":"Wang Y, Abolhassani H. Updates of cancer hallmarks in patients with inborn errors of immunity. Curr Opin Allergy Clin Immunol. 2022;22(6):352\u201363.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"1810_CR14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","volume":"141","author":"PC Mayor","year":"2018","unstructured":"Mayor PC, et al. Cancer in primary immunodeficiency diseases: cancer incidence in the United States immune deficiency network registry. J Allergy Clin Immunol. 2018;141(3):1028\u201335.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1810_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/ijc.23168","volume":"122","author":"N Bogdanova","year":"2008","unstructured":"Bogdanova N, et al. Nijmegen breakage syndrome mutations and risk of breast cancer. Int J Cancer. 2008;122(4):802\u20136.","journal-title":"Int J Cancer"},{"issue":"4","key":"1810_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/1573396315666190917154058","volume":"15","author":"R Kebudi","year":"2019","unstructured":"Kebudi R, Kiykim A, Sahin MK. Primary immunodeficiency and cancer in children; a review of the literature. Curr Pediatr Rev. 2019;15(4):245\u201350.","journal-title":"Curr Pediatr Rev"},{"issue":"7","key":"1810_CR17","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"3","key":"1810_CR18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Kocarnik JM, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8(3):420\u201344.","journal-title":"JAMA Oncol"},{"key":"1810_CR19","unstructured":"Gross T, Shiramizu, B. Lymphoproliferative disorders and malignancies related to immunodeficiencies. Principles and practice of pediatric oncology. Philadelphia, PA: Lippincott Williams & Wilkins, 2006. 748."},{"issue":"2","key":"1810_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/10428194.2019.1672056","volume":"61","author":"M Herber","year":"2020","unstructured":"Herber M, et al. Primary immunodeficiencies and lymphoma: a systematic review of literature. Leuk Lymphoma. 2020;61(2):274\u201384.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"1810_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","volume":"33","author":"F Suarez","year":"2015","unstructured":"Suarez F, et al. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol. 2015;33(2):202\u20138.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1810_CR22","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/jgh.15848","volume":"37","author":"B Zheng","year":"2022","unstructured":"Zheng B, et al. Immunogenetics of gastrointestinal cancers: a systematic review and retrospective survey of inborn errors of immunity in humans. J Gastroenterol Hepatol. 2022;37(6):973\u201382.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2B","key":"1810_CR23","first-page":"1263","volume":"28","author":"K Salavoura","year":"2008","unstructured":"Salavoura K, et al. Development of cancer in patients with primary immunodeficiencies. Anticancer Res. 2008;28(2B):1263\u20139.","journal-title":"Anticancer Res"},{"key":"1810_CR24","doi-asserted-by":"publisher","first-page":"622509","DOI":"10.3389\/fimmu.2020.622509","volume":"11","author":"W Jiang","year":"2021","unstructured":"Jiang W, et al. Exhausted CD8+ T cells in the tumor immune microenvironment: new pathways to therapy. Front Immunol. 2021;11:622509.","journal-title":"Front Immunol"},{"issue":"3","key":"1810_CR25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/cei.12765","volume":"184","author":"E Magen","year":"2016","unstructured":"Magen E, et al. Helicobacter pylori infection in patients with selective immunoglobulin a deficiency. Clin Exp Immunol. 2016;184(3):332\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1810_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.clim.2009.01.010","volume":"131","author":"M Quiding-J\u00e4rbrink","year":"2009","unstructured":"Quiding-J\u00e4rbrink M, et al. Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients. Clin Immunol. 2009;131(3):463\u201371.","journal-title":"Clin Immunol"},{"issue":"23","key":"1810_CR27","doi-asserted-by":"publisher","first-page":"12739","DOI":"10.3390\/ijms222312739","volume":"22","author":"S Frigerio","year":"2021","unstructured":"Frigerio S, et al. The role of the immune system in IBD-associated colorectal cancer: from pro to anti-tumorigenic mechanisms. Int J Mol Sci. 2021;22(23):12739.","journal-title":"Int J Mol Sci"},{"key":"1810_CR28","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.3389\/fimmu.2018.03135","volume":"9","author":"P Kralickova","year":"2018","unstructured":"Kralickova P, et al. CVID-associated tumors: Czech nationwide study focused on epidemiology, immunology, and genetic background in a cohort of patients with CVID. Front Immunol. 2018;9:3135.","journal-title":"Front Immunol"},{"key":"1810_CR29","doi-asserted-by":"publisher","first-page":"102945","DOI":"10.1016\/j.critrevonc.2020.102945","volume":"150","author":"S Khanmohammadi","year":"2020","unstructured":"Khanmohammadi S, et al. Lymphoma in the setting of autoimmune diseases: a review of association and mechanisms. Crit Rev Oncol Hematol. 2020;150:102945.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"1810_CR30","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.aller.2017.01.006","volume":"45","author":"A Tak Manesh","year":"2017","unstructured":"Tak Manesh A, et al. Epidemiology and pathophysiology of malignancy in common variable immunodeficiency? Allergol Immunopathol (Madr). 2017;45(6):602\u201315.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"10","key":"1810_CR31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1080\/1744666X.2019.1658523","volume":"15","author":"F Kiaee","year":"2019","unstructured":"Kiaee F, et al. Malignancy in common variable immunodeficiency: a systematic review and meta-analysis. Expert Rev Clin Immunol. 2019;15(10):1105\u201313.","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"1810_CR32","doi-asserted-by":"publisher","first-page":"8416124","DOI":"10.1155\/2020\/8416124","volume":"2020","author":"N Weifenbach","year":"2020","unstructured":"Weifenbach N, Schneckenburger AA, L\u00f6tters S. Global distribution of common variable immunodeficiency (CVID) in the light of the UNDP human development index (HDI): a preliminary perspective of a rare disease. J Immunol Res. 2020;2020(1):8416124.","journal-title":"J Immunol Res"},{"issue":"2","key":"1810_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/sj.leu.2403221","volume":"18","author":"F Gumy-Pause","year":"2004","unstructured":"Gumy-Pause F, Wacker P, Sappino AP. ATM gene and lymphoid malignancies. Leukemia. 2004;18(2):238\u201342.","journal-title":"Leukemia"},{"issue":"8","key":"1810_CR34","first-page":"ECR27","volume":"89","author":"S Pasic","year":"2004","unstructured":"Pasic S, et al. T-cell lymphoblastic leukemia\/lymphoma in Nijmegen breakage syndrome. Haematologica. 2004;89(8):ECR27.","journal-title":"Haematologica"},{"key":"1810_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1172-7-13","volume":"7","author":"KH Chrzanowska","year":"2012","unstructured":"Chrzanowska KH, et al. Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis. 2012;7:13.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1810_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/carcin\/bgl126","volume":"28","author":"L Kr\u00fcger","year":"2007","unstructured":"Kr\u00fcger L, et al. Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein. Carcinogenesis. 2007;28(1):107\u201311.","journal-title":"Carcinogenesis"},{"issue":"20","key":"1810_CR37","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1093\/hmg\/ddh278","volume":"13","author":"I Demuth","year":"2004","unstructured":"Demuth I, et al. An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability. Hum Mol Genet. 2004;13(20):2385\u201397.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"1810_CR38","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1182\/blood-2003-09-3359","volume":"103","author":"R Sharifi","year":"2004","unstructured":"Sharifi R, et al. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. Blood. 2004;103(10):3821\u20137.","journal-title":"Blood"},{"issue":"1","key":"1810_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1182\/blood-2010-06-284935","volume":"117","author":"C Booth","year":"2011","unstructured":"Booth C, et al. X-linked lymphoproliferative disease due to SAP\/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood: J Am Soc Hematol. 2011;117(1):53\u201362.","journal-title":"Blood: J Am Soc Hematol"},{"issue":"1\u20132","key":"1810_CR40","first-page":"4","volume":"668","author":"AD Auerbach","year":"2009","unstructured":"Auerbach AD. Fanconi anemia and its diagnosis. Mutat Res - Fundam Mol Mech Mutagen. 2009;668(1\u20132):4\u201310.","journal-title":"Mutat Res - Fundam Mol Mech Mutagen"},{"issue":"3","key":"1810_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrc.2017.116","volume":"18","author":"G Nalepa","year":"2018","unstructured":"Nalepa G, Clapp DW. Fanconi anaemia and cancer: an intricate relationship. Nat Rev Cancer. 2018;18(3):168\u201385.","journal-title":"Nat Rev Cancer"},{"key":"1810_CR42","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1007\/s11033-011-1381-2","volume":"39","author":"L Shen","year":"2012","unstructured":"Shen L, et al. Association between ATM polymorphisms and cancer risk: a meta-analysis. Mol Biol Rep. 2012;39:5719\u201325.","journal-title":"Mol Biol Rep"},{"issue":"5","key":"1810_CR43","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.blre.2008.03.009","volume":"22","author":"H Tran","year":"2008","unstructured":"Tran H, et al. Immunodeficiency-associated lymphomas. Blood Rev. 2008;22(5):261\u201381.","journal-title":"Blood Rev"},{"issue":"7","key":"1810_CR44","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/em.22358","volume":"61","author":"J Rageul","year":"2020","unstructured":"Rageul J, Kim H. Fanconi anemia and the underlying causes of genomic instability. Environ Mol Mutagen. 2020;61(7):693\u2013708.","journal-title":"Environ Mol Mutagen"},{"issue":"1","key":"1810_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/cei.13405","volume":"200","author":"A Arcas-Garc\u00eda","year":"2020","unstructured":"Arcas-Garc\u00eda A, et al. The IL-2RG R328X nonsense mutation allows partial STAT-5 phosphorylation and defines a critical region involved in the leaky-SCID phenotype. Clin Exp Immunol. 2020;200(1):61\u201372.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1810_CR46","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jaci.2010.09.036","volume":"127","author":"MA Slatter","year":"2011","unstructured":"Slatter MA, et al. Polymorphous lymphoproliferative disorder with Hodgkin-like features in common [gamma]-chain-deficient severe combined immunodeficiency. J Allergy Clin Immunol. 2011;127(2):533.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1810_CR47","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/pbc.21651","volume":"51","author":"P Mustillo","year":"2008","unstructured":"Mustillo P, et al. Tumor immune surveillance defect of X-linked severe combined immunodeficiency is not Epstein-Barr virus specific. Pediatr Blood Cancer. 2008;51(5):706\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"1810_CR48","first-page":"123548","volume":"1","author":"A Fedorova","year":"2015","unstructured":"Fedorova A, et al. (2015) Non-hodgkin lymphoma in children with primary immunodeficiencies: clinical manifestations, diagnosis, and management, belarusian experience. Lymphoma. 2015;1:123548.","journal-title":"Lymphoma"},{"issue":"2","key":"1810_CR49","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jaci.2020.03.043","volume":"146","author":"G Prunotto","year":"2020","unstructured":"Prunotto G, et al. HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency. J Allergy Clin Immunol. 2020;146(2):447\u201350.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1810_CR50","doi-asserted-by":"publisher","first-page":"e29487","DOI":"10.1002\/pbc.29487","volume":"69","author":"A Muleviciene","year":"2022","unstructured":"Muleviciene A, et al. Childhood Kaposi sarcoma related to hypomorphic severe combined immunodeficiency caused by a novel CORO1A mutation. Pediatr Blood Cancer. 2022;69(5):e29487.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1810_CR51","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10875-022-01412-4","volume":"43","author":"A Lev","year":"2023","unstructured":"Lev A, et al. SLP76 mutation associated with combined immunodeficiency and EBV-related lymphoma. J Clin Immunol. 2023;43(3):625\u201335.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1810_CR52","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jaci.2014.04.042","volume":"134","author":"H Abolhassani","year":"2014","unstructured":"Abolhassani H, et al. A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(6):1375\u201380.","journal-title":"J Allergy Clin Immunol"},{"issue":"19","key":"1810_CR53","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1056\/NEJMoa073966","volume":"358","author":"C Schuetz","year":"2008","unstructured":"Schuetz C, et al. An immunodeficiency disease with RAG mutations and granulomas. N Engl J Med. 2008;358(19):2030\u20138.","journal-title":"N Engl J Med"},{"issue":"4","key":"1810_CR54","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molimm.2013.05.004","volume":"56","author":"\u0130Y Bajin","year":"2013","unstructured":"Bajin \u0130Y, et al. Atypical combined immunodeficiency due to Artemis defect: a case presenting as hyperimmunoglobulin M syndrome and with LGLL. Mol Immunol. 2013;56(4):354\u20137.","journal-title":"Mol Immunol"},{"issue":"3","key":"1810_CR55","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1172\/JCI16774","volume":"111","author":"D Moshous","year":"2003","unstructured":"Moshous D, et al. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest. 2003;111(3):381\u20137.","journal-title":"J Clin Invest"},{"issue":"9","key":"1810_CR56","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.dnarep.2010.07.001","volume":"9","author":"L Woodbine","year":"2010","unstructured":"Woodbine L, et al. An Artemis polymorphic variant reduces Artemis activity and confers cellular radiosensitivity. DNA Repair. 2010;9(9):1003\u201310.","journal-title":"DNA Repair"},{"issue":"3","key":"1810_CR57","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.clim.2013.08.006","volume":"149","author":"PP Lee","year":"2013","unstructured":"Lee PP, et al. The many faces of Artemis-deficient combined immunodeficiency\u2014Two patients with DCLRE1C mutations and a systematic literature review of genotype\u2013phenotype correlation. Clin Immunol. 2013;149(3):464\u201374.","journal-title":"Clin Immunol"},{"issue":"1","key":"1810_CR58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jpeds.2007.03.059","volume":"151","author":"M Husain","year":"2007","unstructured":"Husain M, et al. Burkitt\u2019s lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase. J Pediatr. 2007;151(1):93\u20135.","journal-title":"J Pediatr"},{"issue":"6","key":"1810_CR59","doi-asserted-by":"publisher","first-page":"e876","DOI":"10.1542\/peds.2005-1068","volume":"116","author":"DA Kaufman","year":"2005","unstructured":"Kaufman DA, et al. Cerebral lymphoma in an adenosine deaminase\u2013deficient patient with severe combined immunodeficiency receiving polyethylene glycol\u2013conjugated adenosine deaminase. Pediatrics. 2005;116(6):e876\u20139.","journal-title":"Pediatrics"},{"key":"1810_CR60","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fimmu.2018.00113","volume":"9","author":"M Migliavacca","year":"2018","unstructured":"Migliavacca M, et al. First occurrence of plasmablastic lymphoma in adenosine deaminase-deficient severe combined immunodeficiency disease patient and review of the literature. Front Immunol. 2018;9:113.","journal-title":"Front Immunol"},{"issue":"10","key":"1810_CR61","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/00000478-199510000-00008","volume":"19","author":"MB Resnick","year":"1995","unstructured":"Resnick MB, Kozakewich HP, Perez-Atayde AR. Hepatic adenoma in the pediatric age group. Clinicopathological observations and assessment of cell proliferative activity. Am J Surg Pathol. 1995;19(10):1181\u201390.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1810_CR62","first-page":"A3","volume":"151","author":"SS Long","year":"2007","unstructured":"Long SS. Lymphoma despite metabolic reconstitution in adenosine deaminase deficiency-severe combined immunodeficiency. J Pediatr. 2007;151(1):A3.","journal-title":"J Pediatr"},{"issue":"3","key":"1810_CR63","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0022-3476(86)80892-7","volume":"108","author":"N Kapoor","year":"1986","unstructured":"Kapoor N, et al. Lymphoma in a patient with severe combined immunodeficiency with adenosine deaminase deficiency, following unsustained engraftment of histoincompatible T cell-depleted bone marrow. J Pediatr. 1986;108(3):435\u20138.","journal-title":"J Pediatr"},{"issue":"2","key":"1810_CR64","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1089\/ped.2014.0478","volume":"28","author":"F Genel","year":"2015","unstructured":"Genel F, et al. Adenosine deaminase-deficient severe combined immunodeficiency and diffuse large B-cell lymphoma. Pediatr Allergy Immunol Pulmonol. 2015;28(2):138\u201342.","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"3","key":"1810_CR65","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jaci.2011.10.028","volume":"129","author":"C Kesserwan","year":"2012","unstructured":"Kesserwan C, et al. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase\u2013deficient severe combined immune deficiency. J Allergy Clin Immunol. 2012;129(3):762\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1810_CR66","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/pde.14597","volume":"38","author":"TD Wahjudi","year":"2021","unstructured":"Wahjudi TD, et al. Multicentric dermatofibrosarcoma protuberans in a child with severe combined immunodeficiency due to adenosine deaminase deficiency. Pediatr Dermatol. 2021;38(4):875\u20138.","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"1810_CR67","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/MPH.0000000000002661","volume":"45","author":"D Ucku","year":"2023","unstructured":"Ucku D, et al. Hepatocellular carcinoma in ADA-SCID patient after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2023;45(5):285\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"1810_CR68","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ajmg.a.30869","volume":"137A","author":"TI Ben-Omran","year":"2005","unstructured":"Ben-Omran TI, et al. A patient with mutations in DNA Ligase IV: clinical features and overlap with Nijmegen breakage syndrome. Am J Med Genet A. 2005;137A(3):283\u20137.","journal-title":"Am J Med Genet A"},{"issue":"7","key":"1810_CR69","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/ajmg.a.31644","volume":"143","author":"N Toita","year":"2007","unstructured":"Toita N, et al. Epstein-Barr virus-associated B-cell lymphoma in a patient with DNA ligase IV (LIG4) syndrome. Am J Med Genet Part A. 2007;143(7):742\u20135.","journal-title":"Am J Med Genet Part A"},{"key":"1810_CR70","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.clim.2016.01.002","volume":"163","author":"SO Sharapova","year":"2016","unstructured":"Sharapova SO, et al. Next generation sequencing revealed DNA ligase IV deficiency in a \u201cdevelopmentally normal\u201d patient with massive brain Epstein-Barr virus-positive diffuse large B-cell lymphoma. Clin Immunol. 2016;163:108\u201310.","journal-title":"Clin Immunol"},{"issue":"2","key":"1810_CR71","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0167-8140(00)00249-8","volume":"57","author":"PB Rogers","year":"2000","unstructured":"Rogers PB, et al. Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol. 2000;57(2):143\u201354.","journal-title":"Radiother Oncol"},{"key":"1810_CR72","doi-asserted-by":"publisher","first-page":"695993","DOI":"10.3389\/fimmu.2021.695993","volume":"12","author":"X Luo","year":"2021","unstructured":"Luo X, et al. Characterization of a cohort of patients with LIG4 deficiency reveals the founder effect of p. R278L, unique to the Chinese population. Front Immunol. 2021;12:695993.","journal-title":"Front Immunol"},{"issue":"12","key":"1810_CR73","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.bbmt.2011.05.008","volume":"17","author":"NR Kamani","year":"2011","unstructured":"Kamani NR, et al. Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International blood and marrow transplant research. Biol Blood Marrow Transplant. 2011;17(12):1783\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"1810_CR74","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/ijc.2910120204","volume":"12","author":"JH Kersey","year":"1973","unstructured":"Kersey JH, Spector BD, Good RA. Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry. Int J Cancer. 1973;12(2):333\u201347.","journal-title":"Int J Cancer"},{"key":"1810_CR75","doi-asserted-by":"crossref","unstructured":"van der Berg H, et al. Malignant B\u2010cell lymphoma in an infant with severe combined immunodeficiency with short\u2010limbed skeletal dysplasia. Acta Paediatr. 1997; 86(7): 778-780.","DOI":"10.1111\/j.1651-2227.1997.tb08588.x"},{"key":"1810_CR76","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fped.2019.00232","volume":"7","author":"M Maffeis","year":"2019","unstructured":"Maffeis M, et al. Primary immunodeficiencies and oncological risk: the experience of the children\u2019s hospital of Brescia. Front Pediatr. 2019;7:232.","journal-title":"Front Pediatr"},{"issue":"4","key":"1810_CR77","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/1097-0142(19800815)46:4<692::AID-CNCR2820460410>3.0.CO;2-Q","volume":"46","author":"G Frizzera","year":"1980","unstructured":"Frizzera G, et al. Lymphoreticular disorders in primary immunodeficiencies: new findings based on an up-to-date histologic classification of 35 cases. Cancer. 1980;46(4):692\u20139.","journal-title":"Cancer"},{"issue":"1","key":"1810_CR78","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0090-1229(78)90200-3","volume":"11","author":"BD Spector","year":"1978","unstructured":"Spector BD, Perry GS 3rd, Kersey JH. Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the immunodeficiency\u2013cancer registry. Clin Immunol Immunopathol. 1978;11(1):12\u201329.","journal-title":"Clin Immunol Immunopathol"},{"issue":"8","key":"1810_CR79","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1007\/s10875-022-01330-5","volume":"42","author":"A Yagoubi","year":"2022","unstructured":"Yagoubi A, et al. Algerian registry for inborn errors of immunity in children: report of 887 children (1985\u20132021). J Clin Immunol. 2022;42(8):1660\u201371.","journal-title":"J Clin Immunol"},{"issue":"8","key":"1810_CR80","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1182\/blood-2005-07-2955","volume":"107","author":"K Warnatz","year":"2006","unstructured":"Warnatz K, et al. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood. 2006;107(8):3045\u201352.","journal-title":"Blood"},{"issue":"1","key":"1810_CR81","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/archdermatol.2011.262","volume":"148","author":"EY Chu","year":"2012","unstructured":"Chu EY, et al. Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol. 2012;148(1):79\u201384.","journal-title":"Arch Dermatol"},{"issue":"6","key":"1810_CR82","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","volume":"124","author":"KR Engelhardt","year":"2009","unstructured":"Engelhardt KR, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124(6):1289-302 e4.","journal-title":"J Allergy Clin Immunol"},{"key":"1810_CR83","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.clim.2016.08.002","volume":"178","author":"L Al Shekaili","year":"2017","unstructured":"Al Shekaili L, et al. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation. Clin Immunol. 2017;178:39\u201344.","journal-title":"Clin Immunol"},{"issue":"2","key":"1810_CR84","doi-asserted-by":"publisher","first-page":"e28091","DOI":"10.1002\/pbc.28091","volume":"67","author":"A Kiykim","year":"2020","unstructured":"Kiykim A, et al. Malignancy and lymphoid proliferation in primary immune deficiencies; hard to define, hard to treat. Pediatr Blood Cancer. 2020;67(2):e28091.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"1810_CR85","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/pai.13231","volume":"31","author":"S Cekic","year":"2020","unstructured":"Cekic S, et al. The evaluation of malignancies in Turkish primary immunodeficiency patients; a multicenter study. Pediatr Allergy Immunol. 2020;31(5):528\u201336.","journal-title":"Pediatr Allergy Immunol"},{"key":"1810_CR86","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10689-021-00266-w","volume":"20","author":"C Kelaidi","year":"2021","unstructured":"Kelaidi C, Tzotzola V, Polychronopoulou S. The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay. Fam Cancer. 2021;20:363\u201380.","journal-title":"Fam Cancer"},{"issue":"5","key":"1810_CR87","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1172\/JCI37901","volume":"119","author":"K Huck","year":"2009","unstructured":"Huck K, et al. Girls homozygous for an IL-2\u2013inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest. 2009;119(5):1350\u20138.","journal-title":"J Clin Invest"},{"issue":"3","key":"1810_CR88","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3324\/haematol.2010.033910","volume":"96","author":"P Stepensky","year":"2011","unstructured":"Stepensky P, et al. IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach. Haematologica. 2011;96(3):472\u20136.","journal-title":"Haematologica"},{"issue":"8","key":"1810_CR89","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s10875-014-0110-8","volume":"34","author":"S Ghosh","year":"2014","unstructured":"Ghosh S, et al. Interleukin-2-inducible T-cell kinase (ITK) deficiency - clinical and molecular aspects. J Clin Immunol. 2014;34(8):892\u20139.","journal-title":"J Clin Immunol"},{"key":"1810_CR90","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.clim.2018.12.016","volume":"198","author":"B Shadur","year":"2019","unstructured":"Shadur B, et al. Management of XLP-1 and ITK deficiency: the challenges posed by PID with an unpredictable spectrum of disease manifestations. Clin Immunol. 2019;198:39\u201345.","journal-title":"Clin Immunol"},{"key":"1810_CR91","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10875-016-0324-z","volume":"36","author":"HG Tanyildiz","year":"2016","unstructured":"Tanyildiz HG, et al. Lymphoma secondary to congenital and acquired immunodeficiency syndromes at a Turkish pediatric oncology center. J Clin Immunol. 2016;36:667\u201376.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1810_CR92","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/pai.13497","volume":"32","author":"C Caka","year":"2021","unstructured":"Caka C, et al. Selective IgM deficiency: follow-up and outcome. Pediatr Allergy Immunol. 2021;32(6):1327\u201334.","journal-title":"Pediatr Allergy Immunol"},{"issue":"9","key":"1810_CR93","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1084\/jem.20130592","volume":"210","author":"M Byun","year":"2013","unstructured":"Byun M, et al. Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J Exp Med. 2013;210(9):1743\u201359.","journal-title":"J Exp Med"},{"issue":"9","key":"1810_CR94","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1097\/INF.0b013e3182936280","volume":"32","author":"W-I Lee","year":"2013","unstructured":"Lee W-I, et al. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype. Pediatr Infect Dis J. 2013;32(9):1010\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"1810_CR95","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jaci.2016.07.039","volume":"139","author":"MT de la Morena","year":"2017","unstructured":"de la Morena MT, et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. J Allergy Clin Immunol. 2017;139(4):1282\u201392.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1810_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03967-4","volume":"7","author":"W-I Lee","year":"2017","unstructured":"Lee W-I, et al. A nationwide study of severe and protracted diarrhoea in patients with primary immunodeficiency diseases. Sci Rep. 2017;7(1):1\u201311.","journal-title":"Sci Rep"},{"key":"1810_CR97","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s10875-016-0291-4","volume":"36","author":"EA Leven","year":"2016","unstructured":"Leven EA, et al. Hyper IgM syndrome: a report from the USIDNET registry. J Clin Immunol. 2016;36:490\u2013501.","journal-title":"J Clin Immunol"},{"key":"1810_CR98","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s10620-006-9702-3","volume":"52","author":"N Nagaraj","year":"2007","unstructured":"Nagaraj N, Egwim C, Adler DG. X-linked hyper-IgM syndrome associated with poorly differentiated neuroendocrine tumor presenting as obstructive jaundice secondary to extensive adenopathy. Dig Dis Sci. 2007;52:2312\u20136.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1810_CR99","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","volume":"131","author":"J Levy","year":"1997","unstructured":"Levy J, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131(1):47\u201354.","journal-title":"J Pediatr"},{"issue":"2","key":"1810_CR100","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ajh.10460","volume":"75","author":"M Nagasawa","year":"2004","unstructured":"Nagasawa M, et al. Coagulopathy in a patient with X-linked hyper-IgM syndrome who developed Kaposi\u2019s sarcoma. Am J Hematol. 2004;75(2):116\u20137.","journal-title":"Am J Hematol"},{"issue":"5","key":"1810_CR101","doi-asserted-by":"publisher","first-page":"847","DOI":"10.5858\/2008-132-847-PDGNCA","volume":"132","author":"RK Malhotra","year":"2008","unstructured":"Malhotra RK, Li W. Poorly differentiated gastroenteropancreatic neuroendocrine carcinoma associated with X-linked hyperimmunoglobulin M syndrome. Arch Pathol Lab Med. 2008;132(5):847\u201350.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"1810_CR102","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","volume":"82","author":"JA Winkelstein","year":"2003","unstructured":"Winkelstein JA, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine. 2003;82(6):373\u201384.","journal-title":"Medicine"},{"issue":"3","key":"1810_CR103","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.clim.2008.08.005","volume":"129","author":"M Erd\u0151s","year":"2008","unstructured":"Erd\u0151s M, et al. Neuroendocrine carcinoma associated with X-linked hyper-immunoglobulin M syndrome: report of four cases and review of the literature. Clin Immunol. 2008;129(3):455\u201361.","journal-title":"Clin Immunol"},{"issue":"9","key":"1810_CR104","doi-asserted-by":"publisher","first-page":"e18601","DOI":"10.1097\/MD.0000000000018601","volume":"99","author":"F Ashrafi","year":"2020","unstructured":"Ashrafi F, et al. A case report of sinusoidal diffuse large B-cell lymphoma in a STK4 deficient patient. Medicine (Baltimore). 2020;99(9):e18601.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1810_CR105","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s10875-021-01047-x","volume":"41","author":"A Rawat","year":"2021","unstructured":"Rawat A, et al. Skewed TCR alpha, but not beta, gene rearrangements and lymphoma associated with a pathogenic TRAC variant. J Clin Immunol. 2021;41(6):1395\u20139.","journal-title":"J Clin Immunol"},{"issue":"8","key":"1810_CR106","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/08880018.2021.1924326","volume":"38","author":"N Edeer Karaca","year":"2021","unstructured":"Edeer Karaca N, et al. Combined immunodeficiency with marginal zone lymphoma due to a novel homozygous mutation in IL-21R gene and successful treatment with hematopoietic stem cell transplantation. Pediatr Hematol Oncol. 2021;38(8):745\u201352.","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"1810_CR107","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/08880010490457231","volume":"21","author":"A Varan","year":"2004","unstructured":"Varan A, et al. Malignant solid tumors associated with congenital immunodeficiency disorders. Pediatr Hematol Oncol. 2004;21(5):441\u201351.","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"1810_CR108","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13223-022-00747-2","volume":"18","author":"M Tavakol","year":"2022","unstructured":"Tavakol M, et al. Diversity of malignancies in patients with different types of inborn errors of immunity. Allergy Asthma Clin Immunol. 2022;18(1):106.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"1810_CR109","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5223\/pghn.2023.26.4.201","volume":"26","author":"M Cakir","year":"2023","unstructured":"Cakir M, et al. Primary immunodeficiencies in children initially admitted with gastrointestinal\/liver manifestations. Pediatr Gastroenterol Hepatol Nutr. 2023;26(4):201.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"6","key":"1810_CR110","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3109\/08880018.2013.792893","volume":"30","author":"S Emir","year":"2013","unstructured":"Emir S, et al. Characteristics of children with non-hodgkin lymphoma associated with primary immune deficiency diseases: descriptions of five patients. Pediatr Hematol Oncol. 2013;30(6):544\u201353.","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"1810_CR111","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1182\/blood-2003-05-1480","volume":"103","author":"K Imai","year":"2004","unstructured":"Imai K, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103(2):456\u201364.","journal-title":"Blood"},{"issue":"2","key":"1810_CR112","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/ajh.2830400210","volume":"40","author":"NJ Meropol","year":"1992","unstructured":"Meropol NJ, et al. Coincident Kaposi sarcoma and T-cell lymphoma in a patient with the Wiskott-Aldrich syndrome. Am J Hematol. 1992;40(2):126\u201334.","journal-title":"Am J Hematol"},{"issue":"4","key":"1810_CR113","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/1097-0142(19930815)72:4<1376::AID-CNCR2820720437>3.0.CO;2-Q","volume":"72","author":"M Nakanishi","year":"1993","unstructured":"Nakanishi M, et al. Distinct clonotypic Epstein-Barr virus-induced fatal lymphoproliferative disorder in a patient with wiskott-aldrich syndrome. Cancer. 1993;72(4):1376\u201381.","journal-title":"Cancer"},{"issue":"1","key":"1810_CR114","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/08880019709030889","volume":"14","author":"K Yoshida","year":"1997","unstructured":"Yoshida K, et al. Epstein-Barr virus-associated malignant lymphoma with macroamylasemia and monoclonal gammopathy in a patient with Wiskott-Aldrich syndrome. Pediatr Hematol Oncol. 1997;14(1):85\u20139.","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"1810_CR115","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/1097-0142(19800115)45:2<372::AID-CNCR2820450230>3.0.CO;2-N","volume":"45","author":"P Periman","year":"1980","unstructured":"Periman P, et al. Hodgkin\u2019s disease occurring in a patient with the Wiskott-Aldrich syndrome. Cancer. 1980;45(2):372\u20136.","journal-title":"Cancer"},{"issue":"6","key":"1810_CR116","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1055\/s-2003-45498","volume":"215","author":"T Niehues","year":"2003","unstructured":"Niehues T, et al. Immunodeficiency and Hodgkin\u2019s disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies. Klin Padiatr. 2003;215(6):315\u201320.","journal-title":"Klin Padiatr"},{"issue":"5","key":"1810_CR117","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/jnci\/53.5.1205","volume":"53","author":"KK Takemoto","year":"1974","unstructured":"Takemoto KK, et al. Isolation of papovavirus from brain tumor and urine of a patient with Wiskott-Aldrich syndrome. J Natl Cancer Inst. 1974;53(5):1205\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"1810_CR118","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0165-5876(03)00155-1","volume":"67","author":"G Palenzuela","year":"2003","unstructured":"Palenzuela G, et al. Malignant B cell non-Hodgkin\u2019s lymphoma of the larynx in children with Wiskott Aldrich syndrome. Int J Pediatr Otorhinolaryngol. 2003;67(9):989\u201393.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"6","key":"1810_CR119","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3109\/07357908509039813","volume":"3","author":"JD Cotelingam","year":"1985","unstructured":"Cotelingam JD, et al. Malignant lymphoma in patients with the Wiskott-Aldrich syndrome. Cancer Invest. 1985;3(6):515\u201322.","journal-title":"Cancer Invest"},{"issue":"2","key":"1810_CR120","first-page":"218","volume":"110","author":"RP Faraci","year":"1975","unstructured":"Faraci RP, et al. Malignant lymphoma of the jejunum in a patient with Wiskott-Aldrich syndrome. Surgical treatment Arch Surg. 1975;110(2):218\u201320.","journal-title":"Surgical treatment Arch Surg"},{"issue":"226","key":"1810_CR121","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/adc.42.226.608","volume":"42","author":"J Radl","year":"1967","unstructured":"Radl J, et al. Paraproteinaemia and unusual dys-gamma-globulinaemia in a case of Wiskott-Aldrich syndrome. An immunochemical study. Arch Dis Child. 1967;42(226):608\u201314.","journal-title":"Arch Dis Child"},{"issue":"5","key":"1810_CR122","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0022-3476(66)80449-3","volume":"68","author":"HA Pearson","year":"1966","unstructured":"Pearson HA, et al. Platelet survival in Wiskott-Aldrich syndrome. J Pediatr. 1966;68(5):754\u201360.","journal-title":"J Pediatr"},{"issue":"236","key":"1810_CR123","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/adc.44.236.536","volume":"44","author":"MM Brand","year":"1969","unstructured":"Brand MM, Marinkovich VA. Primary malignant reticulosis of the brain in Wiskott-Aldrich syndrome. Report of a case. Arch Dis Child. 1969;44(236):536\u201342.","journal-title":"Arch Dis Child"},{"issue":"1","key":"1810_CR124","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0090-1229(81)90015-5","volume":"18","author":"JJ Hutter Jr","year":"1981","unstructured":"Hutter JJ Jr, Jones JF. Results of a thymic epithelial transplant in a child with Wiskott-Aldrich syndrome and central nervous system lymphoma. Clin Immunol Immunopathol. 1981;18(1):121\u20135.","journal-title":"Clin Immunol Immunopathol"},{"issue":"5","key":"1810_CR125","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0022-3476(66)80450-X","volume":"68","author":"RW ten Bensel","year":"1966","unstructured":"ten Bensel RW, Stadlan EM, Krivit W. The development of malignancy in the course of the Aldrich syndrome. J Pediatr. 1966;68(5):761\u20137.","journal-title":"J Pediatr"},{"issue":"1\u20132","key":"1810_CR126","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/07853890.2016.1140224","volume":"48","author":"WI Lee","year":"2016","unstructured":"Lee WI, et al. The effects of prenatal genetic analysis on fetuses born to carrier mothers with primary immunodeficiency diseases. Ann Med. 2016;48(1\u20132):103\u201310.","journal-title":"Ann Med"},{"issue":"1","key":"1810_CR127","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/1097-0142(197401)33:1<280::AID-CNCR2820330141>3.0.CO;2-H","volume":"33","author":"KP Heidelberger","year":"1974","unstructured":"Heidelberger KP, LeGolvan DP. Wiskott-Aldrich syndrome and cerebral neoplasia: report of a case with localized reticulum cell sarcoma. Cancer. 1974;33(1):280\u20134.","journal-title":"Cancer"},{"issue":"5","key":"1810_CR128","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/archpedi.1975.02120420058019","volume":"129","author":"WA Sellars","year":"1975","unstructured":"Sellars WA, South MA. Wiskott-Aldrich syndrome with 18-year survival. Treatment with transfer factor. Am J Dis Child. 1975;129(5):622\u20137.","journal-title":"Am J Dis Child"},{"issue":"4","key":"1810_CR129","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0002-9343(68)90051-X","volume":"44","author":"MD Cooper","year":"1968","unstructured":"Cooper MD, et al. Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med. 1968;44(4):499\u2013513.","journal-title":"Am J Med"},{"issue":"1","key":"1810_CR130","first-page":"48","volume":"28","author":"S Pasic","year":"2006","unstructured":"Pasic S, et al. Burkitt lymphoma-induced ileocolic intussusception in Wiskott-Aldrich syndrome. J Pediatr Hematol Oncol. 2006;28(1):48\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1810_CR131","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00431-006-0107-2","volume":"165","author":"C Picard","year":"2006","unstructured":"Picard C, et al. Kaposi\u2019s sarcoma in a child with Wiskott-Aldrich syndrome. Eur J Pediatr. 2006;165:453\u20137.","journal-title":"Eur J Pediatr"},{"issue":"12","key":"1810_CR132","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3324\/haematol.2016.147116","volume":"101","author":"A Attarbaschi","year":"2016","unstructured":"Attarbaschi A, et al. Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents. Haematologica. 2016;101(12):1581.","journal-title":"Haematologica"},{"issue":"6","key":"1810_CR133","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S0022-3476(05)82002-5","volume":"125","author":"KE Sullivan","year":"1994","unstructured":"Sullivan KE, et al. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125(6):876\u201385.","journal-title":"J Pediatr"},{"issue":"2","key":"1810_CR134","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/RLU.0000000000004020","volume":"47","author":"C Li","year":"2022","unstructured":"Li C, et al. FDG PET\/CT demonstrated Epstein-Barr virus\u2013associated leiomyosarcoma in a pediatric patient with Wiskott-Aldrich syndrome. Clin Nucl Med. 2022;47(2):190\u20131.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"1810_CR135","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0022-3476(80)80133-8","volume":"97","author":"GS Perry","year":"1980","unstructured":"Perry GS, et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892\u20131979). J Pediatr. 1980;97(1):72\u20138.","journal-title":"J Pediatr"},{"key":"1810_CR136","doi-asserted-by":"publisher","first-page":"1062261","DOI":"10.3389\/fimmu.2022.1062261","volume":"13","author":"X Sun","year":"2023","unstructured":"Sun X, et al. Sinonasal diffuse large B-cell lymphoma in a patient with Wiskott-Aldrich syndrome: a case report and literature review. Front Immunol. 2023;13:1062261.","journal-title":"Front Immunol"},{"issue":"2","key":"1810_CR137","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/pbc.23393","volume":"59","author":"P Coccia","year":"2012","unstructured":"Coccia P, et al. Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome. Pediatr Blood Cancer. 2012;59(2):318\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1810_CR138","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10875-022-01367-6","volume":"43","author":"S Senthil","year":"2023","unstructured":"Senthil S, et al. Wiskott aldrich syndrome-2 caused by novel Wiskott Aldrich syndrome protein-interacting protein (WIP) deficiency is associated with juvenile myelomonocytic leukaemia\u2014a case report. J Clin Immunol. 2023;43(1):82\u20134.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1810_CR139","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/0002-9343(78)90744-1","volume":"65","author":"FP Li","year":"1978","unstructured":"Li FP, et al. A family with acute leukemia, hypoplastic anemia and cerebellar ataxia: association with bone marrow C-monosomy. Am J Med. 1978;65(6):933\u201340.","journal-title":"Am J Med"},{"issue":"1","key":"1810_CR140","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cancergencyto.2005.12.013","volume":"168","author":"JT Sandlund","year":"2006","unstructured":"Sandlund JT, et al. A subtle t(3;8) results in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma\/leukemia and ataxia-telangiectasia. Cancer Genet Cytogenet. 2006;168(1):69\u201372.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"1810_CR141","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00005792-196405000-00021","volume":"43","author":"RR Young","year":"1964","unstructured":"Young RR, Austen KF, Moser HW. Abnormalities of serum gamma 1A globulin and ataxia telangiectasia. Medicine. 1964;43(2):423.","journal-title":"Medicine"},{"issue":"10","key":"1810_CR142","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/sj.leu.2402210","volume":"15","author":"N Viniou","year":"2001","unstructured":"Viniou N, et al. Acute myeloid leukemia in a patient with ataxia-telangiectasia: a case report and review of the literature. Leukemia. 2001;15(10):1668\u201370.","journal-title":"Leukemia"},{"issue":"3","key":"1810_CR143","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0090-4295(97)00244-6","volume":"50","author":"CR deVries","year":"1997","unstructured":"deVries CR, Kaplan GW. An unusual case of urinary incontinence, ataxiatelangiectasia, and metastatic dysgerminoma: case report and review of the literature. Urology. 1997;50(3):453\u20135.","journal-title":"Urology"},{"issue":"2","key":"1810_CR144","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jso.2930390214","volume":"39","author":"C Mock","year":"1988","unstructured":"Mock C, et al. Ataxia telangiectasia and acinic cell carcinoma of the parotid gland. J Surg Oncol. 1988;39(2):133\u20138.","journal-title":"J Surg Oncol"},{"issue":"6","key":"1810_CR145","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/030089168106700613","volume":"67","author":"G Pastore","year":"1981","unstructured":"Pastore G, Cordero di Montezemolo L, Madon E. Ataxia telangiectasia and acute lymphoblastic leukemia: report of a case. Tumori. 1981;67(6):585\u20137.","journal-title":"Tumori"},{"issue":"2","key":"1810_CR146","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3109\/08880019509029550","volume":"12","author":"MW Ben Arush","year":"1995","unstructured":"Ben Arush MW, et al. Ataxia telangiectasia and lymphoma: an indication for individualized chemotherapy dosing\u2014report of treatment in a highly inbred Arab family. Pediatr Hematol Oncol. 1995;12(2):163\u20139.","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"1810_CR147","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/bjc.1992.208","volume":"66","author":"AM Taylor","year":"1992","unstructured":"Taylor AM. Ataxia telangiectasia genes and predisposition to leukaemia, lymphoma and breast cancer. Br J Cancer. 1992;66(1):5\u20139.","journal-title":"Br J Cancer"},{"issue":"6","key":"1810_CR148","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpedi.1967.02090270073006","volume":"114","author":"SP Gotoff","year":"1967","unstructured":"Gotoff SP, Amirmokri E, Liebner EJ. Ataxia telangiectasia. Neoplasia, untoward response to x-irradiation, and tuberous sclerosis. Am J Dis Child. 1967;114(6):617\u201325.","journal-title":"Am J Dis Child"},{"issue":"665","key":"1810_CR149","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1259\/0007-1285-56-665-343","volume":"56","author":"R Abadir","year":"1983","unstructured":"Abadir R, Hakami N. Ataxia telangiectasia with cancer. An indication for reduced radiotherapy and chemotherapy doses. Br J Radiol. 1983;56(665):343\u20135.","journal-title":"Br J Radiol"},{"issue":"6","key":"1810_CR150","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/1097-0142(19840915)54:6<1113::AID-CNCR2820540632>3.0.CO;2-C","volume":"54","author":"T Narita","year":"1984","unstructured":"Narita T, Takagi KJC. Ataxia\u2013telangiectasia with dysgerminoma of right ovary, papillary carcinoma of thyroid, and adenocarcinoma of pancreas. Cancer. 1984;54(6):1113\u20136.","journal-title":"Cancer"},{"issue":"1","key":"1810_CR151","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0165-4608(81)90005-4","volume":"4","author":"R Bernstein","year":"1981","unstructured":"Bernstein R, Pinto M, Jenkins T. Ataxia telangiectasia with evolution of monosomy 14 and emergence of Hodgkin\u2019s disease. Cancer Genet Cytogenet. 1981;4(1):31\u20137.","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"1810_CR152","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0022-3476(70)80011-7","volume":"77","author":"RD Feigin","year":"1970","unstructured":"Feigin RD, et al. Ataxia telangiectasia with granulocytopenia. J Pediatr. 1970;77(3):431\u20138.","journal-title":"J Pediatr"},{"issue":"6","key":"1810_CR153","first-page":"546","volume":"46","author":"MM Patil","year":"2009","unstructured":"Patil MM, Patil SV. Ataxia telangiectasia with hepatocellular carcinoma. Indian Pediatr. 2009;46(6):546.","journal-title":"Indian Pediatr"},{"issue":"1","key":"1810_CR154","first-page":"51","volume":"26","author":"Y Sakiyama","year":"1984","unstructured":"Sakiyama Y, et al. Ataxia telangiectasia with persistent epstein-barr virus infection and malignant lymphome. Pediatr Int. 1984;26(1):51\u20135.","journal-title":"Pediatr Int"},{"issue":"3","key":"1810_CR155","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0387-7604(81)80051-4","volume":"3","author":"SI Pascual-Pascual","year":"1981","unstructured":"Pascual-Pascual SI, et al. Ataxia-telangiectasia (AT). Contribution with eighteen personal cases. Brain Dev. 1981;3(3):289\u201396.","journal-title":"Brain Dev"},{"issue":"2","key":"1810_CR156","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0090-8258(88)90219-3","volume":"29","author":"S Pecorelli","year":"1988","unstructured":"Pecorelli S, et al. Ataxia-telangiectasia and endodermal sinus tumor of the ovary: report of a case. Gynecol Oncol. 1988;29(2):240\u20134.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1810_CR157","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00000441-197909000-00008","volume":"278","author":"A Al Saadi","year":"1979","unstructured":"Al Saadi A, Yang SS, McCaughey RS. Ataxia-telangiectasia and hepatocellular carcinoma. Am J Med Sci. 1979;278(2):157\u201360.","journal-title":"Am J Med Sci"},{"issue":"3","key":"1810_CR158","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1651-2227.1982.tb09462.x","volume":"71","author":"T Sugimoto","year":"1982","unstructured":"Sugimoto T, et al. Ataxia-telangiectasia associated with non-T, non-B cell acute lymphocytic leukemia. Acta Paediatr Scand. 1982;71(3):509\u201310.","journal-title":"Acta Paediatr Scand"},{"issue":"4","key":"1810_CR159","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.pediatrneurol.2006.05.011","volume":"35","author":"AT Masri","year":"2006","unstructured":"Masri AT, et al. Ataxia-telangiectasia complicated by craniopharyngioma\u2013a new observation. Pediatr Neurol. 2006;35(4):287\u20138.","journal-title":"Pediatr Neurol"},{"issue":"7344","key":"1810_CR160","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0140-6736(64)91209-7","volume":"1","author":"RD Peterson","year":"1964","unstructured":"Peterson RD, Kelly WD, Good RA. Ataxia-telangiectasia. Its association with a defective thymus, immunological-deficiency disease, and malignancy. Lancet. 1964;1(7344):1189\u201393.","journal-title":"Lancet"},{"issue":"5","key":"1810_CR161","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/archopht.1967.00980020584004","volume":"77","author":"RD Harley","year":"1967","unstructured":"Harley RD, Baird HW, Craven EM. Ataxia-telangiectasia. Report of seven cases. Arch Ophthalmol. 1967;77(5):582\u201392.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"1810_CR162","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/00005072-197911000-00007","volume":"38","author":"GD Amromin","year":"1979","unstructured":"Amromin GD, Boder E, Teplitz R. Ataxia-telangiectasia with a 32 year survival. A clinicopathological report. J Neuropathol Exp Neurol. 1979;38(6):621\u201343.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"1810_CR163","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1001\/jama.1969.03160360030006","volume":"210","author":"AF Haerer","year":"1969","unstructured":"Haerer AF, Jackson JF, Evers CG. Ataxia-telangiectasia with gastric adenocarcinoma. JAMA. 1969;210(10):1884\u20137.","journal-title":"JAMA"},{"issue":"5","key":"1810_CR164","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/1097-0142(197511)36:5<1838::AID-CNCR2820360540>3.0.CO;2-K","volume":"36","author":"CI Goldsmith","year":"1975","unstructured":"Goldsmith CI, Hart WR. Ataxia-telangiectasia with ovarian gonadoblastoma and contralateral dysgerminoma. Cancer. 1975;36(5):1838\u201342.","journal-title":"Cancer"},{"issue":"1","key":"1810_CR165","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF00428672","volume":"389","author":"F Yoshitomi","year":"1980","unstructured":"Yoshitomi F, Zaitsu Y, Tanaka K. Ataxia-telangiectasia with renal cell carcinoma and hepatoma. Virchows Arch A Pathol Anat Histol. 1980;389(1):119\u201325.","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"4","key":"1810_CR166","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1017\/S0317167100007794","volume":"36","author":"RA Yanofsky","year":"2009","unstructured":"Yanofsky RA, et al. Ataxia-telangiectasia: atypical presentation and toxicity of cancer treatment. Can J Neurol Sci. 2009;36(4):462\u20137.","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"1810_CR167","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1182\/blood.V52.5.1003.1003","volume":"52","author":"R Levitt","year":"1978","unstructured":"Levitt R, et al. Atypical lymphoid leukemia in ataxia telangiectasia. Blood. 1978;52(5):1003\u201311.","journal-title":"Blood"},{"issue":"4","key":"1810_CR168","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/MPH.0000000000001471","volume":"42","author":"A Bahadir","year":"2020","unstructured":"Bahadir A, et al. Bladder artery embolization for massive hematuria treatment in a patient with ataxia-telangiectasia acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2020;42(4):316\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"1810_CR169","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1651-2227.2008.00736.x","volume":"97","author":"JM Cohen","year":"2008","unstructured":"Cohen JM, Cuckow P, Davies EG. Bladder wall telangiectasis causing life-threatening haematuria in ataxia-telangiectasia: a new observation. Acta Paediatr. 2008;97(5):667\u20139.","journal-title":"Acta Paediatr"},{"issue":"4","key":"1810_CR170","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/1097-0142(197610)38:4<1781::AID-CNCR2820380454>3.0.CO;2-M","volume":"38","author":"SE Siegel","year":"1976","unstructured":"Siegel SE, et al. Carcinoma of the stomach in childhood. Cancer. 1976;38(4):1781\u20134.","journal-title":"Cancer"},{"issue":"3","key":"1810_CR171","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/088800102753541314","volume":"19","author":"RY Tamminga","year":"2002","unstructured":"Tamminga RY, et al. Chemo- and radiosensitivity testing in a patient with ataxia telangiectasia and Hodgkin disease. Pediatr Hematol Oncol. 2002;19(3):163\u201371.","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"1810_CR172","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1203\/00006450-196909000-00001","volume":"3","author":"RJPR Miller","year":"1969","unstructured":"Miller RJPR. Childhood Cancer and Congenital Defects A Study of US Death Certificates During the Period 1960\u20131966. Pediatr Res. 1969;3(5):389\u201397.","journal-title":"Pediatr Res"},{"issue":"1","key":"1810_CR173","first-page":"11","volume":"4","author":"KM Jo","year":"2016","unstructured":"Jo KM, et al. Childhood colon cancer in a patient with ataxia telangiectasia. Ann Transl Med. 2016;4(1):11.","journal-title":"Ann Transl Med"},{"issue":"4","key":"1810_CR174","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0165-4608(82)90091-7","volume":"6","author":"N Wake","year":"1982","unstructured":"Wake N, et al. Chromosomes and causation of human cancer and leukemia. XLVIII. T-cell acute leukemia in ataxia telangiectasia. Cancer Genet Cytogenet. 1982;6(4):345\u20137.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"1810_CR175","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10875-015-0226-5","volume":"36","author":"SOL Reyes","year":"2016","unstructured":"Reyes SOL, et al. Clinical features, non-infectious manifestations and survival analysis of 161 children with primary immunodeficiency in Mexico: a single center experience over two decades. J Clin Immunol. 2016;36(1):56\u201365.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1810_CR176","doi-asserted-by":"publisher","first-page":"113","DOI":"10.25002\/tji.2019.1168","volume":"7","author":"O Boyarchuk","year":"2019","unstructured":"Boyarchuk O, Dmytrash L. Clinical manifestations in the patients with primary immunodeficiencies: Data from one regional center. Turk J Immunol. 2019;7(3):113\u20139.","journal-title":"Turk J Immunol"},{"issue":"12","key":"1810_CR177","first-page":"682","volume":"22","author":"S Alyasin","year":"2019","unstructured":"Alyasin S, et al. Clinical Presentation of Ataxia-Telangiectasia. Arch Iran Med. 2019;22(12):682\u20136.","journal-title":"Arch Iran Med"},{"issue":"4","key":"1810_CR178","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/ijc.2910370407","volume":"37","author":"AM Taylor","year":"1986","unstructured":"Taylor AM, Butterworth SV. Clonal evolution of T-cell chronic lymphocytic leukaemia in a patient with ataxia telangiectasia. Int J Cancer. 1986;37(4):511\u20136.","journal-title":"Int J Cancer"},{"issue":"3","key":"1810_CR179","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0190-9622(84)80089-4","volume":"10","author":"LE Cohen","year":"1984","unstructured":"Cohen LE, et al. Common and uncommon cutaneous findings in patients with ataxia-telangiectasia. J Am Acad Dermatol. 1984;10(3):431\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1810_CR180","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2230.1993.tb02251.x","volume":"18","author":"R Joshi","year":"1993","unstructured":"Joshi R, et al. Cutaneous granuloma with ataxia telangiectasia\u2014a case report and review of literature. Clin Exp Dermatol. 1993;18(5):458\u2013561.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"1810_CR181","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000330335","volume":"223","author":"LY Chiam","year":"2011","unstructured":"Chiam LY, et al. Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: reflection of inappropriate immune regulation? Dermatology. 2011;223(1):13\u20139.","journal-title":"Dermatology"},{"issue":"4","key":"1810_CR182","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0165-4608(80)90041-2","volume":"1","author":"RS Sparkes","year":"1980","unstructured":"Sparkes RS, et al. Cytogenetic abnormalities in ataxia telangiectasia with T-cell chronic lymphocytic leukemia. Cancer Genet Cytogen. 1980;1(4):329\u201336.","journal-title":"Cancer Genet Cytogen"},{"issue":"6","key":"1810_CR183","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/ppul.10422","volume":"37","author":"C Sandoval","year":"2004","unstructured":"Sandoval C, Swift M. Cytomegalovirus pneumonitis in a patient with Hodgkin disease and ataxia-telangiectasia. Pediatr Pulmonol. 2004;37(6):559\u201360.","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"1810_CR184","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0165-4608(87)90055-0","volume":"26","author":"R Becher","year":"1987","unstructured":"Becher R, Duhrsen C. Distinct chromosome abnormalities in ataxia telangiectasia with chronic T-cell lymphocytic leukemia. Cancer Genet Cytogenet. 1987;26(2):217\u201325.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"1810_CR185","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10875-005-2822-2","volume":"25","author":"WI Lee","year":"2005","unstructured":"Lee WI, et al. Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J Clin Immunol. 2005;25(2):162\u201373.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1810_CR186","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/08880010701451434","volume":"24","author":"Y Koksal","year":"2007","unstructured":"Koksal Y, et al. Dysgerminoma in a child with ataxia\u2013telangiectasia. Pediatr Hematol Oncol. 2007;24(6):431\u20136.","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"1810_CR187","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1053\/hupa.2002.30214","volume":"33","author":"C Reyes","year":"2002","unstructured":"Reyes C, et al. Epstein-Barr virus\u2013associated smooth muscle tumors in ataxia-telangiectasia: a case report and review. Hum Pathol. 2002;33(1):133\u20136.","journal-title":"Hum Pathol"},{"issue":"6262","key":"1810_CR188","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/bmj.282.6262.425","volume":"282","author":"AK Saemundsen","year":"1981","unstructured":"Saemundsen AK, et al. Epstein-Barr-virus-carrying lymphoma in a patient with ataxia-telangiectasia. Br Med J (Clin Res Ed). 1981;282(6262):425\u20137.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"1810_CR189","first-page":"62","volume":"34","author":"H Irsfeld","year":"2000","unstructured":"Irsfeld H, et al. Fatal outcome in two girls with Hodgkin disease complicating ataxia-telangiectasia (Louis-Bar syndrome) despite favorable response to modified-dose chemotherapy. Commentary. 2000;34(1):62\u20136.","journal-title":"Commentary"},{"issue":"2","key":"1810_CR190","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/jmg.16.2.160","volume":"16","author":"MA Frais","year":"1979","unstructured":"Frais MA. Gastric adenocarcinoma due to ataxia-telangiectasia (Louis-Bar syndrome). J Med Genet. 1979;16(2):160\u20131.","journal-title":"J Med Genet"},{"key":"1810_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7819-7-29","volume":"7","author":"IA Otabor","year":"2009","unstructured":"Otabor IA, et al. Gastric outlet obstruction due to adenocarcinoma in a patient with Ataxia-Telangiectasia syndrome: a case report and review of the literature. World J Surg Oncol. 2009;7:1\u20135.","journal-title":"World J Surg Oncol"},{"issue":"2","key":"1810_CR192","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0022-3476(77)80828-7","volume":"91","author":"E Cameron","year":"1977","unstructured":"Cameron E, et al. Heat stable E-receptors on leukemic lymphoblasts in ataxia-telangiectasia. J Pediatr. 1977;91(2):269\u201371.","journal-title":"J Pediatr"},{"issue":"13","key":"1810_CR193","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1056\/NEJM197903293001303","volume":"300","author":"A Saxon","year":"1979","unstructured":"Saxon A, Stevens RH, Golde DW. Helper and suppressor t-lymphocyte leukemia in ataxia telangiectasia. N Engl J Med. 1979;300(13):700\u20134.","journal-title":"N Engl J Med"},{"issue":"3","key":"1810_CR194","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/pbc.22072","volume":"53","author":"NE Kaymaz","year":"2009","unstructured":"Kaymaz NE, et al. Hemorrhagic cystitis in a child with Hodgkin lymphoma and ataxia-telangiectasia after cyclophosphamide. Pediatr Blood Cancer. 2009;53(3):516.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1810_CR195","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/mpo.10251","volume":"40","author":"C Sandoval","year":"2003","unstructured":"Sandoval C, Swift M. Hodgkin disease in ataxia-telangiectasia patients with poor outcomes. Med Pediatr Oncol. 2003;40(3):162\u20136.","journal-title":"Med Pediatr Oncol"},{"key":"1810_CR196","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12308-010-0062-8","volume":"3","author":"JM Hummel","year":"2010","unstructured":"Hummel JM, Thorland EC, Lim MS. Hodgkin lymphoma in a young child contributing to a diagnosis of ataxia telangiectasia: review of the literature. J Hematopathology. 2010;3:69\u201376.","journal-title":"J Hematopathology"},{"issue":"5","key":"1810_CR197","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ppul.10057","volume":"33","author":"B Yal\u00e7in","year":"2002","unstructured":"Yal\u00e7in B, et al. Hodgkin\u2019s disease and ataxia telangiectasia with pulmonary cavities. Pediatr Pulmonol. 2002;33(5):399\u2013403.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"1810_CR198","first-page":"974576","volume":"2009","author":"M Spasova","year":"2009","unstructured":"Spasova M, et al. Hodgkin\u2032 s disease with atypical clinical presentation, associated with ataxia-telangiectasia. Sch Res Exch. 2009;2009(1):974576.","journal-title":"Sch Res Exch"},{"issue":"5","key":"1810_CR199","first-page":"907","volume":"33","author":"F Yoshitomi","year":"1983","unstructured":"Yoshitomi F, Tanaka K. Immunodeficiency-malignancy association at autopsy IN JAPAN. Acta Pathol Jpn. 1983;33(5):907\u201310.","journal-title":"Acta Pathol Jpn"},{"issue":"1","key":"1810_CR200","first-page":"69","volume":"110","author":"IM Rosenthal","year":"1965","unstructured":"Rosenthal IM, Markowitz AS, Medenis R. Immunologic Incompetence in Ataxia-Telangiectasia. Am J Dis Child. 1965;110(1):69\u201375.","journal-title":"Am J Dis Child"},{"issue":"6","key":"1810_CR201","first-page":"787","volume":"39","author":"JP Johnson","year":"1986","unstructured":"Johnson JP, et al. Inverted duplication of JH associated with chromosome 14 translocation and T-cell leukemia in ataxia-telangiectasia. Am J Hum Genet. 1986;39(6):787\u201396.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1810_CR202","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/08880019109033457","volume":"8","author":"F Mouchet","year":"1991","unstructured":"Mouchet F, et al. Leiomyoma of the suprarenal gland in a child with ataxia-telangiectasia. Pediatr Hematol Oncol. 1991;8(3):235\u201341.","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"1810_CR203","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1182\/blood.V87.2.423.bloodjournal872423","volume":"87","author":"AM Taylor","year":"1996","unstructured":"Taylor AM, et al. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996;87(2):423\u201338.","journal-title":"Blood"},{"issue":"9","key":"1810_CR204","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/adc.63.9.1079","volume":"63","author":"JA Eyre","year":"1988","unstructured":"Eyre JA, Gardner-Medwin D, Summerfield GP. Leukoencephalopathy after prophylactic radiation for leukaemia in ataxia telangiectasia. Arch Dis Child. 1988;63(9):1079\u201380.","journal-title":"Arch Dis Child"},{"issue":"5","key":"1810_CR205","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/bmt.2012.207","volume":"48","author":"M Ussowicz","year":"2013","unstructured":"Ussowicz M, et al. Long-term survival after allogeneic-matched sibling PBSC transplantation with conditioning consisting of low-dose busilvex and fludarabine in a 3-year-old boy with ataxia-telangiectasia syndrome and ALL. Bone Marrow Transplant. 2013;48(5):740\u20131.","journal-title":"Bone Marrow Transplant"},{"issue":"23","key":"1810_CR206","doi-asserted-by":"publisher","first-page":"9287","DOI":"10.1073\/pnas.85.23.9287","volume":"85","author":"MP Davey","year":"1988","unstructured":"Davey MP, et al. Juxtaposition of the T-cell receptor alpha-chain locus (14q11) and a region (14q32) of potential importance in leukemogenesis by a 14;14 translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia-telangiectasia. Proc Natl Acad Sci U S A. 1988;85(23):9287\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1810_CR207","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/0002-9343(66)90080-5","volume":"41","author":"RD Peterson","year":"1966","unstructured":"Peterson RD, Cooper MD, Good RA. Lymphoid tissue abnormalities associated with ataxia-telangiectasia. Am J Med. 1966;41(3):342\u201359.","journal-title":"Am J Med"},{"issue":"1","key":"1810_CR208","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/ped.2014.0453","volume":"28","author":"T Patiroglu","year":"2015","unstructured":"Patiroglu T, et al. Malignancies in primary immunodeficiencies: a single center experience. Pediatr Allergy Immunol Pulmonol. 2015;28(1):47\u201354.","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"1","key":"1810_CR209","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ppul.22535","volume":"48","author":"C Rosas-Salazar","year":"2013","unstructured":"Rosas-Salazar C, Gunawardena SW, Spahr JE. Malignant pleural mesothelioma in a child with ataxia\u2013telangiectasia. Pediatr Pulmonol. 2013;48(1):94\u20137.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"1810_CR210","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/pde.14200","volume":"37","author":"S Oska","year":"2020","unstructured":"Oska S, et al. Melanoma arising in a patient with ataxia-telangiectasia: a call for full skin examinations in this patient population. Pediatr Dermatol. 2020;37(4):767\u20138.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"1810_CR211","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0092-8674(88)90495-3","volume":"53","author":"G Russo","year":"1988","unstructured":"Russo G, et al. Molecular analysis of at (7; 14)(g35; g32) chromosome translocation in a T cell leukemia of a patient with ataxia telangiectasia. Cell. 1988;53(1):137\u201344.","journal-title":"Cell"},{"key":"1810_CR212","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1093\/annonc\/11.suppl_1.S141","volume":"11","author":"K Seidemann","year":"2000","unstructured":"Seidemann K, et al. Non-Hodgkin\u2019s lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials. Ann Oncol. 2000;11:S141\u20135.","journal-title":"Ann Oncol"},{"issue":"7","key":"1810_CR213","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/00043426-200407000-00009","volume":"26","author":"A Makis","year":"2004","unstructured":"Makis A, Polychronopoulou S, Haidas S. Osteosarcoma as a second tumor after treatment for primary non-Hodgkin\u2019s lymphoma in a child with ataxia-telangiectasia: presentation of a case and review of possible pathogenetic mechanisms. J Pediatr Hematol\/Oncol. 2004;26(7):444\u20136.","journal-title":"J Pediatr Hematol\/Oncol"},{"issue":"5","key":"1810_CR214","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/pbc.21016","volume":"50","author":"B Brasseur","year":"2008","unstructured":"Brasseur B, et al. Papillary thyroid carcinoma in a 9-year-old girl with ataxia-telangiectasia. Pediatr Blood Cancer. 2008;50(5):1058\u201360.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"1810_CR215","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/088800101753328448","volume":"18","author":"C Sandoval","year":"2001","unstructured":"Sandoval C, et al. Parotid and thyroid gland cancers in patients with ataxia-telangiectasia. Pediatr Hematol Oncol. 2001;18(8):485\u201390.","journal-title":"Pediatr Hematol Oncol"},{"issue":"4","key":"1810_CR216","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/00005072-196810000-00009","volume":"27","author":"MJ Aguilar","year":"1968","unstructured":"Aguilar MJ, et al. Pathological observations in ataxia-telangiectasia. A report of five cases. J Neuropathol Exp Neurol. 1968;27(4):659\u201376.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1810_CR217","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2214\/ajr.123.1.144","volume":"123","author":"GD Shackelford","year":"1975","unstructured":"Shackelford GD, Mcalister WH. Primary immunodeficiency diseases and malignancy. Am J Roentgenol. 1975;123(1):144\u201353.","journal-title":"Am J Roentgenol"},{"issue":"5","key":"1810_CR218","first-page":"557","volume":"116","author":"JL Morgan","year":"1968","unstructured":"Morgan JL, Holcomb TM, Morrissey RW. Radiation reaction in ataxia telangiectasia. Am J Dis Child. 1968;116(5):557\u20138.","journal-title":"Am J Dis Child"},{"issue":"3","key":"1810_CR219","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/00004728-198905000-00039","volume":"13","author":"C Levine","year":"1989","unstructured":"Levine C, Vrlenich L. Renal lymphoma in ataxia-telangiectasia: CT contribution. J Comput Assist Tomogr. 1989;13(3):537\u20139.","journal-title":"J Comput Assist Tomogr"},{"key":"1810_CR220","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10875-018-0581-0","volume":"39","author":"D Buchbinder","year":"2019","unstructured":"Buchbinder D, et al. Rubella virus-associated cutaneous granulomatous disease: a unique complication in immune-deficient patients, not limited to DNA repair disorders. J Clin Immunol. 2019;39:81\u20139.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1810_CR221","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1620\/tjem.121.127","volume":"121","author":"A Watanabe","year":"1977","unstructured":"Watanabe A, et al. Stomach cancer of a 14-year-old boy with ataxia-telangiectasia. Tohoku J Exp Med. 1977;121(2):127\u201331.","journal-title":"Tohoku J Exp Med"},{"issue":"6","key":"1810_CR222","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/MPH.0b013e3182804d59","volume":"35","author":"S Machida","year":"2013","unstructured":"Machida S, et al. Successful treatment of diffuse large B-cell lymphoma in a patient with ataxia telangiectasia using rituximab. J Pediatr Hematol\/Oncol. 2013;35(6):482\u20135.","journal-title":"J Pediatr Hematol\/Oncol"},{"issue":"4","key":"1810_CR223","first-page":"486","volume":"40","author":"E Kang","year":"2015","unstructured":"Kang E, Jung JW. Sugammadex reversal of rocuronium-induced neuromuscular block in a patient with ataxia-telangiectasia. Rawal Med J. 2015;40(4):486\u20138.","journal-title":"Rawal Med J"},{"issue":"04","key":"1810_CR224","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-2008-1066517","volume":"6","author":"P O\u011fuzkurt","year":"1996","unstructured":"O\u011fuzkurt P, et al. Splenic leiomyoma: an uncommon localization. European J Pediatr Surg. 1996;6(04):235\u20137.","journal-title":"European J Pediatr Surg"},{"issue":"10","key":"1810_CR225","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/MPH.0b013e31814d67f4","volume":"29","author":"D Janic","year":"2007","unstructured":"Janic D, et al. T-cell acute lymphoblastic leukemia in a child with ataxia-telangiectasia: case report. J Pediatr Hematol Oncol. 2007;29(10):713\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"1810_CR226","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1053\/clon.1999.9013","volume":"11","author":"HA Phillips","year":"1999","unstructured":"Phillips HA, Howard GC. Testicular seminoma in a patient with ataxia-telangiectasia. Clin Oncol (R Coll Radiol). 1999;11(1):63\u20134.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"1810_CR227","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7326\/0003-4819-66-3-507","volume":"66","author":"DG Miller","year":"1967","unstructured":"Miller DG. The association of immune disease and malignant lymphoma. Ann Intern Med. 1967;66(3):507\u201321.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1810_CR228","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/1097-0142(19820901)50:5<877::AID-CNCR2820500513>3.0.CO;2-U","volume":"50","author":"J Pritchard","year":"1982","unstructured":"Pritchard J, Sandland MR, Breatnach FB, Pincott JR, Cox R, Husband P. The effects of radiation therapy for Hodgkin\u2019s disease in a child with ataxia telangiectasia. A clinical, biological and pathologic study. Cancer. 1982;50(5):877\u201386.","journal-title":"Cancer"},{"issue":"3","key":"1810_CR229","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.transci.2013.04.001","volume":"48","author":"M Keklik","year":"2013","unstructured":"Keklik M, et al. The management of hyperleukocytosis in an adult patient with acute lymphoblastic leukemia and ataxia-telangiectasia. Transfus Apher Sci. 2013;48(3):293\u20135.","journal-title":"Transfus Apher Sci"},{"issue":"6","key":"1810_CR230","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/(SICI)1096-911X(199912)33:6<536::AID-MPO3>3.0.CO;2-Z","volume":"33","author":"K Seidemann","year":"1999","unstructured":"Seidemann K, et al. Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials. Med Pediatr Oncol. 1999;33(6):536\u201344.","journal-title":"Med Pediatr Oncol"},{"issue":"6","key":"1810_CR231","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/(SICI)1096-911X(199812)31:6<491::AID-MPO5>3.0.CO;2-B","volume":"31","author":"C Sandoval","year":"1998","unstructured":"Sandoval C, Swift M. Treatment of lymphoid malignancies in patients with ataxia-telangiectasia. Med Pediatr Oncol. 1998;31(6):491\u20137.","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"1810_CR232","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0090-8258(89)80045-9","volume":"32","author":"RA Gatti","year":"1989","unstructured":"Gatti RA, Nieberg R, Boder E. Uterine tumors in ataxia-telangiectasia. Gynecol Oncol. 1989;32(2):257\u201360.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1810_CR233","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0733-8635(18)30100-1","volume":"13","author":"RA Gatti","year":"1995","unstructured":"Gatti RA. Ataxia-telangiectasia. Dermatol Clin. 1995;13(1):1\u20136.","journal-title":"Dermatol Clin"},{"issue":"7","key":"1810_CR234","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00251-017-0983-9","volume":"69","author":"E Mortaz","year":"2017","unstructured":"Mortaz E, et al. A new ataxia-telangiectasia mutation in an 11-year-old female. Immunogenetics. 2017;69(7):415\u20139.","journal-title":"Immunogenetics"},{"issue":"6","key":"1810_CR235","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3109\/08880018.2013.777949","volume":"30","author":"B Bielorai","year":"2013","unstructured":"Bielorai B, et al. Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant. Pediatr Hematol Oncol. 2013;30(6):574\u201382.","journal-title":"Pediatr Hematol Oncol"},{"issue":"4","key":"1810_CR236","doi-asserted-by":"publisher","first-page":"442","DOI":"10.24953\/turkjped.2016.04.018","volume":"58","author":"E Ulusoy","year":"2016","unstructured":"Ulusoy E, et al. An unusual manifestation: Papillary thyroid carcinoma in a patient with ataxia-telengiectasia. Turk J Pediatr. 2016;58(4):442\u20135.","journal-title":"Turk J Pediatr"},{"issue":"4","key":"1810_CR237","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/MPH.0b013e31828fccdf","volume":"35","author":"A P\u00e9rez-Villena","year":"2013","unstructured":"P\u00e9rez-Villena A, et al. Ataxia-telangiectasia and wilms tumor: reduced treatment but early relapse. J Pediatr Hematol\/Oncol. 2013;35(4):308\u201310.","journal-title":"J Pediatr Hematol\/Oncol"},{"issue":"11","key":"1810_CR238","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.12998\/wjcc.v8.i11.2387","volume":"8","author":"XL Li","year":"2020","unstructured":"Li XL, Wang YL. Ataxia-telangiectasia complicated with Hodgkin\u2019s lymphoma: a case report. World J Clin Cases. 2020;8(11):2387\u201391.","journal-title":"World J Clin Cases"},{"issue":"5","key":"1810_CR239","first-page":"493","volume":"9","author":"F Ye","year":"2018","unstructured":"Ye F, et al. Ataxia-telangiectasia with a novel ATM gene mutation and Burkitt leukemia: a case report. Mol Clin Oncol. 2018;9(5):493\u20138.","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"1810_CR240","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1097\/MPH.0b013e3181bfd3d9","volume":"32","author":"BM Pietrucha","year":"2010","unstructured":"Pietrucha BM, et al. Ataxia-telangiectasia with hyper-IgM and Wilms tumor: fatal reaction to irradiation. J Pediatr Hematol Oncol. 2010;32(1):e28-30.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1810_CR241","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.clim.2017.01.009","volume":"178","author":"NJH van Os","year":"2017","unstructured":"van Os NJH, et al. Ataxia-telangiectasia: immunodeficiency and survival. Clin Immunol. 2017;178:45\u201355.","journal-title":"Clin Immunol"},{"issue":"1","key":"1810_CR242","first-page":"615368","volume":"2015","author":"FD Ayg\u00fcn","year":"2015","unstructured":"Ayg\u00fcn FD, et al. Bladder wall telangiectasia in a patient with ataxia-telangiectasia and how to manage? Case Rep Pediatr. 2015;2015(1):615368.","journal-title":"Case Rep Pediatr"},{"issue":"1","key":"1810_CR243","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3174\/ajnr.A3646","volume":"35","author":"DD Lin","year":"2014","unstructured":"Lin DD, et al. Cerebral abnormalities in adults with ataxia-telangiectasia. AJNR Am J Neuroradiol. 2014;35(1):119\u201323.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"14","key":"1810_CR244","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1200\/JCO.2009.25.5067","volume":"28","author":"CH Lin","year":"2010","unstructured":"Lin CH, et al. Child with ataxia telangiectasia developing acute myeloid leukemia. J Clin Oncol. 2010;28(14):e213\u20134.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1810_CR245","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1212\/WNL.0b013e3181af33bd","volume":"73","author":"MM Verhagen","year":"2009","unstructured":"Verhagen MM, et al. Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology. 2009;73(6):430\u20137.","journal-title":"Neurology"},{"issue":"8","key":"1810_CR246","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1097\/MPH.0b013e318279b3f7","volume":"35","author":"T Patiroglu","year":"2013","unstructured":"Patiroglu T, et al. Gastric signet ring carcinoma in a patient with ataxia-telangiectasia: a case report and review of the literature. J Pediatr Hematol Oncol. 2013;35(8):e341\u20133.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"1810_CR247","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ana.25394","volume":"85","author":"K Schon","year":"2019","unstructured":"Schon K, et al. Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasia. Ann Neurol. 2019;85(2):170\u201380.","journal-title":"Ann Neurol"},{"issue":"1","key":"1810_CR248","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08923973.2011.567989","volume":"34","author":"V Cecinati","year":"2012","unstructured":"Cecinati V, et al. Hepatic non-Hodgkin lymphoma and hepatoblastoma complicating ataxia-telangiectasia. Immunopharmacol Immunotoxicol. 2012;34(1):1\u20133.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"6","key":"1810_CR249","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1097\/MPH.0000000000001537","volume":"42","author":"MF Jacobs","year":"2020","unstructured":"Jacobs MF, et al. Hepatosplenic alpha\/beta T-cell lymphoma as second malignancy in young adult patient with previously undiagnosed ataxia-telangiectasia. J Pediatr Hematol Oncol. 2020;42(6):e463.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8","key":"1810_CR250","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.1097\/MPH.0000000000001294","volume":"40","author":"A Mijalovsky","year":"2018","unstructured":"Mijalovsky A, et al. Malignant peritoneal mesothelioma in an infant with familial ATM mutations. J Pediatr Hematol Oncol. 2018;40(8):e511\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"1810_CR251","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/jhg.2017.6","volume":"62","author":"J Roohi","year":"2017","unstructured":"Roohi J, et al. New diagnosis of atypical ataxia-telangiectasia in a 17-year-old boy with T-cell acute lymphoblastic leukemia and a novel ATM mutation. J Hum Genet. 2017;62(5):581\u20134.","journal-title":"J Hum Genet"},{"issue":"2","key":"1810_CR252","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.jpag.2012.09.003","volume":"26","author":"CS Danby","year":"2013","unstructured":"Danby CS, et al. Non-hodgkin B-cell lymphoma of the ovary in a child with Ataxia-telangiectasia. J Pediatr Adolesc Gynecol. 2013;26(2):e43\u20135.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"9","key":"1810_CR253","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.3109\/10428194.2011.577256","volume":"52","author":"A Brioli","year":"2011","unstructured":"Brioli A, et al. Patient with ataxia telangiectasia who developed acute myeloid leukemia. Leuk Lymphoma. 2011;52(9):1818\u201320.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"1810_CR254","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1097\/MPH.0000000000001672","volume":"43","author":"S-GK Sze","year":"2021","unstructured":"Sze S-GK, et al. Retrospective diagnosis of ataxia-telangiectasia in an adolescent patient with a remote history of t-cell leukemia. J Pediatr Hematol Oncol. 2021;43(1):e138\u201340.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"1810_CR255","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1365-2141.2011.08863.x","volume":"155","author":"K Bienemann","year":"2011","unstructured":"Bienemann K, et al. Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey. Br J Haematol. 2011;155(4):468\u201376.","journal-title":"Br J Haematol"},{"issue":"3","key":"1810_CR256","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/humu.22016","volume":"33","author":"MM Verhagen","year":"2012","unstructured":"Verhagen MM, et al. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype\u2013phenotype study. Hum Mutat. 2012;33(3):561\u201371.","journal-title":"Hum Mutat"},{"key":"1810_CR257","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s12185-009-0408-0","volume":"90","author":"T Morio","year":"2009","unstructured":"Morio T, et al. Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan. Int J Lab Hematol. 2009;90:455\u201362.","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"1810_CR258","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jaci.2011.03.052","volume":"128","author":"R Micol","year":"2011","unstructured":"Micol R, et al. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. J Allergy Clin Immunol. 2011;128(2):382\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1810_CR259","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1046\/j.1365-2559.2001.01039.x","volume":"38","author":"D Canioni","year":"2001","unstructured":"Canioni D, et al. Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria. Histopathology. 2001;38(2):146\u201359.","journal-title":"Histopathology"},{"issue":"8","key":"1810_CR260","first-page":"1228","volume":"116","author":"CM Vajdic","year":"2010","unstructured":"Vajdic CM, et al. Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency? Blood J Am Soc Hematol. 2010;116(8):1228\u201334.","journal-title":"Blood J Am Soc Hematol"},{"issue":"2","key":"1810_CR261","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/jnci\/93.2.121","volume":"93","author":"JH Olsen","year":"2001","unstructured":"Olsen JH, et al. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst. 2001;93(2):121\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1810_CR262","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2007.03.002","volume":"37","author":"M Moin","year":"2007","unstructured":"Moin M, et al. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurol. 2007;37(1):21\u20138.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"1810_CR263","first-page":"89","volume":"77","author":"D Morrell","year":"1986","unstructured":"Morrell D, Cromartie E, Swift M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst. 1986;77(1):89\u201392.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1810_CR264","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0165-4608(90)90003-S","volume":"46","author":"F Hecht","year":"1990","unstructured":"Hecht F, Hecht BK. Cancer in ataxia-telangiectasia patients. Cancer Genet Cytogen. 1990;46(1):9\u201319.","journal-title":"Cancer Genet Cytogen"},{"issue":"4","key":"1810_CR265","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jpeds.2003.12.046","volume":"144","author":"A Nowak-Wegrzyn","year":"2004","unstructured":"Nowak-Wegrzyn A, et al. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr. 2004;144(4):505\u201311.","journal-title":"J Pediatr"},{"issue":"1","key":"1810_CR266","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/ped.2017.0788","volume":"31","author":"AS Sasihuseyinoglu","year":"2018","unstructured":"Sasihuseyinoglu AS, et al. Ataxia-telangiectasia clinical and laboratory features: single center results. Pediatr Allergy Immunol Pulmonol. 2018;31(1):9\u201314.","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"4","key":"1810_CR267","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/bjc.2011.266","volume":"105","author":"A Reiman","year":"2011","unstructured":"Reiman A, et al. Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours. Br J Cancer. 2011;105(4):586\u201391.","journal-title":"Br J Cancer"},{"issue":"7","key":"1810_CR268","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/1097-0142(19800401)45:7<1675::AID-CNCR2820450725>3.0.CO;2-D","volume":"45","author":"SR Toledano","year":"1980","unstructured":"Toledano SR, Lange BJ. Ataxia-telangiectasia and acute lymphoblastic leukemia. Cancer. 1980;45(7):1675\u20138.","journal-title":"Cancer"},{"key":"1810_CR269","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s002470050578","volume":"29","author":"RC Murphy","year":"1999","unstructured":"Murphy RC, et al. Malignancies in pediatric patients with ataxia telangiectasia. Pediatr Radiol. 1999;29:225\u201330.","journal-title":"Pediatr Radiol"},{"issue":"1","key":"1810_CR270","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1200\/JCO.2011.40.1430","volume":"31","author":"MD DeWire","year":"2013","unstructured":"DeWire MD, et al. Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia: a case report and review of the literature. J Clin Oncol. 2013;31(1):e12.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1810_CR271","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1097\/MPH.0000000000002039","volume":"44","author":"D \u00d6zy\u00f6r\u00fck","year":"2022","unstructured":"\u00d6zy\u00f6r\u00fck D, et al. The development of chylothorax in a child with T-cell lymphoblastic lymphoma and ataxia telangiectasia during induction therapy. J Pediatr Hematol\/Oncol. 2022;44(2):e554\u20136.","journal-title":"J Pediatr Hematol\/Oncol"},{"issue":"1","key":"1810_CR272","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5578\/tt.20229912","volume":"70","author":"I Sak","year":"2022","unstructured":"Sak I, et al. The investigated case of etiology of chylous pleural effusion: ataxia-telangiectasia. Tuberkuloz ve Toraks. 2022;70(1):102\u20136.","journal-title":"Tuberkuloz ve Toraks"},{"issue":"6","key":"1810_CR273","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/pai.13461","volume":"32","author":"P Amirifar","year":"2021","unstructured":"Amirifar P, et al. The spectrum of ATM gene mutations in Iranian patients with ataxia-telangiectasia. Pediatr Allergy Immunol. 2021;32(6):1316\u201326.","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"1810_CR274","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/bjh.17736","volume":"194","author":"S Bakhtiar","year":"2021","unstructured":"Bakhtiar S, et al. The incidence and type of cancer in patients with ataxia-telangiectasia via a retrospective single-centre study. Br J Haematol. 2021;194(5):879\u201387.","journal-title":"Br J Haematol"},{"issue":"18","key":"1810_CR275","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.1182\/bloodadvances.2021006654","volume":"6","author":"X Ye","year":"2022","unstructured":"Ye X, et al. Genomic characterization of lymphomas in patients with inborn errors of immunity. Blood Adv. 2022;6(18):5403\u201314.","journal-title":"Blood Adv"},{"issue":"12","key":"1810_CR276","doi-asserted-by":"publisher","first-page":"e29778","DOI":"10.1002\/pbc.29778","volume":"69","author":"LM Sneha","year":"2022","unstructured":"Sneha LM, et al. Ataxia-telangiectasia after hepatoblastoma: the reverse chronology. Pediatr Blood Cancer. 2022;69(12):e29778.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1810_CR277","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1200\/JCO.21.01495","volume":"40","author":"CM Dutzmann","year":"2022","unstructured":"Dutzmann CM, et al. Cancer in children with fanconi anemia and ataxia-telangiectasia-a nationwide register-based cohort study in Germany. J Clin Oncol. 2022;40(1):32\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1810_CR278","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/abr.abr_169_21","volume":"11","author":"R Sherkat","year":"2022","unstructured":"Sherkat R, et al. Spontaneous regression of diffuse large B-cell lymphoma in a patient with ataxia-telangiectasia. Adv Biomed Res. 2022;11(1):31.","journal-title":"Adv Biomed Res"},{"issue":"4","key":"1810_CR279","doi-asserted-by":"publisher","first-page":"bvac026","DOI":"10.1210\/jendso\/bvac026","volume":"6","author":"FY Miasaki","year":"2022","unstructured":"Miasaki FY, et al. Thyroid and breast cancer in 2 sisters with monoallelic mutations in the ataxia telangiectasia mutated (ATM) gene. J Endocrine Soc. 2022;6(4):bvac026.","journal-title":"J Endocrine Soc"},{"issue":"5","key":"1810_CR280","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000515696","volume":"12","author":"RS Rodriguez","year":"2021","unstructured":"Rodriguez RS, et al. Novel compound heterozygous mutation c. 3955_3958dup and c. 5825C> T in the ATM gene: clinical evidence of ataxia-telangiectasia and cancer in a peruvian family. Mol Syndromol. 2021;12(5):289\u201393.","journal-title":"Mol Syndromol"},{"key":"1810_CR281","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cancergen.2022.05.039","volume":"266","author":"MF Jacobs","year":"2022","unstructured":"Jacobs MF, et al. Homozygous ATM mutation due to germline uniparental isodisomy in patient with T acute lymphoblastic leukemia and hepatosplenic T-cell lymphoma. Cancer Genet. 2022;266:15\u20138.","journal-title":"Cancer Genet"},{"key":"1810_CR282","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejpn.2021.03.008","volume":"32","author":"J Bistritzer","year":"2021","unstructured":"Bistritzer J, et al. Phenotypic variability in patients with unique double homozygous mutations causing variant ataxia telangiectasia. Eur J Paediatr Neurol. 2021;32:36\u20139.","journal-title":"Eur J Paediatr Neurol"},{"key":"1810_CR283","doi-asserted-by":"publisher","first-page":"852937","DOI":"10.3389\/fimmu.2022.852937","volume":"13","author":"S Chandra","year":"2022","unstructured":"Chandra S, et al. Primary immunodeficiencies and hematologic malignancies: a diagnostic approach. Front Immunol. 2022;13:852937.","journal-title":"Front Immunol"},{"issue":"6","key":"1810_CR284","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12185-021-03203-w","volume":"114","author":"D Sato","year":"2021","unstructured":"Sato D, et al. Refractory T-cell\/histiocyte-rich large B-cell lymphoma in a patient with ataxia\u2013telangiectasia caused by novel compound heterozygous variants in ATM. Int J Hematol. 2021;114(6):735\u201341.","journal-title":"Int J Hematol"},{"issue":"11","key":"1810_CR285","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/ajh.26321","volume":"96","author":"ES Martin","year":"2021","unstructured":"Martin ES, et al. Spectrum of hematological malignancies, clonal evolution and outcomes in 144 mayo clinic patients with germline predisposition syndromes. Am J Hematol. 2021;96(11):1450\u201360.","journal-title":"Am J Hematol"},{"issue":"3","key":"1810_CR286","first-page":"95","volume":"48","author":"M Mizuno","year":"2023","unstructured":"Mizuno M, et al. Ataxia telangiectasia in a patient with breast cancer: a case report. Tokai J Exp Clin Med. 2023;48(3):95\u20138.","journal-title":"Tokai J Exp Clin Med"},{"issue":"1","key":"1810_CR287","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13256-023-04050-5","volume":"17","author":"D Abla","year":"2023","unstructured":"Abla D, et al. Spontaneous remission of angioimmunoblastic T-cell lymphoma in a child with ataxia\u2013telangiectasia: a case report. J Med Case Rep. 2023;17(1):347.","journal-title":"J Med Case Rep"},{"issue":"2","key":"1810_CR288","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3390\/ijms24021099","volume":"24","author":"J Czarny","year":"2023","unstructured":"Czarny J, et al. Successful treatment of large B-cell lymphoma in a child with compound heterozygous mutation in the ATM gene. Int J Mol Sci. 2023;24(2):1099.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1810_CR289","doi-asserted-by":"publisher","first-page":"e30535","DOI":"10.1002\/pbc.30535","volume":"70","author":"B Rivalta","year":"2023","unstructured":"Rivalta B, et al. Thyroid carcinoma in two patients with ataxia-telangiectasia: tailored diagnostic and therapeutic use of radioiodine. Pediatr Blood Cancer. 2023;70(10):e30535.","journal-title":"Pediatr Blood Cancer"},{"key":"1810_CR290","doi-asserted-by":"publisher","first-page":"1103726","DOI":"10.3389\/fped.2023.1103726","volume":"11","author":"A Ollech","year":"2023","unstructured":"Ollech A, et al. A horse or a zebra? Unusual manifestations of common cutaneous infections in primary immunodeficiency pediatric patients. Front Pediatr. 2023;11:1103726.","journal-title":"Front Pediatr"},{"key":"1810_CR291","doi-asserted-by":"publisher","first-page":"988645","DOI":"10.3389\/fped.2022.988645","volume":"10","author":"K Jo\u0144czyk-Potoczna","year":"2022","unstructured":"Jo\u0144czyk-Potoczna K, Potoczny J, Szczawi\u0144ska-Pop\u0142onyk A. Imaging in children with ataxia-telangiectasia\u2014The radiologist\u2019s approach. Front Pediatr. 2022;10:988645.","journal-title":"Front Pediatr"},{"key":"1810_CR292","doi-asserted-by":"publisher","first-page":"972952","DOI":"10.3389\/fped.2022.972952","volume":"10","author":"A Szczawi\u0144ska-Pop\u0142onyk","year":"2022","unstructured":"Szczawi\u0144ska-Pop\u0142onyk A, et al. Infections and immune dysregulation in ataxia-telangiectasia children with hyper-IgM and non-hyper-IgM phenotypes: a single-center experience. Front Pediatr. 2022;10:972952.","journal-title":"Front Pediatr"},{"issue":"5","key":"1810_CR293","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/00043426-200009000-00017","volume":"22","author":"DM Loeb","year":"2000","unstructured":"Loeb DM, Lederman HM, Winkelstein JA. Lymphoid malignancy as a presenting sign of ataxia-telangiectasia. J Pediatr Hematol Oncol. 2000;22(5):464\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"752","key":"1810_CR294","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1259\/0007-1285-63-752-624","volume":"63","author":"P Plowman","year":"1990","unstructured":"Plowman P, et al. An instance of clinical radiation morbidity and cellular radiosensitivity, not associated with ataxia-telangiectasia. Brit J Radiol. 1990;63(752):624\u20138.","journal-title":"Brit J Radiol"},{"issue":"3","key":"1810_CR295","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0022-3476(87)80469-9","volume":"111","author":"AE Cairney","year":"1987","unstructured":"Cairney AE, et al. Wilms tumor in three patients with Bloom syndrome. J Pediatr. 1987;111(3):414\u20136.","journal-title":"J Pediatr"},{"issue":"1","key":"1810_CR296","first-page":"131","volume":"35","author":"M Draznin","year":"2009","unstructured":"Draznin M, et al. An unusual case of Bloom syndrome presenting with basal cell carcinoma. Dermatol Surg. 2009;35(1):131\u20134.","journal-title":"Dermatol Surg"},{"issue":"1","key":"1810_CR297","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0022-3476(66)80426-2","volume":"68","author":"D Bloom","year":"1966","unstructured":"Bloom D. The syndrome of congenital telangiectaticerythema and stunted growth. J Pediatr. 1966;68(1):103\u201313.","journal-title":"J Pediatr"},{"issue":"1","key":"1810_CR298","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3315\/jdcr.2012.1086","volume":"6","author":"A Masmoudi","year":"2012","unstructured":"Masmoudi A, et al. Clinical and laboratory findings in 8 patients with Bloom\u2019s syndrome. J Dermatol Case Rep. 2012;6(1):29.","journal-title":"J Dermatol Case Rep"},{"issue":"3","key":"1810_CR299","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1111\/bjh.16789","volume":"190","author":"D Nie","year":"2020","unstructured":"Nie D, et al. Complete remission of refractory juvenile acute myeloid leukaemia with RUNX1-PRDM16 in Bloom syndrome after haematopoietic stem cell transplantation. Br J Haematol. 2020;190(3):e166\u20139.","journal-title":"Br J Haematol"},{"key":"1810_CR300","doi-asserted-by":"publisher","unstructured":"Huson SM, et al. Infantile fibrosarcoma with TPM3-NTRK1 fusion in a boy with Bloom syndrome. Fam Cancer. 2020;1\u20136. https:\/\/doi.org\/10.1007\/s10689-020-00221-1.","DOI":"10.1007\/s10689-020-00221-1"},{"issue":"2","key":"1810_CR301","doi-asserted-by":"publisher","first-page":"e28815","DOI":"10.1002\/pbc.28815","volume":"68","author":"C Fein Levy","year":"2021","unstructured":"Fein Levy C, et al. Multidisciplinary management of endocrinopathies and treatment-related toxicities in patients with Bloom syndrome and cancer. Pediatr Blood Cancer. 2021;68(2):e28815.","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"1810_CR302","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1084\/jem.20080789","volume":"205","author":"S P\u00e9ron","year":"2008","unstructured":"P\u00e9ron S, et al. Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J Exp Med. 2008;205(11):2465\u201372.","journal-title":"J Exp Med"},{"issue":"1","key":"1810_CR303","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1215\/15228517-2007-037","volume":"10","author":"S Gururangan","year":"2008","unstructured":"Gururangan S, et al. Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation. Neuro Oncol. 2008;10(1):93\u20137.","journal-title":"Neuro Oncol"},{"issue":"1","key":"1810_CR304","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2052-1839-14-2","volume":"14","author":"K Engel","year":"2014","unstructured":"Engel K, et al. An adult patient with nijmegen breakage syndrome and hodgkin\u2019s lymphoma. BMC Hematol. 2014;14(1):2.","journal-title":"BMC Hematol"},{"issue":"2","key":"1810_CR305","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/mpo.10079","volume":"40","author":"E Barth","year":"2003","unstructured":"Barth E, et al. Anthracyclines in Nijmegen breakage syndrome. Med Pediatr Oncol. 2003;40(2):122\u20134.","journal-title":"Med Pediatr Oncol"},{"issue":"8","key":"1810_CR306","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1128\/JCM.01077-13","volume":"51","author":"T \u0160tajner","year":"2013","unstructured":"\u0160tajner T, et al. Atypical strain of Toxoplasma gondii causing fatal reactivation after hematopoietic stem cell transplantion in a patient with an underlying immunological deficiency. J Clin Microbiol. 2013;51(8):2686\u201390.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1810_CR307","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1824-7288-39-59","volume":"39","author":"S Pasic","year":"2013","unstructured":"Pasic S, et al. Nijmegen breakage syndrome and chronic polyarthritis. Ital J Pediatr. 2013;39(1):59.","journal-title":"Ital J Pediatr"},{"issue":"5","key":"1810_CR308","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1136\/adc.82.5.400","volume":"82","author":"J Heil","year":"2000","unstructured":"Heil J, et al. International nijmegen breakage syndrome study group: nijmegen breakage syndrome. Arch Dis Child. 2000;82(5):400\u20136.","journal-title":"Arch Dis Child"},{"key":"1810_CR309","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s10875-015-0186-9","volume":"35","author":"B Wolska-Ku\u015bnierz","year":"2015","unstructured":"Wolska-Ku\u015bnierz B, et al. Nijmegen breakage syndrome: clinical and immunological features, long-term outcome and treatment options\u2013a retrospective analysis. J Clin Immunol. 2015;35:538\u201349.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1810_CR310","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1067\/mpd.2002.122724","volume":"140","author":"IB Resnick","year":"2002","unstructured":"Resnick IB, et al. Nijmegen breakage syndrome: clinical characteristics and mutation analysis in eight unrelated Russian families. J Pediatr. 2002;140(3):355\u201361.","journal-title":"J Pediatr"},{"issue":"2","key":"1810_CR311","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/pbc.21789","volume":"52","author":"B Dembowska-Baginska","year":"2009","unstructured":"Dembowska-Baginska B, et al. Non-Hodgkin lymphoma (NHL) in children with nijmegen breakage syndrome (NBS). Pediatr Blood Cancer. 2009;52(2):186\u201390.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"1810_CR312","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cancergencyto.2004.02.022","volume":"154","author":"S Meyer","year":"2004","unstructured":"Meyer S, et al. Rhabdomyosarcoma in Nijmegen breakage syndrome: strong association with perianal primary site. Cancer Genet Cytogenet. 2004;154(2):169\u201374.","journal-title":"Cancer Genet Cytogenet"},{"issue":"8","key":"1810_CR313","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/pbc.24994","volume":"61","author":"A Pastorczak","year":"2014","unstructured":"Pastorczak A, et al. Secondary acute monocytic leukemia positive for 11q23 rearrangement in Nijmegen breakage syndrome. Pediatr Blood Cancer. 2014;61(8):1469\u201371.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1810_CR314","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/bmt.2009.207","volume":"45","author":"MH Albert","year":"2010","unstructured":"Albert MH, et al. Successful SCT for Nijmegen breakage syndrome. Bone Marrow Transplant. 2010;45(4):622\u20136.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"1810_CR315","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MPH.0b013e318190d72c","volume":"31","author":"A Jovanovic","year":"2009","unstructured":"Jovanovic A, et al. Successful treatment of hodgkin lymphoma in nijmegen breakage syndrome. J Pediatr Hematol Oncol. 2009;31(1):49\u201352.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"1810_CR316","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1515\/bjmg-2016-0012","volume":"19","author":"SA Kocheva","year":"2016","unstructured":"Kocheva SA, et al. T-lymphoblastic leukemia\/lymphoma in macedonian patients with Nijmegen breakage syndrome. Balkan J Med Genet. 2016;19(1):91\u20134.","journal-title":"Balkan J Med Genet"},{"issue":"3","key":"1810_CR317","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/path.2418","volume":"216","author":"M G\u0142adkowska-Dura","year":"2008","unstructured":"G\u0142adkowska-Dura M, et al. Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation. J Pathol: J Pathol Soc Great Britain and Ireland. 2008;216(3):337\u201344.","journal-title":"J Pathol: J Pathol Soc Great Britain and Ireland"},{"issue":"8","key":"1810_CR318","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00277-003-0697-y","volume":"82","author":"AS Michallet","year":"2003","unstructured":"Michallet AS, et al. T-cell prolymphocytic leukemia with autoimmune manifestations in Nijmegen breakage syndrome. Ann Hematol. 2003;82(8):515\u20137.","journal-title":"Ann Hematol"},{"issue":"9","key":"1810_CR319","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3816\/CLM.2007.n.046","volume":"7","author":"M Dumic","year":"2007","unstructured":"Dumic M, et al. Successful treatment of diffuse large B-cell non-hodgkin lymphoma with modified CHOP (cyclophosphamide\/doxorubicin\/vincristine\/prednisone) chemotherapy and rituximab in a patient with Nijmegen syndrome. Clin Lymphoma Myeloma. 2007;7(9):590\u20133.","journal-title":"Clin Lymphoma Myeloma"},{"issue":"5","key":"1810_CR320","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3109\/15513819409037676","volume":"14","author":"CA Van de Kaa","year":"1994","unstructured":"Van de Kaa CA, et al. Postmortem findings in the Nijmegen breakage syndrome. Pediatr Pathol. 1994;14(5):787\u201396.","journal-title":"Pediatr Pathol"},{"issue":"6 Suppl","key":"1810_CR321","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1080\/09553009414552021","volume":"66","author":"CM Weemaes","year":"1994","unstructured":"Weemaes CM, Smeets DF, van der Burgt CJ. Nijmegen breakage syndrome: a progress report. Int J Radiat Biol. 1994;66(6 Suppl):S185\u20138.","journal-title":"Int J Radiat Biol"},{"issue":"3","key":"1810_CR322","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/00043426-200303000-00013","volume":"25","author":"S Bakhshi","year":"2003","unstructured":"Bakhshi S, et al. Medulloblastoma with adverse reaction to radiation therapy in nijmegen breakage syndrome. J Pediatr Hematol Oncol. 2003;25(3):248\u201351.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"1810_CR323","doi-asserted-by":"publisher","first-page":"503","DOI":"10.55782\/ane-2004-1532","volume":"64","author":"M Bekiesi\u0144ska-Figatowska","year":"2004","unstructured":"Bekiesi\u0144ska-Figatowska M, et al. Magnetic resonance imaging of brain abnormalities in patients with the Nijmegen breakage syndrome. Acta Neurobiol Exp. 2004;64(4):503\u20139.","journal-title":"Acta Neurobiol Exp"},{"issue":"1","key":"1810_CR324","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/mpo.10275","volume":"41","author":"L Distel","year":"2003","unstructured":"Distel L, et al. Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome. Med Pediatr Oncol. 2003;41(1):44\u20138.","journal-title":"Med Pediatr Oncol"},{"issue":"3","key":"1810_CR325","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/ajmg.1320570321","volume":"57","author":"KH Chrzanowska","year":"1995","unstructured":"Chrzanowska KH, et al. Eleven Polish patients with microcephaly, immunodeficiency, and chromosomal instability: the Nijmegen breakage syndrome. Am J Med Genet. 1995;57(3):462\u201371.","journal-title":"Am J Med Genet"},{"key":"1810_CR326","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s002340050011","volume":"42","author":"M Bekiesi\u0144ska-Figatowska","year":"2000","unstructured":"Bekiesi\u0144ska-Figatowska M, et al. Cranial MRI in the Nijmegen breakage syndrome. Neuroradiology. 2000;42:43\u20137.","journal-title":"Neuroradiology"},{"issue":"3","key":"1810_CR327","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/jmg.34.3.196","volume":"34","author":"R Tupler","year":"1997","unstructured":"Tupler R, et al. A variant of the Nijmegen breakage syndrome with unusual cytogenetic features and intermediate cellular radiosensitivity. J Med Genet. 1997;34(3):196\u2013202.","journal-title":"J Med Genet"},{"issue":"2","key":"1810_CR328","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/jmg.33.2.153","volume":"33","author":"I van der Burgt","year":"1996","unstructured":"van der Burgt I, et al. Nijmegen breakage syndrome. J Med Genet. 1996;33(2):153\u20136.","journal-title":"J Med Genet"},{"issue":"1\u20132","key":"1810_CR329","first-page":"31","volume":"4","author":"OV Aleinikova","year":"2015","unstructured":"Aleinikova OV, et al. Should allogeneic hematopoietic stem cell transplantation be a treatment option for patients with Nijmegen breakage syndrome? Belarusian experience. Cell Therapy Transp. 2015;4(1\u20132):31\u20136.","journal-title":"Cell Therapy Transp"},{"issue":"11","key":"1810_CR330","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.leukres.2011.07.034","volume":"35","author":"A Pastorczak","year":"2011","unstructured":"Pastorczak A, et al. Role of 657del5 NBN mutation and 7p12. 2 (IKZF1), 9p21 (CDKN2A), 10q21. 2 (ARID5B) and 14q11. 2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leuk Res. 2011;35(11):1534\u20136.","journal-title":"Leuk Res"},{"issue":"3","key":"1810_CR331","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.clim.2010.01.008","volume":"135","author":"H Gregorek","year":"2010","unstructured":"Gregorek H, et al. Nijmegen breakage syndrome: long-term monitoring of viral and immunological biomarkers in peripheral blood before development of malignancy. Clin Immunol. 2010;135(3):440\u20137.","journal-title":"Clin Immunol"},{"key":"1810_CR332","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3389\/fimmu.2017.00807","volume":"8","author":"E Deripapa","year":"2017","unstructured":"Deripapa E, et al. Prospective study of a cohort of Russian Nijmegen breakage syndrome patients demonstrating predictive value of low kappa-deleting recombination excision circle (KREC) numbers and beneficial effect of hematopoietic stem cell transplantation (HSCT). Front Immunol. 2017;8:807.","journal-title":"Front Immunol"},{"issue":"3","key":"1810_CR333","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1046\/j.1365-2249.2003.02285.x","volume":"134","author":"J Micha\u0142kiewicz","year":"2003","unstructured":"Micha\u0142kiewicz J, et al. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome. Clin Exp Immunol. 2003;134(3):482\u201390.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1810_CR334","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1525-1470.2010.01140.x","volume":"27","author":"CA Vogel","year":"2010","unstructured":"Vogel CA, et al. Chronic noninfectious necrotizing granulomas in a child with Nijmegen breakage syndrome. Pediatr Dermatol. 2010;27(3):285\u20139.","journal-title":"Pediatr Dermatol"},{"key":"1810_CR335","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13039-020-00505-2","volume":"13","author":"M W\u0142odarczyk","year":"2020","unstructured":"W\u0142odarczyk M, Lejman M. Chromosomal instability associated with adverse outcome: a case report of patient with Nijmegen breakage syndrome and rapidly developed T-NHL with complex karyotype. Mol Cytogenet. 2020;13:1\u20139.","journal-title":"Mol Cytogenet"},{"issue":"2","key":"1810_CR336","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/1078-0432.CCR-20-2574","volume":"27","author":"B Wolska-Kusnierz","year":"2021","unstructured":"Wolska-Kusnierz B, et al. hematopoietic stem cell transplantation positively affects the natural history of cancer in nijmegen breakage syndrome HSCT improves survival of patients with NBS with cancer. Clin Cancer Res. 2021;27(2):575\u201384.","journal-title":"Clin Cancer Res"},{"key":"1810_CR337","doi-asserted-by":"publisher","first-page":"1209577","DOI":"10.3389\/fendo.2023.1209577","volume":"14","author":"WM Sarli","year":"2023","unstructured":"Sarli WM, et al. Risk of thyroid neoplasms in patients with 22q11. 2 deletion and DiGeorge-like syndromes: an insight for follow-up. Front Endocrinol. 2023;14:1209577.","journal-title":"Front Endocrinol"},{"issue":"5","key":"1810_CR338","doi-asserted-by":"publisher","first-page":"e227715","DOI":"10.1136\/bcr-2018-227715","volume":"12","author":"R Albar","year":"2019","unstructured":"Albar R, et al. Epstein-Barr virus associated with high-grade B-cell lymphoma in nude severe combined immunodeficiency. BMJ Case Rep CP. 2019;12(5):e227715.","journal-title":"BMJ Case Rep CP"},{"issue":"32","key":"1810_CR339","doi-asserted-by":"publisher","first-page":"408","DOI":"10.18176\/jiaci.0777","volume":"11","author":"H Nigolian","year":"2022","unstructured":"Nigolian H, et al. Immunodeficiency and lymphoma in Jacobsen syndrome. J Investig Allergol Clin Immunol. 2022;11(32):408\u20139.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2 Suppl","key":"1810_CR340","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.jaad.2005.03.055","volume":"54","author":"JM Eisner","year":"2006","unstructured":"Eisner JM, Russell M. Cartilage hair hypoplasia and multiple basal cell carcinomas. J Am Acad Dermatol. 2006;54(2 Suppl):S8-10.","journal-title":"J Am Acad Dermatol"},{"issue":"18","key":"1810_CR341","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1002\/ajmg.a.32478","volume":"146A","author":"M Taskinen","year":"2008","unstructured":"Taskinen M, et al. Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma. Am J Med Genet A. 2008;146A(18):2370\u20135.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"1810_CR342","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/milmed\/149.5.280","volume":"149","author":"AR Mark","year":"1984","unstructured":"Mark AR, Roy MA. Hodgkin\u2019s lymphoma in a child with cartilage-hair hypoplasia: case report. Mil Med. 1984;149(5):280\u20131.","journal-title":"Mil Med"},{"issue":"3","key":"1810_CR343","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0022-3476(99)70456-7","volume":"134","author":"O M\u00e4kitie","year":"1999","unstructured":"M\u00e4kitie O, et al. Increased incidence of cancer in patients with cartilage-hair hypoplasia. J Pediatr. 1999;134(3):315\u20138.","journal-title":"J Pediatr"},{"issue":"3","key":"1810_CR344","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jpeds.2007.11.040","volume":"152","author":"S Toiviainen-Salo","year":"2008","unstructured":"Toiviainen-Salo S, et al. Patients with cartilage-hair hypoplasia have an increased risk for bronchiectasis. J Pediatr. 2008;152(3):422-428.e1.","journal-title":"J Pediatr"},{"issue":"1718","key":"1810_CR345","doi-asserted-by":"publisher","first-page":"w14606","DOI":"10.4414\/smw.2018.14606","volume":"148","author":"A Nguyen","year":"2018","unstructured":"Nguyen A, et al. Diffuse large B-cell lymphoma chemotherapy reveals a combined immunodeficiency syndrome in cartilage hair hypoplasia. Swiss Med Wkly. 2018;148(1718):w14606.","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"1810_CR346","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/adc.84.1.65","volume":"84","author":"O M\u00e4kitie","year":"2001","unstructured":"M\u00e4kitie O, Pukkala E, Kaitila I. Increased mortality in cartilage\u2013hair hypoplasia. Arch Dis Child. 2001;84(1):65\u20137.","journal-title":"Arch Dis Child"},{"issue":"7","key":"1810_CR347","doi-asserted-by":"publisher","first-page":"e28259","DOI":"10.1002\/pbc.28259","volume":"67","author":"BA Speckhart","year":"2020","unstructured":"Speckhart BA, et al. Rituximab and intense chemotherapy in a patient with defective cell mediated immunity due to cartilage-hair hypoplasia and Burkitt lymphoma. Pediatr Blood Cancer. 2020;67(7):e28259.","journal-title":"Pediatr Blood Cancer"},{"key":"1810_CR348","doi-asserted-by":"publisher","first-page":"1004694","DOI":"10.3389\/fimmu.2022.1004694","volume":"13","author":"H-L Kukkola","year":"2022","unstructured":"Kukkola H-L, et al. Lymphomas in cartilage-hair hypoplasia\u2013A case series of 16 patients reveals advanced stage DLBCL as the most common form. Front Immunol. 2022;13:1004694.","journal-title":"Front Immunol"},{"key":"1810_CR349","unstructured":"CA F. Cartilage-hair hypoplasia in the Amish: increased susceptibility to malignancy. Am J Hum Genet. 1983; 35: 89A."},{"issue":"2","key":"1810_CR350","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0002-9343(98)00200-9","volume":"105","author":"TA Nester","year":"1998","unstructured":"Nester TA, et al. Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Med. 1998;105(2):162\u20134.","journal-title":"Am J Med"},{"issue":"12","key":"1810_CR351","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1080\/10428190400004463","volume":"45","author":"GD Leonard","year":"2004","unstructured":"Leonard GD, et al. Non-Hodgkin\u2019s lymphoma in Job\u2019s syndrome: a case report and literature review. Leuk Lymphoma. 2004;45(12):2521\u20135.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"1810_CR352","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1385\/MO:23:1:141","volume":"23","author":"IK Onal","year":"2006","unstructured":"Onal IK, et al. Peripheral T-cell lymphoma and Job\u2019s syndrome: a rare association. Med Oncol. 2006;23(1):141\u20134.","journal-title":"Med Oncol"},{"issue":"6","key":"1810_CR353","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3816\/CLM.2007.n.022","volume":"7","author":"N Wallet","year":"2007","unstructured":"Wallet N, et al. Diffuse large B-cell lymphoma in hyperimmunoglobulinemia E syndrome. Clin Lymphoma Myeloma. 2007;7(6):425\u20137.","journal-title":"Clin Lymphoma Myeloma"},{"key":"1810_CR354","unstructured":"Oztop I, et al. The development of pulmonary adenocarcinoma in a patient with Job's syndrome, a rare immunodeficiency condition. London, England: SAGE Publications Sage UK; 1980."},{"issue":"9","key":"1810_CR355","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1016\/j.leukres.2010.01.024","volume":"34","author":"D Belada","year":"2010","unstructured":"Belada D, et al. Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: successful treatment with risk-adapted rituximab-based immunochemotherapy. Leuk Res. 2010;34(9):e232\u20134.","journal-title":"Leuk Res"},{"issue":"3","key":"1810_CR356","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10875-021-01197-y","volume":"42","author":"A Urban","year":"2022","unstructured":"Urban A, et al. Malignancy in STAT3 deficient hyper IgE syndrome. J Clin Immunol. 2022;42(3):699\u2013702.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1810_CR357","doi-asserted-by":"publisher","first-page":"e849","DOI":"10.1097\/MPH.0000000000002364","volume":"44","author":"N Ravichandran","year":"2022","unstructured":"Ravichandran N, et al. Management of peripheral T-Cell lymphoma in children and adolescents including STAT 3 mutation hyper-IgE syndrome: one size does not fit all. J Pediatr Hematol Oncol. 2022;44(4):e849\u201354.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1810_CR358","doi-asserted-by":"crossref","unstructured":"Kowalchuk RM. Case of the season. Semin Roentgenol. 1996;31(4):254\u2013256.","DOI":"10.1016\/S0037-198X(96)80015-0"},{"issue":"5","key":"1810_CR359","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1346-8138.2002.tb00271.x","volume":"29","author":"SE Chang","year":"2002","unstructured":"Chang SE, et al. A case of hyper-IgE syndrome complicated by cutaneous, nodal, and liver peripheral T cell lymphomas. J Dermatol. 2002;29(5):320\u20132.","journal-title":"J Dermatol"},{"issue":"12","key":"1810_CR360","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1365-4632.2003.01829.x","volume":"42","author":"MW Lee","year":"2003","unstructured":"Lee MW, et al. Extensive xanthelasma associated with anaplastic large cell lymphoma and hyperimmunoglobulin E syndrome. Int J Dermatol. 2003;42(12):944\u20136.","journal-title":"Int J Dermatol"},{"issue":"2","key":"1810_CR361","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s10875-010-9479-1","volume":"31","author":"WI Lee","year":"2011","unstructured":"Lee WI, et al. Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES). J Clin Immunol. 2011;31(2):272\u201380.","journal-title":"J Clin Immunol"},{"issue":"5","key":"1810_CR362","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1086\/511685","volume":"44","author":"KL McCarthy","year":"2007","unstructured":"McCarthy KL, et al. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy. Clin Infect Dis. 2007;44(5):e55\u20136.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1810_CR363","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0091-6749(89)90471-5","volume":"83","author":"LJ Gorin","year":"1989","unstructured":"Gorin LJ, et al. Burkitt\u2019s lymphoma developing in a 7-year-old boy with hyper-IgE syndrome. J Allergy Clin Immunol. 1989;83(1):5\u201310.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1810_CR364","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/1097-0142(197706)39:6<2386::AID-CNCR2820390612>3.0.CO;2-X","volume":"39","author":"JF Bale","year":"1977","unstructured":"Bale JF, Wilson JF, Hill HRJC. Fatal histiocytic lymphoma of the brain associated with hyperimmunoglobulinemia-e and recurrent infections. Cancer. 1977;39(6):2386\u201390.","journal-title":"Cancer"},{"issue":"1","key":"1810_CR365","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/08880010500313512","volume":"23","author":"MA Kashef","year":"2006","unstructured":"Kashef MA, et al. Hodgkin lymphoma developing in a 4.5-year-old girl with hyper-IgE syndrome. Pediatr Hematol Oncol. 2006;23(1):59\u201363.","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"1810_CR366","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3109\/08880019809016576","volume":"15","author":"S-J Lin","year":"1998","unstructured":"Lin S-J, et al. Hodgkin\u2019s disease in a child with hyperimmunoglobulin E syndrome. Pediatr Hematol Oncol. 1998;15(5):451\u20134.","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"1810_CR367","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1034\/j.1399-3038.2002.00088.x","volume":"13","author":"R Mosseri","year":"2002","unstructured":"Mosseri R, et al. Large T-cell lymphoma in a 13-year-old girl with hyperimmunoglobulinemia E syndrome. Pediatr Allergy Immunol. 2002;13(2):143\u20136.","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"1810_CR368","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00019048-200009030-00006","volume":"9","author":"KK Huber","year":"2000","unstructured":"Huber KK, et al. Malignancies associated with hyper-IgE syndrome: case and review. Infect Dis Clin Pract. 2000;9(3):128\u201330.","journal-title":"Infect Dis Clin Pract"},{"issue":"6","key":"1810_CR369","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s10875-020-00800-y","volume":"40","author":"B Al-Saud","year":"2020","unstructured":"Al-Saud B, et al. A case with purine nucleoside phosphorylase deficiency suffering from late-onset systemic lupus erythematosus and lymphoma. J Clin Immunol. 2020;40(6):833\u20139.","journal-title":"J Clin Immunol"},{"issue":"8423","key":"1810_CR370","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(85)91037-2","volume":"1","author":"LJ Kinlen","year":"1985","unstructured":"Kinlen LJ, et al. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet. 1985;1(8423):263\u20136.","journal-title":"Lancet"},{"key":"1810_CR371","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00247-004-1319-0","volume":"35","author":"O Al Sasi","year":"2005","unstructured":"Al Sasi O, et al. Colonic neuroendocrine carcinoma in a child. Pediatr Radiol. 2005;35:339\u201343.","journal-title":"Pediatr Radiol"},{"issue":"9","key":"1810_CR372","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1097\/00042737-200012090-00013","volume":"12","author":"C Bachmeyer","year":"2000","unstructured":"Bachmeyer C, et al. Gastric adenocarcinoma in a patient with X-linked agammaglobulinaemia. Eur J Gastroenterol Hepatol. 2000;12(9):1033\u20135.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"1810_CR373","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1183\/09031936.01.17305700","volume":"17","author":"JM Echave-Sustaeta","year":"2001","unstructured":"Echave-Sustaeta JM, et al. X-linked agammaglobulinaemia and squamous lung cancer. Eur Respir J. 2001;17(3):570\u20132.","journal-title":"Eur Respir J"},{"issue":"1","key":"1810_CR374","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5301\/ejo.5000487","volume":"25","author":"G Gokce","year":"2015","unstructured":"Gokce G, et al. Epiphora as the presenting sign of relapsed non-Hodgkin lymphoma in a child with Bruton agammaglobulinemia. Eur J Ophthalmol. 2015;25(1):65\u20137.","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"1810_CR375","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s10434-000-0692-7","volume":"7","author":"K Mimori","year":"2000","unstructured":"Mimori K, et al. Analysis of the genetic alterations in a case of juvenile multiple colon carcinoma with hypogammaglobulinemia. Ann Surg Oncol. 2000;7(9):692\u20135.","journal-title":"Ann Surg Oncol"},{"issue":"8858","key":"1810_CR376","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/0140-6736(93)90883-I","volume":"341","author":"JW van der Meer","year":"1993","unstructured":"van der Meer JW, et al. Colorectal cancer in patients with X-linked agammaglobulinaemia. Lancet. 1993;341(8858):1439\u201340.","journal-title":"Lancet"},{"issue":"5","key":"1810_CR377","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/1097-0142(19930901)72:5<1528::AID-CNCR2820720506>3.0.CO;2-V","volume":"72","author":"P Lavilla","year":"1993","unstructured":"Lavilla P, et al. X-linked agammaglobulinemia and gastric adenocarcinoma. Cancer. 1993;72(5):1528\u201331.","journal-title":"Cancer"},{"issue":"1","key":"1810_CR378","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cgh.2007.08.019","volume":"6","author":"LA Brosens","year":"2008","unstructured":"Brosens LA, et al. Multiple colorectal neoplasms in X-linked agammaglobulinemia. Clin Gastroenterol Hepatol. 2008;6(1):115\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1810_CR379","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s10875-013-9971-5","volume":"34","author":"ATS Boone","year":"2014","unstructured":"Boone ATS, et al. Gastric adenocarcinoma in the context of X-linked agammaglobulinemia: case report and review of the literature. J Clin Immunol. 2014;34:134\u20137.","journal-title":"J Clin Immunol"},{"key":"1810_CR380","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fped.2016.00100","volume":"4","author":"J Hajjar","year":"2016","unstructured":"Hajjar J, et al. Gastric Adenocarcinoma in a patient with X-Linked Agammaglobulinemia and HIV: case report and review of the literature. Front Pediatr. 2016;4:100.","journal-title":"Front Pediatr"},{"issue":"3","key":"1810_CR381","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/01.MPG.0000153003.59448.36","volume":"41","author":"GM Lackmann","year":"2005","unstructured":"Lackmann GM, et al. A teenager with X-linked agammaglobulinemia and vitamin B12 deficiency anemia. J Pediatr Gastroenterol Nutr. 2005;41(3):360\u20132.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"1810_CR382","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10875-015-0127-7","volume":"35","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, et al. X-linked agammaglobulinemia associated with B-precursor acute lymphoblastic leukemia. J Clin Immunol. 2015;35(2):108\u201311.","journal-title":"J Clin Immunol"},{"issue":"9","key":"1810_CR383","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/pbc.25554","volume":"62","author":"RF Abu-Arja","year":"2015","unstructured":"Abu-Arja RF, et al. Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia. Pediatr Blood Cancer. 2015;62(9):1674\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1810_CR384","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12881-019-0880-1","volume":"20","author":"M Li","year":"2019","unstructured":"Li M, et al. Metastatic colorectal cancer and severe hypocalcemia following irinotecan administration in a patient with X-linked agammaglobulinemia: a case report. BMC Med Genet. 2019;20(1):157.","journal-title":"BMC Med Genet"},{"issue":"3","key":"1810_CR385","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s10875-008-9262-8","volume":"29","author":"Y Wang","year":"2009","unstructured":"Wang Y, et al. Mutation of the BTK gene and clinical feature of X-linked agammaglobulinemia in mainland China. J Clin Immunol. 2009;29(3):352\u20136.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1810_CR386","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.joms.2005.12.041","volume":"65","author":"MM Imanguli","year":"2007","unstructured":"Imanguli MM, et al. Myofibroblastic tumor of the lower lip in a patient with X-linked hypogammaglobulinemia and isolated growth hormone deficiency: a case report. J Oral Maxillofac Surg. 2007;65(6):1219\u201322.","journal-title":"J Oral Maxillofac Surg"},{"key":"1810_CR387","doi-asserted-by":"publisher","unstructured":"S\u00e1 A, et al. Skin cancer in congenital X-linked agammaglobulinaemia. BMJ Case Rep. 2021;14(2). https:\/\/doi.org\/10.1136\/bcr-2020-240523.","DOI":"10.1136\/bcr-2020-240523"},{"key":"1810_CR388","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3389\/fimmu.2020.02001","volume":"11","author":"Y-H Yeh","year":"2020","unstructured":"Yeh Y-H, et al. Distinct clinical features and novel mutations in Taiwanese patients with X-linked agammaglobulinemia. Front Immunol. 2020;11:2001.","journal-title":"Front Immunol"},{"issue":"4","key":"1810_CR389","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/cup.13860","volume":"48","author":"H Daou","year":"2021","unstructured":"Daou H, et al. CD8-positive cutaneous lymphoproliferation associated with large granular lymphocyte leukemia in a patient with X-linked agammaglobulinemia. J Cutan Pathol. 2021;48(4):567\u201371.","journal-title":"J Cutan Pathol"},{"issue":"10","key":"1810_CR390","doi-asserted-by":"publisher","first-page":"e00863","DOI":"10.14309\/crj.0000000000000863","volume":"9","author":"NA Majeed","year":"2022","unstructured":"Majeed NA, et al. Angiosarcoma in long-standing nodular regenerative hyperplasia. ACG Case Rep J. 2022;9(10):e00863.","journal-title":"ACG Case Rep J"},{"key":"1810_CR391","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/BF00915792","volume":"3","author":"G Luzi","year":"1983","unstructured":"Luzi G, Businco L, Aiuti F. Primary immunodeficiency syndromes in Italy: a report of the national register in children and adults. J Clin Immunol. 1983;3:316\u201320.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1810_CR392","first-page":"140","volume":"60","author":"JC Van der Hilst","year":"2002","unstructured":"Van der Hilst JC, Smits BW, Van Der Meer JW. Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution. Neth J Med. 2002;60(3):140\u20137.","journal-title":"Neth J Med"},{"issue":"4","key":"1810_CR393","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jaci.2017.04.037","volume":"140","author":"M Ben-Ali","year":"2017","unstructured":"Ben-Ali M, et al. Homozygous transcription factor 3 gene (TCF3) mutation is associated with severe hypogammaglobulinemia and B-cell acute lymphoblastic leukemia. J Allergy Clin Immunol. 2017;140(4):1191-1194.e4.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1810_CR394","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.0954-6820.1963.tb17439.x","volume":"173","author":"R Pelkonen","year":"1963","unstructured":"Pelkonen R, Siurala M, Vuopio P. Inherited agammaglobulinemia with malabsorption and marked alterations in the gastrointestinal mucosa. Acta Med Scand. 1963;173(5):549\u201355.","journal-title":"Acta Med Scand"},{"issue":"6","key":"1810_CR395","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/S0022-3476(70)80083-X","volume":"77","author":"AI Freeman","year":"1970","unstructured":"Freeman AI, Sinks LF, Cohen MM. Lymphosarcoma in siblings, associated with cytogenetic abnormalities, immune deficiency, and abnormal erythropoiesis. J Pediatr. 1970;77(6):996\u20131003.","journal-title":"J Pediatr"},{"issue":"6","key":"1810_CR396","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/ajcp\/52.6.726","volume":"52","author":"KS Tung","year":"1969","unstructured":"Tung KS, Hoffman GC, Lonsdale D. Lymphoproliferative lesion in congenital thymic aplasia associated with agammaglobulinemia. Am J Clin Pathol. 1969;52(6):726\u201332.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"1810_CR397","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1182\/blood.V21.2.197.197","volume":"21","author":"AR Page","year":"1963","unstructured":"Page AR, Hansen AE, Good RA. Occurrence of leukemia and lymphoma in patients with agammaglobulinemia. Blood. 1963;21(2):197\u2013206.","journal-title":"Blood"},{"issue":"4","key":"1810_CR398","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2967\/jnmt.116.175745","volume":"44","author":"E Tatci","year":"2016","unstructured":"Tatci E, et al. 18F-FDG PET\/CT imaging of hodgkin lymphoma in a child with common variable immunodeficiency. J Nucl Med Technol. 2016;44(4):259\u201360.","journal-title":"J Nucl Med Technol"},{"issue":"4","key":"1810_CR399","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12029-010-9158-8","volume":"41","author":"K Gandhi","year":"2010","unstructured":"Gandhi K, et al. A case of explosive progression of hepatocellular carcinoma in a patient with common variable immunodeficiency (CVID). J Gastrointest Cancer. 2010;41(4):281\u20134.","journal-title":"J Gastrointest Cancer"},{"issue":"11","key":"1810_CR400","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1001\/archinte.1978.03630360064025","volume":"138","author":"WM Battle","year":"1978","unstructured":"Battle WM, Brooks FP. Adenocarcinoma of the stomach with common variable immunodeficiency syndrome. Arch Intern Med. 1978;138(11):1682\u20134.","journal-title":"Arch Intern Med"},{"issue":"4","key":"1810_CR401","doi-asserted-by":"publisher","first-page":"605","DOI":"10.7326\/0003-4819-76-4-605","volume":"76","author":"PE Hermans","year":"1972","unstructured":"Hermans PE, Huizenga KA. Association of gastric carcinoma with idiopathic late-onset immunoglobulin deficiency. Ann Intern Med. 1972;76(4):605\u20139.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1810_CR402","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/MD.0b013e31817a90ba","volume":"87","author":"P Seve","year":"2008","unstructured":"Seve P, et al. Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of 18 patients. Medicine (Baltimore). 2008;87(3):177\u201384.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1810_CR403","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","volume":"130","author":"L Mellemkjaer","year":"2002","unstructured":"Mellemkjaer L, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol. 2002;130(3):495\u2013500.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"1810_CR404","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1155\/2008\/614279","volume":"19","author":"A Hofmann","year":"2008","unstructured":"Hofmann A, Zaharatos G, Miller M. Case report and review of the literature: toxoplasma gondii encephalitis in a 40-year-old woman with common variable immunodeficiency and a new diagnosis of large granular lymphocytic leukemia. Can J Infect Dis Med Microbiol. 2008;19(4):309\u201310.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"1","key":"1810_CR405","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archinte.1982.00340140092017","volume":"142","author":"E Gelmann","year":"1982","unstructured":"Gelmann E, et al. Chemotherapy for lymphoma in a patient with common variable immunodeficiency: case report, literature review, and recommendations for chemotherapy in immunodeficient patients. Arch Intern Med. 1982;142(1):90\u20132.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1810_CR406","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/BF00917124","volume":"9","author":"C Cunningham-Rundles","year":"1989","unstructured":"Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol. 1989;9(1):22\u201333.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1810_CR407","first-page":"260","volume":"18","author":"M Aydogan","year":"2008","unstructured":"Aydogan M, et al. Clinical and immunologic features of pediatric patients with common variable immunodeficiency and respiratory complications. J Investig Allergol Clin Immunol. 2008;18(4):260\u20135.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"1810_CR408","first-page":"222","volume":"20","author":"O Ardeniz","year":"2010","unstructured":"Ardeniz O, et al. Clinical and immunological analysis of 23 adult patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2010;20(3):222\u201336.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"8","key":"1810_CR409","first-page":"14203","volume":"8","author":"UY Malkan","year":"2015","unstructured":"Malkan UY, et al. Common variable immune deficiency associated Hodgkin\u2019s lymphoma complicated with EBV-linked hemophagocytic lymphohistiocytosis: a case report. Int J Clin Exp Med. 2015;8(8):14203.","journal-title":"Int J Clin Exp Med"},{"key":"1810_CR410","doi-asserted-by":"crossref","unstructured":"Cunningham-Rundles C. Common variable immune deficiency: case studies. Hematology Am Soc\u00a0Hematol Educ Program. 2019;(1):449\u2013456.","DOI":"10.1182\/hematology.2019002062"},{"issue":"1","key":"1810_CR411","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1081\/CNV-120027583","volume":"22","author":"AC Mehta","year":"2004","unstructured":"Mehta AC, Faber-Langendoen K, Duggan DB. Common variable immunodeficiency and breast cancer. Cancer Invest. 2004;22(1):93\u20136.","journal-title":"Cancer Invest"},{"issue":"4","key":"1810_CR412","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/BF01789177","volume":"31","author":"I Vorechovsky","year":"1990","unstructured":"Vorechovsky I, et al. Common variable immunodeficiency and malignancy: a report of two cases and possible explanation for the association. Cancer Immunol Immunother. 1990;31(4):250\u20134.","journal-title":"Cancer Immunol Immunother"},{"key":"1810_CR413","doi-asserted-by":"publisher","first-page":"428703","DOI":"10.1155\/2011\/428703","volume":"2011","author":"AA Jesus","year":"2011","unstructured":"Jesus AA, et al. Common variable immunodeficiency associated with hepatosplenic T-cell lymphoma mimicking juvenile systemic lupus erythematosus. Clin Dev Immunol. 2011;2011:428703.","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"1810_CR414","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12029-015-9776-2","volume":"47","author":"A Goldberg","year":"2016","unstructured":"Goldberg A, Rose L, McCue P. Common variable immunodeficiency disease and rectal squamous cell carcinoma: a case report of a rare syndromic tumor type. J Gastrointest Cancer. 2016;47(4):470\u20133.","journal-title":"J Gastrointest Cancer"},{"issue":"5","key":"1810_CR415","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1023\/A:1025373601374","volume":"23","author":"B Piqueras","year":"2003","unstructured":"Piqueras B, et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol. 2003;23(5):385\u2013400.","journal-title":"J Clin Immunol"},{"issue":"12 Suppl","key":"1810_CR416","first-page":"ECR61","volume":"91","author":"M Delia","year":"2006","unstructured":"Delia M, et al. Common variable immunodeficiency patient with large granular lymphocytosis developing extranodal diffuse large B-cell lymphoma: a case report. Haematologica. 2006;91(12 Suppl):ECR61.","journal-title":"Haematologica"},{"issue":"1","key":"1810_CR417","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/clim.1999.4725","volume":"92","author":"C Cunningham-Rundles","year":"1999","unstructured":"Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34\u201348.","journal-title":"Clin Immunol"},{"key":"1810_CR418","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12308-013-0181-0","volume":"6","author":"K Kelemen","year":"2013","unstructured":"Kelemen K, et al. Crystal-storing histiocytosis and extranodal marginal zone lymphoma of the lung in a child with common variable immunodeficiency. J Hematop. 2013;6:219\u201324.","journal-title":"J Hematop"},{"issue":"8","key":"1810_CR419","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1177\/1066896911399901","volume":"22","author":"G Petrilli","year":"2014","unstructured":"Petrilli G, et al. Epstein\u2013barr virus\u2013associated adrenal smooth muscle tumors and disseminated diffuse large b-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22(8):712\u201321.","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"1810_CR420","first-page":"136","volume":"64","author":"IM Desar","year":"2006","unstructured":"Desar IM, et al. Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency. Neth J Med. 2006;64(5):136\u201340.","journal-title":"Neth J Med"},{"issue":"6","key":"1810_CR421","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/BF00198249","volume":"19","author":"JE Cox","year":"1994","unstructured":"Cox JE, Ott DJ. Gastric adenocarcinoma in a patient with common variable immunodeficiency. Abdom Imaging. 1994;19(6):501\u20132.","journal-title":"Abdom Imaging"},{"issue":"7","key":"1810_CR422","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1177\/1066896914532540","volume":"22","author":"G De Petris","year":"2014","unstructured":"De Petris G, et al. Gastric adenocarcinoma in common variable immunodeficiency: features of cancer and associated gastritis may be characteristic of the condition. Int J Surg Pathol. 2014;22(7):600\u20136.","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"1810_CR423","first-page":"e201","volume":"50","author":"YL Yap","year":"2009","unstructured":"Yap YL, So JB. Gastric adenocarcinoma occurring in a young patient with common variable immunodeficiency syndrome. Singapore Med J. 2009;50(6):e201\u20133.","journal-title":"Singapore Med J"},{"key":"1810_CR424","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.3389\/fimmu.2018.02546","volume":"9","author":"F Pulvirenti","year":"2018","unstructured":"Pulvirenti F, et al. Gastric cancer is the leading cause of death in Italian adult patients with common variable immunodeficiency. Front Immunol. 2018;9:2546.","journal-title":"Front Immunol"},{"issue":"12","key":"1810_CR425","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","volume":"31","author":"JA Daniels","year":"2007","unstructured":"Daniels JA, et al. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007;31(12):1800\u201312.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1810_CR426","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/jgh.12587","volume":"29","author":"KP Loh","year":"2014","unstructured":"Loh KP, Hunt JP, Mehendiratta V. Gastrointestinal: Incidentally detected gastric carcinoma in patient with common variable immunoglobulin deficiency. J Gastroenterol Hepatol. 2014;29(6):1127.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1810_CR427","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/1042819031000123474","volume":"45","author":"V Mail\u00e4nder","year":"2004","unstructured":"Mail\u00e4nder V, et al. Guillain-Barre-Strohl syndrome unraveled as paraneoplastic syndrome of B-cell acute lymphoblastic leukemia in a patient with preceding common variable immunodeficiency syndrome with Evans syndrome. Leuk Lymphoma. 2004;45(1):189\u201392.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"1810_CR428","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/08880010701369982","volume":"24","author":"A Aghamohammadi","year":"2007","unstructured":"Aghamohammadi A, et al. Hodgkin lymphoma in two siblings with common variable immunodeficiency. Pediatr Hematol Oncol. 2007;24(5):337\u201342.","journal-title":"Pediatr Hematol Oncol"},{"issue":"9","key":"1810_CR429","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/jcp.48.9.871","volume":"48","author":"C Christopoulos","year":"1995","unstructured":"Christopoulos C, et al. Hodgkin\u2019s disease in a patient with common variable immunodeficiency. J Clin Pathol. 1995;48(9):871\u20133.","journal-title":"J Clin Pathol"},{"issue":"11","key":"1810_CR430","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1080\/1042819031000110955","volume":"44","author":"A Hisamoto","year":"2003","unstructured":"Hisamoto A, et al. Human herpes virus-8-negative primary effusion lymphoma in a patient with common variable immunodeficiency. Leuk Lymphoma. 2003;44(11):2019\u201322.","journal-title":"Leuk Lymphoma"},{"key":"1810_CR431","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3389\/fimmu.2019.03022","volume":"10","author":"M Christiansen","year":"2019","unstructured":"Christiansen M, et al. Identification of novel genetic variants in CVID patients with autoimmunity, autoinflammation, or malignancy. Front Immunol. 2019;10:3022.","journal-title":"Front Immunol"},{"issue":"4","key":"1810_CR432","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/BF00915550","volume":"7","author":"C Cunningham-Rundles","year":"1987","unstructured":"Cunningham-Rundles C, et al. Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol. 1987;7(4):294\u20139.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1810_CR433","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10875-007-9135-6","volume":"28","author":"N Rezaei","year":"2008","unstructured":"Rezaei N, et al. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications. J Clin Immunol. 2008;28(1):78\u201384.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1810_CR434","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1365-2249.1994.tb06513.x","volume":"95","author":"EW Herbst","year":"1994","unstructured":"Herbst EW, et al. Intestinal B cell defects in common variable immunodeficiency. Clin Exp Immunol. 1994;95(2):215\u201321.","journal-title":"Clin Exp Immunol"},{"key":"1810_CR435","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.3389\/fimmu.2018.01656","volume":"9","author":"P Scheuerlein","year":"2018","unstructured":"Scheuerlein P, et al. Is it safe to switch from intravenous immunoglobulin to subcutaneous immunoglobulin in patients with common variable immunodeficiency and autoimmune thrombocytopenia? Front Immunol. 2018;9:1656.","journal-title":"Front Immunol"},{"key":"1810_CR436","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s10620-006-9299-6","volume":"52","author":"M Dunnigan","year":"2007","unstructured":"Dunnigan M, et al. Large cell lymphoma presenting as a flare of colitis in a patient with common variable immune deficiency. Dig Dis Sci. 2007;52:830\u20134.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"1810_CR437","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1086\/606059","volume":"49","author":"M Malphettes","year":"2009","unstructured":"Malphettes M, et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis. 2009;49(9):1329\u201338.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1810_CR438","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/jcp.54.9.713","volume":"54","author":"S Jolles","year":"2001","unstructured":"Jolles S, et al. Long term recovery of IgG and IgM production during HIV infection in a patient with common variable immunodeficiency (CVID). J Clin Pathol. 2001;54(9):713\u20135.","journal-title":"J Clin Pathol"},{"issue":"5","key":"1810_CR439","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10875-011-9565-z","volume":"31","author":"SP da Silva","year":"2011","unstructured":"da Silva SP, et al. Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events. J Clin Immunol. 2011;31(5):784\u201391.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1810_CR440","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1046\/j.0902-4441.2003.00082.x","volume":"71","author":"V Le Guern","year":"2003","unstructured":"Le Guern V, et al. Lymphoma complicating common variable immunodeficiency with granulomatous disease: report of two cases. Eur J Haematol. 2003;71(6):459\u201363.","journal-title":"Eur J Haematol"},{"issue":"2","key":"1810_CR441","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/10428190500285285","volume":"47","author":"A Aghamohammadi","year":"2006","unstructured":"Aghamohammadi A, et al. Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency. Leuk Lymphoma. 2006;47(2):343\u20136.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"1810_CR442","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ajh.10050","volume":"69","author":"C Cunningham-Rundles","year":"2002","unstructured":"Cunningham-Rundles C, et al. Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol. 2002;69(3):171\u20138.","journal-title":"Am J Hematol"},{"issue":"1","key":"1810_CR443","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/187152912801823084","volume":"12","author":"C Watkins","year":"2012","unstructured":"Watkins C, et al. Malignancy in common variable immune deficiency: report of two rare cases of gastrointestinal malignancy and a review of the literature. Cardiovasc Hematol Disord Drug Targets. 2012;12(1):21\u20137.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"3","key":"1810_CR444","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000444261","volume":"2","author":"S Stenton","year":"2016","unstructured":"Stenton S, et al. Metachronous diffuse large B-cell lymphoma and kaposi sarcoma of the right eyelid and lacrimal gland in a patient with granulomatous common variable immunodeficiency. Ocul Oncol Pathol. 2016;2(3):197\u2013201.","journal-title":"Ocul Oncol Pathol"},{"issue":"4","key":"1810_CR445","doi-asserted-by":"publisher","first-page":"546","DOI":"10.5217\/ir.2017.15.4.546","volume":"15","author":"Y Liu","year":"2017","unstructured":"Liu Y, et al. Monomorphic epitheliotropic intestinal T-cell lymphoma complicated by common variable immunodeficiency. Intest Res. 2017;15(4):546\u20137.","journal-title":"Intest Res"},{"issue":"4","key":"1810_CR446","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jaci.2014.11.029","volume":"135","author":"C Wehr","year":"2015","unstructured":"Wehr C, et al. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency. J Allergy Clin Immunol. 2015;135(4):988-97 e6.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1810_CR447","first-page":"456","volume":"7","author":"ME Conley","year":"1988","unstructured":"Conley ME, et al. Multifocal adenocarcinoma of the stomach in a child with common variable immunodeficiency. J Pediatr Gastroenterol Nutr. 1988;7(3):456\u201360.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"1810_CR448","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.11622\/smedj.2014147","volume":"55","author":"M Todorovic","year":"2014","unstructured":"Todorovic M, et al. Multiple malignancies in a female patient with common variable immunodeficiency syndrome. Singapore Med J. 2014;55(10):e162\u20134.","journal-title":"Singapore Med J"},{"issue":"4","key":"1810_CR449","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s10875-016-0269-2","volume":"36","author":"J Toh","year":"2016","unstructured":"Toh J, et al. Myelodysplastic Syndrome and Acute Lymphocytic Leukemia in Common Variable Immunodeficiency (CVID). J Clin Immunol. 2016;36(4):366\u20139.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1810_CR450","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/jpsu.2002.29445","volume":"37","author":"I Yal\u00e7\u0131n","year":"2002","unstructured":"Yal\u00e7\u0131n I, et al. Myofibroblastic tumors involving bilateral adrenal glands and skin in a patient with common variable immunodeficiency. J Pediatr Surg. 2002;37(1):124\u20136.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"1810_CR451","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2214\/ajr.163.5.7976886","volume":"163","author":"C Chiaramonte","year":"1994","unstructured":"Chiaramonte C, Glick SN. Nodular lymphoid hyperplasia of the small bowel complicated by jejunal lymphoma in a patient with common variable immune deficiency syndrome. AJR Am J Roentgenol. 1994;163(5):1118\u20139.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"1810_CR452","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ajh.2830370202","volume":"37","author":"C Cunningham-Rundles","year":"1991","unstructured":"Cunningham-Rundles C, et al. Non-Hodgkin lymphoma in common variable immunodeficiency. Am J Hematol. 1991;37(2):69\u201374.","journal-title":"Am J Hematol"},{"key":"1810_CR453","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00431-015-2508-6","volume":"174","author":"MP Gibert","year":"2015","unstructured":"Gibert MP, et al. Non-Hodgkin lymphoma in pediatric patients with common variable immunodeficiency. Eur J Pediatr. 2015;174:1069\u201376.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"1810_CR454","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/01676830.2017.1337170","volume":"36","author":"VS Parikh","year":"2017","unstructured":"Parikh VS, et al. Orbital diffuse large B-cell lymphoma with combined variable immunodeficiency. Orbit. 2017;36(5):340\u20133.","journal-title":"Orbit"},{"key":"1810_CR455","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10875-011-9604-9","volume":"32","author":"C Rivoisy","year":"2012","unstructured":"Rivoisy C, et al. Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency. J Clin Immunol. 2012;32:98\u2013105.","journal-title":"J Clin Immunol"},{"issue":"5\u20136","key":"1810_CR456","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3109\/10428199909058418","volume":"32","author":"SR Gottesman","year":"1999","unstructured":"Gottesman SR, et al. Peripheral T cell lymphoma in a patient with common variable immunodeficiency disease: case report and literature review. Leuk Lymphoma. 1999;32(5\u20136):589\u201395.","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"1810_CR457","doi-asserted-by":"publisher","first-page":"966","DOI":"10.4158\/EP14533.CR","volume":"21","author":"C Ogrin","year":"2015","unstructured":"Ogrin C, et al. Positive test for antithyroglobulin antibodies due to administration of immunoglobulin replacement therapy in a patient with thyroid cancer. Endocr Pract. 2015;21(8):966\u201371.","journal-title":"Endocr Pract"},{"issue":"3","key":"1810_CR458","first-page":"169","volume":"7","author":"A Ramyar","year":"2008","unstructured":"Ramyar A, et al. Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency. Iran J Allergy Asthma Immunol. 2008;7(3):169\u201375.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"3","key":"1810_CR459","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/01913129709021926","volume":"21","author":"GW Mierau","year":"1997","unstructured":"Mierau GW, Greffe BS, Weeks DA. Primary leiomyosarcoma of brain in an adolescent with common variable immunodeficiency syndrome. Ultrastruct Pathol. 1997;21(3):301\u20135.","journal-title":"Ultrastruct Pathol"},{"issue":"1","key":"1810_CR460","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000050475","volume":"68","author":"F Reichenberger","year":"2001","unstructured":"Reichenberger F, et al. Pulmonary mucosa-associated lymphoid tissue lymphoma in a patient with common variable immunodeficiency syndrome. Respiration. 2001;68(1):109\u201312.","journal-title":"Respiration"},{"issue":"7","key":"1810_CR461","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/BF01957899","volume":"155","author":"R Sumazaki","year":"1996","unstructured":"Sumazaki R, et al. Rapidly progressive hepatitis C in a patient with common variable immunodeficiency. Eur J Pediatr. 1996;155(7):532\u20134.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1810_CR462","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.transci.2013.04.014","volume":"48","author":"R Ekart","year":"2013","unstructured":"Ekart R, et al. Rare manifestation of the thrombotic microangiopathy in a patient with sarcoidosis, common variable immunodeficiency and large B-cell non-hodgkin lymphoma: case report. Transfus Apher Sci. 2013;48(3):345\u20137.","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"1810_CR463","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.clim.2015.06.013","volume":"160","author":"M Vlkova","year":"2015","unstructured":"Vlkova M, et al. Regulatory B cells in CVID patients fail to suppress multifunctional IFN-gamma+ TNF-alpha+ CD4+ T cells differentiation. Clin Immunol. 2015;160(2):292\u2013300.","journal-title":"Clin Immunol"},{"issue":"1","key":"1810_CR464","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04384.x","volume":"165","author":"F Dhalla","year":"2011","unstructured":"Dhalla F, et al. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165(1):1\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1810_CR465","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3129\/can j ophthalmol.i07-022","volume":"42","author":"C Goldsmith","year":"2007","unstructured":"Goldsmith C, Shaw A, Burton RL. Serous retinal detachment secondary to uveal lymphoma in a patient with common variable immunodeficiency syndrome. Can J Ophthalmol. 2007;42(2):338\u20139.","journal-title":"Can J Ophthalmol"},{"issue":"5","key":"1810_CR466","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/014556130408300516","volume":"83","author":"H Tcheurekdjian","year":"2004","unstructured":"Tcheurekdjian H, Jenkins O, Hostoffer R. Simultaneous nonparotid cranial mucosa-associated lymphoid tissue lymphoma and common variable immunodeficiency. Ear Nose Throat J. 2004;83(5):352\u20134.","journal-title":"Ear Nose Throat J"},{"issue":"5","key":"1810_CR467","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1081-1206(10)61096-4","volume":"97","author":"PR Ogershok","year":"2006","unstructured":"Ogershok PR, et al. Spectrum of illness in pediatric common variable immunodeficiency. Ann Allergy Asthma Immunol. 2006;97(5):653\u20136.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"1810_CR468","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/PAS.0000000000000661","volume":"40","author":"A Furudo\u00ef","year":"2016","unstructured":"Furudo\u00ef A, et al. Spleen histologic appearance in common variable immunodeficiency: analysis of 17 cases. Am J Surg Pathol. 2016;40(7):958\u201367.","journal-title":"Am J Surg Pathol"},{"issue":"23","key":"1810_CR469","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1200\/JCO.2011.35.6659","volume":"29","author":"FN Croles","year":"2011","unstructured":"Croles FN, et al. Splenic gas as a result of a non-Hodgkin\u2019s lymphoma in a patient with common variable immunodeficiency. J Clin Oncol. 2011;29(23):e666\u20137.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1810_CR470","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2169\/internalmedicine.32.152","volume":"32","author":"T Ohnoshi","year":"1993","unstructured":"Ohnoshi T, et al. Successful treatment of non-Hodgkin\u2019s lymphoma in a patient with common variable immunodeficiency. Intern Med. 1993;32(2):152\u20135.","journal-title":"Intern Med"},{"issue":"5","key":"1810_CR471","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s10875-012-9671-6","volume":"32","author":"LJ Maarschalk-Ellerbroek","year":"2012","unstructured":"Maarschalk-Ellerbroek LJ, et al. The spectrum of disease manifestations in patients with common variable immunodeficiency disorders and partial antibody deficiency in a university hospital. J Clin Immunol. 2012;32(5):907\u201321.","journal-title":"J Clin Immunol"},{"issue":"3\u20134","key":"1810_CR472","first-page":"41","volume":"56","author":"M Shibukawa","year":"2007","unstructured":"Shibukawa M, et al. Treatment of meningioma in a patient with congenital immunodeficiency disorder. Hiroshima J Med Sci. 2007;56(3\u20134):41\u20134.","journal-title":"Hiroshima J Med Sci"},{"issue":"1","key":"1810_CR473","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40364-016-0061-8","volume":"4","author":"E Rael","year":"2016","unstructured":"Rael E, et al. Treatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphoma. Biomark Res. 2016;4(1):7.","journal-title":"Biomark Res"},{"issue":"3","key":"1810_CR474","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0046-8177(98)90042-9","volume":"29","author":"BK Kleinschmidt-DeMasters","year":"1998","unstructured":"Kleinschmidt-DeMasters BK, et al. Unusual dural and skull-based mesenchymal neoplasms: a report of four cases. Hum Pathol. 1998;29(3):240\u20135.","journal-title":"Hum Pathol"},{"issue":"1","key":"1810_CR475","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000355957","volume":"163","author":"P Kralickova","year":"2014","unstructured":"Kralickova P, et al. Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports. Int Arch Allergy Immunol. 2014;163(1):69\u201374.","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"1810_CR476","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajhg.2015.07.008","volume":"97","author":"M Fliegauf","year":"2015","unstructured":"Fliegauf M, et al. Haploinsufficiency of the NF-\u03baB1 subunit p50 in common variable immunodeficiency. Am J Hum Genet. 2015;97(3):389\u2013403.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1810_CR477","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/cei.12748","volume":"184","author":"J Brent","year":"2016","unstructured":"Brent J, et al. Clinical and laboratory correlates of lung disease and cancer in adults with idiopathic hypogammaglobulinaemia. Clin Exp Immunol. 2016;184(1):73\u201382.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"1810_CR478","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1053\/hupa.2000.7626","volume":"31","author":"C Ariatti","year":"2000","unstructured":"Ariatti C, et al. Common-variable immunodeficiency-related lymphomas associate with mutations and rearrangements of BCL-6: pathogenetic and histogenetic implications. Hum Pathol. 2000;31(7):871\u20133.","journal-title":"Hum Pathol"},{"key":"1810_CR479","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","volume":"11","author":"HE Ho","year":"2020","unstructured":"Ho HE, Cunningham-Rundles C. Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis. Front Immunol. 2020;11:149.","journal-title":"Front Immunol"},{"issue":"3","key":"1810_CR480","first-page":"208","volume":"22","author":"P Mohammadinejad","year":"2012","unstructured":"Mohammadinejad P, et al. Pediatric patients with common variable immunodeficiency: long-term follow-up. J Investig Allergol Clin Immunol. 2012;22(3):208\u201314.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"7","key":"1810_CR481","first-page":"1650","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick ES, et al. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood, J Am Soc Hematol. 2012;119(7):1650\u20137.","journal-title":"Blood, J Am Soc Hematol"},{"issue":"6","key":"1810_CR482","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/cells9061498","volume":"9","author":"I Gullo","year":"2020","unstructured":"Gullo I, et al. The dysfunctional immune system in common variable immunodeficiency increases the susceptibility to gastric cancer. Cells. 2020;9(6):1498.","journal-title":"Cells"},{"key":"1810_CR483","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10875-017-0456-9","volume":"38","author":"EJ Feuille","year":"2018","unstructured":"Feuille EJ, et al. Autoimmune cytopenias and associated conditions in CVID: a report from the USIDNET registry. J Clin Immunol. 2018;38:28\u201334.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1810_CR484","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/oxfordjournals.qjmed.a068735","volume":"86","author":"RA Hermaszewski","year":"1993","unstructured":"Hermaszewski RA, Webster ADB. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. QJM: Int J Med. 1993;86(1):31\u201342.","journal-title":"QJM: Int J Med"},{"issue":"4","key":"1810_CR485","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/sji.12593","volume":"86","author":"A Valizadeh","year":"2017","unstructured":"Valizadeh A, et al. A comparison of clinical and immunologic phenotypes in familial and sporadic forms of common variable immunodeficiency. Scand J Immunol. 2017;86(4):239\u201347.","journal-title":"Scand J Immunol"},{"issue":"3","key":"1810_CR486","first-page":"159","volume":"6","author":"L Bezrodnik","year":"2011","unstructured":"Bezrodnik L, Gaillard MI, Carelli D. Clinical and immunological assessment of 94 patients with primary humoral immunodeficiency: common variable immunodeficiency, selective IgA deficiency and polysaccharide antibody deficiency syndrome. J Pediatr Infect Dis. 2011;6(3):159\u201366.","journal-title":"J Pediatr Infect Dis"},{"issue":"03","key":"1810_CR487","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/0366-6999.150092","volume":"128","author":"LJ Lin","year":"2015","unstructured":"Lin LJ, Wang YC, Liu XM. Clinical and immunological features of common variable immunodeficiency in China. Chin Med J. 2015;128(03):310\u20135.","journal-title":"Chin Med J"},{"key":"1810_CR488","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.imlet.2019.05.001","volume":"210","author":"Y Bagheri","year":"2019","unstructured":"Bagheri Y, et al. Comparison of clinical and immunological features and mortality in common variable immunodeficiency and agammaglobulinemia patients. Immunol Lett. 2019;210:55\u201362.","journal-title":"Immunol Lett"},{"issue":"5","key":"1810_CR489","first-page":"372","volume":"20","author":"A Aghamohammadi","year":"2010","unstructured":"Aghamohammadi A, et al. 2 correlation between common variable immunodeficiency clinical phenotypes and parental consanguinity in children and adults. J Investig Allergol Clin Immunol. 2010;20(5):372.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"1810_CR490","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s10875-018-0546-3","volume":"38","author":"DK van der Poorten","year":"2018","unstructured":"van der Poorten DK, et al. Gastric cancer screening in common variable immunodeficiency. J Clin Immunol. 2018;38:768\u201377.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1810_CR491","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.clim.2004.07.002","volume":"113","author":"U Salzer","year":"2004","unstructured":"Salzer U, et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol. 2004;113(3):234\u201340.","journal-title":"Clin Immunol"},{"issue":"1\u20132","key":"1810_CR492","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/10428199709058346","volume":"28","author":"MK Jensen","year":"1997","unstructured":"Jensen MK, et al. EBV-positive primary central nervous system lymphomas in monozygote twins with common variable immunodeficiency and suspected multiple sclerosis. Leuk Lymphoma. 1997;28(1\u20132):187\u201393.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"1810_CR493","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/gut.45.1.77","volume":"45","author":"A Zullo","year":"1999","unstructured":"Zullo A, et al. Gastric pathology in patients with common variable immunodeficiency. Gut. 1999;45(1):77\u201381.","journal-title":"Gut"},{"key":"1810_CR494","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","volume":"27","author":"I Quinti","year":"2007","unstructured":"Quinti I, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27:308\u201316.","journal-title":"J Clin Immunol"},{"key":"1810_CR495","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.imlet.2020.03.006","volume":"223","author":"K Guevara-Hoyer","year":"2020","unstructured":"Guevara-Hoyer K, et al. Variable immunodeficiency study: Evaluation of two European cohorts within a variety of clinical phenotypes. Immunol Lett. 2020;223:78\u201388.","journal-title":"Immunol Lett"},{"key":"1810_CR496","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s10875-017-0415-5","volume":"37","author":"LA Sanchez","year":"2017","unstructured":"Sanchez LA, et al. Two sides of the same coin: pediatric-onset and adult-onset common variable immune deficiency. J Clin Immunol. 2017;37:592\u2013602.","journal-title":"J Clin Immunol"},{"key":"1810_CR497","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-018-0941-0","volume":"13","author":"I Odnoletkova","year":"2018","unstructured":"Odnoletkova I, et al. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European society for immunodeficiency (ESID) registry data. Orphanet J Rare Dis. 2018;13:1\u201317.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"1810_CR498","first-page":"1953","volume":"120","author":"I Quinti","year":"2012","unstructured":"Quinti I, et al. Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency. Blood J Am Soc Hematol. 2012;120(9):1953\u20134.","journal-title":"Blood J Am Soc Hematol"},{"key":"1810_CR499","doi-asserted-by":"crossref","unstructured":"Gutierrez MJ, et al. Phenotypic characterization of patients with rheumatologic manifestations of common variable immunodeficiency. Semin Arthritis Rheum. 2018;48(2):318\u2013326.","DOI":"10.1016\/j.semarthrit.2018.02.013"},{"issue":"6","key":"1810_CR500","first-page":"416","volume":"25","author":"P Mohammadinejad","year":"2015","unstructured":"Mohammadinejad P, et al. Primary antibody deficiency in a tertiary referral hospital: a 30-year experiment. J Investig Allergol Clin Immunol. 2015;25(6):416\u201325.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"1810_CR501","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10875-020-00879-3","volume":"41","author":"C Sewell","year":"2021","unstructured":"Sewell C, et al. Common variable immunodeficiency with the concomitant diagnosis of an inflammatory myofibroblastic tumor. J Clin Immunol. 2021;41:230\u20132.","journal-title":"J Clin Immunol"},{"key":"1810_CR502","doi-asserted-by":"publisher","first-page":"e20213133","DOI":"10.1590\/0100-6991e-20213133","volume":"48","author":"P Krein","year":"2021","unstructured":"Krein P, et al. Common variable immunodeficiency: an important but little-known risk factor for gastric cancer. Rev Col Bras Cir. 2021;48:e20213133.","journal-title":"Rev Col Bras Cir"},{"key":"1810_CR503","doi-asserted-by":"publisher","first-page":"742530","DOI":"10.3389\/fimmu.2022.742530","volume":"13","author":"L Bruns","year":"2022","unstructured":"Bruns L, et al. Common variable immunodeficiency-associated cancers: the role of clinical phenotypes, immunological and genetic factors. Front Immunol. 2022;13:742530.","journal-title":"Front Immunol"},{"issue":"6","key":"1810_CR504","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s10875-021-01016-4","volume":"41","author":"C Wehr","year":"2021","unstructured":"Wehr C, et al. altered spectrum of lymphoid neoplasms in a single-center cohort of common variable immunodeficiency with immune dysregulation. J Clin Immunol. 2021;41(6):1250\u201365.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1810_CR505","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/cei.13579","volume":"204","author":"R Shavit","year":"2021","unstructured":"Shavit R, et al. Immunodeficiency (CVID and CD4 lymphopenia) is associated with a high risk of malignancy among adults with primary immune deficiency. Clin Exp Immunol. 2021;204(2):251\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1810_CR506","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/j.oooo.2021.09.004","volume":"133","author":"WA Alamoudi","year":"2022","unstructured":"Alamoudi WA, et al. EBV-positive B-cell ulcerative proliferation in the oral cavity associated with EBV-negative follicular lymphoma in a patient with common variable immunodeficiency: A case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022;133(1):e10\u20139.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1810_CR507","doi-asserted-by":"publisher","first-page":"1033666","DOI":"10.3389\/fimmu.2022.1033666","volume":"13","author":"MD Caba\u00f1ero-Navalon","year":"2022","unstructured":"Caba\u00f1ero-Navalon MD, et al. Current clinical spectrum of common variable immunodeficiency in Spain: the multicentric nationwide GTEM-SEMI-CVID registry. Front Immunol. 2022;13:1033666.","journal-title":"Front Immunol"},{"key":"1810_CR508","doi-asserted-by":"crossref","unstructured":"Thurlapati A, et al. A case of aplastic anemia and colon cancer with underlying spliceosome mutation: is it an incidental finding or a novel association? Cureus. 2022;14(2).","DOI":"10.7759\/cureus.22632"},{"key":"1810_CR509","doi-asserted-by":"crossref","unstructured":"Mateti NR, et al. Myelodysplastic syndrome in a patient with common variable immunodeficiency: a rare occurrence. Cureus. 2022;14(9).","DOI":"10.7759\/cureus.28690"},{"issue":"5","key":"1810_CR510","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/ejh.13687","volume":"107","author":"T Smith","year":"2021","unstructured":"Smith T, Cunningham-Rundles C. Lymphoid malignancy in common variable immunodeficiency in a single-center cohort. Eur J Haematol. 2021;107(5):503\u201316.","journal-title":"Eur J Haematol"},{"key":"1810_CR511","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3389\/fimmu.2018.00694","volume":"9","author":"CA Slade","year":"2018","unstructured":"Slade CA, et al. Delayed diagnosis and complications of predominantly antibody deficiencies in a cohort of australian adults. Front Immunol. 2018;9:694.","journal-title":"Front Immunol"},{"issue":"1","key":"1810_CR512","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10875-017-0452-0","volume":"38","author":"M Desjardins","year":"2018","unstructured":"Desjardins M, et al. Modulation of the interleukin-21 pathway with interleukin-4 distinguishes common variable immunodeficiency patients with more non-infectious clinical complications. J Clin Immunol. 2018;38(1):45\u201355.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1810_CR513","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.anai.2017.07.006","volume":"119","author":"D Ferastraoaru","year":"2017","unstructured":"Ferastraoaru D, Gross R, Rosenstreich D. Increased malignancy incidence in IgE deficient patients not due to concomitant common variable immunodeficiency. Ann Allergy Asthma Immunol. 2017;119(3):267\u201373.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"1810_CR514","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/0394632015617064","volume":"29","author":"N Kutukculer","year":"2016","unstructured":"Kutukculer N, et al. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-\u03b3) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency. Int J Immunopathol Pharmacol. 2016;29(2):241\u201351.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"1810_CR515","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","volume":"134","author":"B Gathmann","year":"2014","unstructured":"Gathmann B, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116\u201326.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1810_CR516","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/cei.12002","volume":"171","author":"V Gouilleux-Gruart","year":"2013","unstructured":"Gouilleux-Gruart V, et al. Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor. Clin Exp Immunol. 2013;171(2):186\u201394.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1810_CR517","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.aller.2013.01.007","volume":"42","author":"N Ram\u00edrez-Vargas","year":"2014","unstructured":"Ram\u00edrez-Vargas N, et al. Clinical and immunological features of common variable immunodeficiency in Mexican patients. Allergol Immunopathol. 2014;42(3):235\u201340.","journal-title":"Allergol Immunopathol"},{"issue":"2","key":"1810_CR518","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2249.2012.04643.x","volume":"170","author":"EA Bateman","year":"2012","unstructured":"Bateman EA, et al. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol. 2012;170(2):202\u201311.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1810_CR519","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10875-010-9493-3","volume":"31","author":"LL Wang","year":"2011","unstructured":"Wang LL, et al. Distribution and clinical features of primary immunodeficiency diseases in Chinese children (2004\u20132009). J Clin Immunol. 2011;31(3):297\u2013308.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1810_CR520","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","volume":"125","author":"M Lucas","year":"2010","unstructured":"Lucas M, et al. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol. 2010;125(6):1354-1360.e4.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"1810_CR521","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1038\/ajg.2010.214","volume":"105","author":"G Malamut","year":"2010","unstructured":"Malamut G, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010;105(10):2262\u201375.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1810_CR522","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/j.1399-3038.2010.01004.x","volume":"21","author":"PL Yong","year":"2010","unstructured":"Yong PL, Orange JS, Sullivan KE. Pediatric common variable immunodeficiency: immunologic and phenotypic associations with switched memory B cells. Pediatr Allergy Immunol. 2010;21(5):852\u20138.","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"1810_CR523","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jpeds.2008.12.020","volume":"154","author":"S Urschel","year":"2009","unstructured":"Urschel S, et al. Common variable immunodeficiency disorders in children: delayed diagnosis despite typical clinical presentation. J Pediatr. 2009;154(6):888\u201394.","journal-title":"J Pediatr"},{"issue":"2","key":"1810_CR524","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","volume":"112","author":"H Chapel","year":"2008","unstructured":"Chapel H, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277\u201386.","journal-title":"Blood"},{"issue":"10","key":"1810_CR525","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1086\/587669","volume":"46","author":"E Oksenhendler","year":"2008","unstructured":"Oksenhendler E, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46(10):1547\u201354.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1810_CR526","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2249.2008.03711.x","volume":"153","author":"C Ward","year":"2008","unstructured":"Ward C, et al. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol. 2008;153(3):331\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1810_CR527","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","volume":"114","author":"CA Bates","year":"2004","unstructured":"Bates CA, et al. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol. 2004;114(2):415\u201321.","journal-title":"J Allergy Clin Immunol"},{"issue":"1\u20134","key":"1810_CR528","first-page":"19","volume":"4","author":"F Pandolfi","year":"1993","unstructured":"Pandolfi F, et al. Abnormalities of lymphocyte subpopulations in CVI do not correlate with increased production of IL-6. Immunodeficiency. 1993;4(1\u20134):19\u201323.","journal-title":"Immunodeficiency"},{"key":"1810_CR529","doi-asserted-by":"publisher","first-page":"104086","DOI":"10.1016\/j.msard.2022.104086","volume":"67","author":"B Martins","year":"2022","unstructured":"Martins B, et al. Common variable immunodeficiency and its inflammatory neurological manifestations: a case report and literature review. Mult Scler Relat Dis. 2022;67:104086.","journal-title":"Mult Scler Relat Dis"},{"issue":"1","key":"1810_CR530","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bmhimx.2015.11.009","volume":"73","author":"MA Mart\u00edn-Mateos","year":"2016","unstructured":"Mart\u00edn-Mateos MA, Piquer Gibert M. Primary immunodeficiencies and B-cell lymphomas. Bol M\u00e9d Hosp Infant M\u00e9xico. 2016;73(1):18\u201325.","journal-title":"Bol M\u00e9d Hosp Infant M\u00e9xico"},{"issue":"2","key":"1810_CR531","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00004836-199209000-00010","volume":"15","author":"G Castellano","year":"1992","unstructured":"Castellano G, et al. Malignant lymphoma of jejunum with common variable hypogammaglobulinemia and diffuse nodular hyperplasia of the small intestine: a case study and literature review. J Clin Gastroenterol. 1992;15(2):128\u201335.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"1810_CR532","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/00043426-199305000-00016","volume":"15","author":"NC de Bruin","year":"1993","unstructured":"de Bruin NC, et al. Small-cell undifferentiated (neuroendocrine) carcinoma of the cecum in a child with common variable immunodeficiency. J Pediatr Hematol\/Oncol. 1993;15(2):258\u201361.","journal-title":"J Pediatr Hematol\/Oncol"},{"issue":"2","key":"1810_CR533","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/1097-0142(19870115)59:2<271::AID-CNCR2820590216>3.0.CO;2-H","volume":"59","author":"JC Durham","year":"1987","unstructured":"Durham JC, et al. Common variable hypogammaglobulinemia complicated by an unusual T-suppressor\/cytotoxic cell lymphoma. Cancer. 1987;59(2):271\u20136.","journal-title":"Cancer"},{"issue":"1","key":"1810_CR534","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0002-9343(88)90519-0","volume":"85","author":"JH Kim","year":"1988","unstructured":"Kim JH, et al. Peripheral T-cell lymphoma complicating common variable hypogammaglobulinemia. Am J Med. 1988;85(1):123\u20135.","journal-title":"Am J Med"},{"issue":"1","key":"1810_CR535","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","volume":"15","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, et al. Dominant-activating germline mutations in the gene encoding the PI (3) K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency. Nat Immunol. 2014;15(1):88\u201397.","journal-title":"Nat Immunol"},{"issue":"1","key":"1810_CR536","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jaci.2014.02.020","volume":"134","author":"S Kracker","year":"2014","unstructured":"Kracker S, et al. Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase delta syndrome. J Allergy Clin Immunol. 2014;134(1):233\u20136.","journal-title":"J Allergy Clin Immunol"},{"key":"1810_CR537","doi-asserted-by":"publisher","first-page":"813261","DOI":"10.3389\/fimmu.2021.813261","volume":"12","author":"Z Yin","year":"2021","unstructured":"Yin Z, et al. Case report: first occurrence of plasmablastic lymphoma in activated phosphoinositide 3-kinase \u03b4 syndrome. Front Immunol. 2021;12:813261.","journal-title":"Front Immunol"},{"issue":"6160","key":"1810_CR538","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","volume":"342","author":"I Angulo","year":"2013","unstructured":"Angulo I, et al. Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342(6160):866\u201371.","journal-title":"Science"},{"issue":"1","key":"1810_CR539","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jaci.2018.04.030","volume":"143","author":"ES Edwards","year":"2019","unstructured":"Edwards ES, et al. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity. J Allergy Clin Immunol. 2019;143(1):276-291.e6.","journal-title":"J Allergy Clin Immunol"},{"key":"1810_CR540","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s10875-014-0012-9","volume":"34","author":"M Crank","year":"2014","unstructured":"Crank M, et al. Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility. J Clin Immunol. 2014;34:272\u20136.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1810_CR541","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaci.2016.08.028","volume":"139","author":"AED Florea","year":"2017","unstructured":"Florea AED, et al. Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD. J Allergy Clin Immunol. 2017;139(3):1032-1035.e6.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1810_CR542","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jaci.2018.04.032","volume":"143","author":"T Okano","year":"2019","unstructured":"Okano T, et al. Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase \u03b4 syndrome type 1. J Allergy Clin Immunol. 2019;143(1):266\u201375.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1810_CR543","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","volume":"138","author":"E Elkaim","year":"2016","unstructured":"Elkaim E, et al. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study. J Allergy Clin Immunol. 2016;138(1):210-218.e9.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1810_CR544","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2015.04.014","volume":"159","author":"V Lougaris","year":"2015","unstructured":"Lougaris V, et al. Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype. Clin Immunol (Orlando, Fla). 2015;159(1):33\u20136.","journal-title":"Clin Immunol (Orlando, Fla.)"},{"issue":"9","key":"1810_CR545","first-page":"1967","volume":"113","author":"U Salzer","year":"2009","unstructured":"Salzer U, et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood J Am Soc Hematol. 2009;113(9):1967\u201376.","journal-title":"Blood J Am Soc Hematol"},{"issue":"11","key":"1810_CR546","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1056\/NEJMoa1512234","volume":"374","author":"HS Kuehn","year":"2016","unstructured":"Kuehn HS, et al. Loss of B cells in patients with heterozygous mutations in IKAROS. N Engl J Med. 2016;374(11):1032\u201343.","journal-title":"N Engl J Med"},{"key":"1810_CR547","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3389\/fimmu.2019.00568","volume":"10","author":"Z Eskandarian","year":"2019","unstructured":"Eskandarian Z, et al. Assessing the functional relevance of variants in the IKAROS family zinc finger protein 1 (IKZF1) in a cohort of patients with primary immunodeficiency. Front Immunol. 2019;10:568.","journal-title":"Front Immunol"},{"issue":"7","key":"1810_CR548","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1172\/JCI98164","volume":"128","author":"D Boutboul","year":"2018","unstructured":"Boutboul D, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Investig. 2018;128(7):3071\u201387.","journal-title":"J Clin Investig"},{"issue":"4","key":"1810_CR549","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jaci.2019.11.051","volume":"146","author":"T Lorenzini","year":"2020","unstructured":"Lorenzini T, et al. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. J Allergy Clin Immunol. 2020;146(4):901\u201311.","journal-title":"J Allergy Clin Immunol"},{"key":"1810_CR550","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2019.00297","volume":"10","author":"C Klemann","year":"2019","unstructured":"Klemann C, et al. Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2. Front Immunol. 2019;10:297.","journal-title":"Front Immunol"},{"issue":"12","key":"1810_CR551","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00439-022-02470-9","volume":"141","author":"M Djursby","year":"2022","unstructured":"Djursby M, et al. Clinical implications of genetic testing in familial intermediate and late-onset colorectal cancer. Hum Genet. 2022;141(12):1925\u201333.","journal-title":"Hum Genet"},{"issue":"9","key":"1810_CR552","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0046-8177(96)90232-4","volume":"27","author":"HJ Zirkin","year":"1996","unstructured":"Zirkin HJ, Levy J, Katchko L. Small cell undifferentiated carcinoma of the colon associated with hepatocellular carcinoma in an immunodeficient patient. Hum Pathol. 1996;27(9):992\u20136.","journal-title":"Hum Pathol"},{"issue":"4","key":"1810_CR553","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/ajcp\/54.4.618","volume":"54","author":"WV Miller","year":"1970","unstructured":"Miller WV, et al. Anaphylactic reaction s to Ig A: a difficult transfusion problem. Am J Clin Pathol. 1970;54(4):618\u201321.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"1810_CR554","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-2007-1018479","volume":"17","author":"M Curzio","year":"1985","unstructured":"Curzio M, et al. Association of ulcerative colitis, sclerosing cholangitis and cholangiocarcinoma in a patient with IgA deficiency. Endoscopy. 1985;17(3):123\u20135.","journal-title":"Endoscopy"},{"issue":"1\u20132","key":"1810_CR555","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02307420","volume":"135","author":"K Miyagi","year":"1995","unstructured":"Miyagi K, et al. Astrocytoma linked to familial ataxia-telangiectasia. Acta Neurochir (Wien). 1995;135(1\u20132):87\u201392.","journal-title":"Acta Neurochir (Wien)"},{"issue":"5\u20136","key":"1810_CR556","first-page":"237","volume":"33","author":"KO Goh","year":"1976","unstructured":"Goh KO, Reddy MM, Webb DR. Cancer in a familial IgA deficiency patient: abnormal chromosomes and B lymphocytes. Oncology. 1976;33(5\u20136):237\u201340.","journal-title":"Oncology"},{"issue":"12","key":"1810_CR557","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/BF02553947","volume":"27","author":"SH Mir-Madjlessi","year":"1984","unstructured":"Mir-Madjlessi SH, et al. Coexisting primary malignant lymphoma and adenocarcinoma of the large intestine in an IgA-deficient boy. Dis Colon Rectum. 1984;27(12):822\u20134.","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"1810_CR558","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.humpath.2015.01.011","volume":"46","author":"S Uccini","year":"2015","unstructured":"Uccini S, et al. Epstein-Barr virus\u2013positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus\u2013positive diffuse large B-cell lymphoma of the elderly. Human Pathol. 2015;46(5):716\u201324.","journal-title":"Human Pathol"},{"issue":"4","key":"1810_CR559","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/1097-0142(197404)33:4<1134::AID-CNCR2820330437>3.0.CO;2-7","volume":"33","author":"AB Hamoudi","year":"1974","unstructured":"Hamoudi AB, et al. Multiple neoplasms in an adolescent child associated with IGA deficiency. Cancer. 1974;33(4):1134\u201344.","journal-title":"Cancer"},{"issue":"1","key":"1810_CR560","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5021\/ad.1994.6.1.81","volume":"6","author":"HJ Kweon","year":"1994","unstructured":"Kweon HJ, et al. Squamous cell carcinoma arising from chronic ulcerative lesion in a patient with disabling pansclerotic morphea. Ann Dermatol. 1994;6(1):81\u20135.","journal-title":"Ann Dermatol"},{"issue":"3","key":"1810_CR561","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1445-5994.1979.tb04145.x","volume":"9","author":"CH Lee","year":"1979","unstructured":"Lee CH, et al. IgA deficiency, superior mediastinal tumour with unusual clinical manifestations. Aust N Z J Med. 1979;9(3):306\u20139.","journal-title":"Aust N Z J Med"},{"key":"1810_CR562","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijscr.2016.11.033","volume":"30","author":"T Hanich","year":"2017","unstructured":"Hanich T, et al. Nodular lymphoid hyperplasia complicated with ileal Burkitt\u2019s lymphoma in an adult patient with selective IgA deficiency. Int J Surg Case Rep. 2017;30:69\u201372.","journal-title":"Int J Surg Case Rep"},{"issue":"5","key":"1810_CR563","first-page":"839","volume":"4","author":"M Verkasalo","year":"1985","unstructured":"Verkasalo M, et al. Fibrosarcoma in a girl with celiac disease and IgA deficiency. J Pediatr Gastroenterol Nutr. 1985;4(5):839\u201341.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"1810_CR564","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1097\/RLU.0000000000002035","volume":"43","author":"HS Ahmed","year":"2018","unstructured":"Ahmed HS, et al. FDG-avid focal liver reaction from proton therapy in a patient with primary esophageal adenocarcinoma. Clin Nucl Med. 2018;43(5):e139\u201341.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"1810_CR565","first-page":"61","volume":"38","author":"C Cunningham-Rundles","year":"1980","unstructured":"Cunningham-Rundles C, et al. Selective IgA deficiency and neoplasia. Vox Sang. 1980;38(2):61\u20137.","journal-title":"Vox Sang"},{"issue":"2","key":"1810_CR566","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/imj.1970.19.2.165","volume":"19","author":"KJ Fraser","year":"1970","unstructured":"Fraser KJ, Rankin JG. Selective deficiency of IgA immunoglobulins associated with carcinoma of the stomach. Australas Ann Med. 1970;19(2):165\u20137.","journal-title":"Australas Ann Med"},{"issue":"3","key":"1810_CR567","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.3324\/haematol.2018.203943","volume":"104","author":"S Zandi","year":"2019","unstructured":"Zandi S, et al. Resolution of celiac disease, IgA deficiency and platelet refractoriness after allogeneic bone marrow transplantation for acute leukemia. Haematologica. 2019;104(3):e121\u20133.","journal-title":"Haematologica"},{"issue":"2","key":"1810_CR568","first-page":"29","volume":"36","author":"IH Turkbeyler","year":"2011","unstructured":"Turkbeyler IH, et al. Esophagus cancer and IgA deficiency in a patient with Dubowitz syndrome: a case report. Tokai J Exp Clin Med. 2011;36(2):29\u201330.","journal-title":"Tokai J Exp Clin Med"},{"key":"1810_CR569","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s10875-014-0124-2","volume":"35","author":"JF Ludvigsson","year":"2015","unstructured":"Ludvigsson JF, et al. IgA deficiency and risk of cancer: a population-based matched cohort study. J Clin Immunol. 2015;35:182\u20138.","journal-title":"J Clin Immunol"},{"key":"1810_CR570","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s10875-013-9948-4","volume":"33","author":"JF Ludvigsson","year":"2013","unstructured":"Ludvigsson JF, Neovius M, Hammarstr\u00f6m L. IgA deficiency & mortality: a population-based cohort study. J Clin Immunol. 2013;33:1317\u201324.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1810_CR571","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1159\/000511066","volume":"13","author":"BM Dakkak","year":"2021","unstructured":"Dakkak BM, et al. Selective immunoglobulin a deficiency, helicobacter pylori infection, and strongyloidiasis in a patient with adenocarcinoma of the stomach. Case Rep Oncol. 2021;13(3):1325\u20139.","journal-title":"Case Rep Oncol"},{"issue":"12","key":"1810_CR572","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1002\/ccr3.3298","volume":"8","author":"H Ida","year":"2020","unstructured":"Ida H, et al. Duodenal nodular lymphoid hyperplasia in a patient with IgA deficiency. Clin Case Rep. 2020;8(12):3593\u20134.","journal-title":"Clin Case Rep"},{"issue":"1","key":"1810_CR573","doi-asserted-by":"publisher","first-page":"26","DOI":"10.14740\/jmc3804","volume":"13","author":"A Kasi","year":"2022","unstructured":"Kasi A, et al. Immunoglobin a deficiency and squamous cell carcinoma with a rare presentation as anal cancer. J Med Cases. 2022;13(1):26.","journal-title":"J Med Cases"},{"key":"1810_CR574","doi-asserted-by":"publisher","first-page":"843741","DOI":"10.3389\/fonc.2022.843741","volume":"12","author":"J Mammadova","year":"2022","unstructured":"Mammadova J, et al. Case report: initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity. Front Oncol. 2022;12:843741.","journal-title":"Front Oncol"},{"issue":"6","key":"1810_CR575","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/00000372-200012000-00008","volume":"22","author":"JY Lei","year":"2000","unstructured":"Lei JY, et al. Microcystic adnexal carcinoma associated with primary immunodeficiency, recurrent diffuse herpes simplex virus infection, and cutaneous T-cell lymphoma. Am J Dermatopathol. 2000;22(6):524\u20139.","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"1810_CR576","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1365-2796.1996.514837000.x","volume":"240","author":"T Zenone","year":"1996","unstructured":"Zenone T, et al. Hodgkin\u2019s disease associated with IgA and IgG subclass deficiency. J Intern Med. 1996;240(2):99\u2013102.","journal-title":"J Intern Med"},{"key":"1810_CR577","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4076\/1757-1626-2-6785","volume":"2","author":"T Saleem","year":"2009","unstructured":"Saleem T, Rabbani M, Jamil B. Primary IgA and IgG subclass deficiency in a 17-year-old Pakistani girl: a case report. Cases J. 2009;2:1\u20134.","journal-title":"Cases J"},{"issue":"22","key":"1810_CR578","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.3390\/jcm11226795","volume":"11","author":"C Picado","year":"2022","unstructured":"Picado C, et al. Skin manifestations in patients with selective immunoglobulin E deficiency. J Clin Med. 2022;11(22):6795.","journal-title":"J Clin Med"},{"issue":"12","key":"1810_CR579","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/1097-0142(19811215)48:12<2624::AID-CNCR2820481214>3.0.CO;2-H","volume":"48","author":"AM Bobrove","year":"1981","unstructured":"Bobrove AM, et al. Coexistence of a primary immunodeficiency disorder and hodgkin\u2019s disease: evidence against a B-Lymphocyte origin for the reed-sternberg cell. Cancer. 1981;48(12):2624\u20139.","journal-title":"Cancer"},{"key":"1810_CR580","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/BF01315216","volume":"25","author":"CB Lamers","year":"1980","unstructured":"Lamers CB, et al. Jejunal lymphoma in a patient with primary adult-onset hypogammaglobulinemia and nodular lymphoid hyperplasia of the small intestine. Dig Dis Sci. 1980;25:553\u20137.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"1810_CR581","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1440-1827.2008.02261.x","volume":"58","author":"J Shiraishi","year":"2008","unstructured":"Shiraishi J, et al. Type AB thymoma accompanied by pure red cell aplasia and Good syndrome with CMV infection of tumor cells. Pathol Int. 2008;58(8):489\u201393.","journal-title":"Pathol Int"},{"issue":"7","key":"1810_CR582","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/1097-0142(19840401)53:7<1492::AID-CNCR2820530711>3.0.CO;2-V","volume":"53","author":"H Tsuchiya","year":"1984","unstructured":"Tsuchiya H, et al. Immunologic studies of peripheral blood in a child with hypogammaglobulinemia. Suggested mechanism for the development of malignant B-cell lymphoma. Cancer. 1984;53(7):1492\u20137.","journal-title":"Cancer"},{"issue":"1","key":"1810_CR583","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0163-4453(79)80054-7","volume":"1","author":"RA Thompson","year":"1979","unstructured":"Thompson RA, Rees-Jones A. The antibody deficiency syndrome: a report on current management. J Infect. 1979;1(1):49\u201360.","journal-title":"J Infect"},{"issue":"11","key":"1810_CR584","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1182\/blood-2004-04-1477","volume":"105","author":"R Clementi","year":"2005","unstructured":"Clementi R, et al. A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood. 2005;105(11):4424\u20138.","journal-title":"Blood"},{"issue":"12","key":"1810_CR585","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1002\/pbc.25646","volume":"62","author":"B Tesi","year":"2015","unstructured":"Tesi B, et al. Spectrum of atypical clinical presentations in patients with biallelic PRF1 missense mutations. Pediatr Blood Cancer. 2015;62(12):2094\u2013100.","journal-title":"Pediatr Blood Cancer"},{"key":"1810_CR586","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10072-010-0467-2","volume":"32","author":"L Chiapparini","year":"2011","unstructured":"Chiapparini L, et al. Hemophagocytic lymphohistiocytosis with neurological presentation: MRI findings and a nearly miss diagnosis. Neurol Sci. 2011;32:473\u20137.","journal-title":"Neurol Sci"},{"issue":"3","key":"1810_CR587","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bcmd.2014.11.023","volume":"54","author":"S Mhatre","year":"2015","unstructured":"Mhatre S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis (FHL) patients in India. Blood Cells Mol Dis. 2015;54(3):250\u20137.","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"1810_CR588","first-page":"2266","volume":"100","author":"R Clementi","year":"2002","unstructured":"Clementi R, et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood J Amn Soc Hematol. 2002;100(6):2266\u20132266.","journal-title":"Blood J Amn Soc Hematol"},{"issue":"8","key":"1810_CR589","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1097\/MPH.0000000000000102","volume":"36","author":"S Mhatre","year":"2014","unstructured":"Mhatre S, et al. Unusual clinical presentations of familial hemophagocytic lymphohistiocytosis type-2. J Pediatr Hematol Oncol. 2014;36(8):e524\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"1810_CR590","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3324\/haematol.2010.029389","volume":"95","author":"J Rohr","year":"2010","unstructured":"Rohr J, et al. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Haematologica. 2010;95(12):2080.","journal-title":"Haematologica"},{"issue":"2","key":"1810_CR591","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1097\/MPH.0000000000002141","volume":"44","author":"M Liao","year":"2022","unstructured":"Liao M, Yu J. Secondary leukemia in a patient with EBV-HLH carrying heterozygous STXBP2 variant. J Pediatr Hematol Oncol. 2022;44(2):e526\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9","key":"1810_CR592","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11926-014-0439-2","volume":"16","author":"M Zhang","year":"2014","unstructured":"Zhang M, et al. Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep. 2014;16(9):439.","journal-title":"Curr Rheumatol Rep"},{"issue":"20","key":"1810_CR593","first-page":"3402","volume":"122","author":"RC Yiu","year":"2013","unstructured":"Yiu RC, Lau LC. Hemophagocytosis and complex marrow karyotype in metastatic adenocarcinoma. Blood J Am Soc Hematol. 2013;122(20):3402\u20133402.","journal-title":"Blood J Am Soc Hematol"},{"issue":"11","key":"1810_CR594","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1182\/blood.V13.11.1063.1063","volume":"13","author":"P Efrati","year":"1958","unstructured":"Efrati P, Jonas W. Chediak\u2019s anomaly of leukocytes in malignant lymphoma associated with leukemic manifestations: case report with necropsy. Blood. 1958;13(11):1063\u201373.","journal-title":"Blood"},{"issue":"6","key":"1810_CR595","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.aller.2019.04.010","volume":"47","author":"IM Carneiro","year":"2019","unstructured":"Carneiro IM, et al. Chediak-Higashi syndrome: lessons from a single-centre case series. Allergol Immunopathol. 2019;47(6):598\u2013603.","journal-title":"Allergol Immunopathol"},{"key":"1810_CR596","doi-asserted-by":"publisher","first-page":"1151166","DOI":"10.3389\/fimmu.2023.1151166","volume":"14","author":"N Brauer","year":"2023","unstructured":"Brauer N, et al. Immunodeficiency with susceptibility to lymphoma with complex genotype affecting energy metabolism (FBP1, ACAD9) and vesicle trafficking (RAB27A). Front Immunol. 2023;14:1151166.","journal-title":"Front Immunol"},{"issue":"11","key":"1810_CR597","doi-asserted-by":"publisher","first-page":"e80131","DOI":"10.1371\/journal.pone.0080131","volume":"8","author":"L Lorenzi","year":"2013","unstructured":"Lorenzi L, et al. Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. PloS one. 2013;8(11):e80131.","journal-title":"PloS one"},{"issue":"5","key":"1810_CR598","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/pbc.21341","volume":"50","author":"KG Lucas","year":"2008","unstructured":"Lucas KG, et al. Epstein Barr virus induced lymphoma in a child with IPEX syndrome. Pediatr Blood Cancer. 2008;50(5):1056\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"1810_CR599","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3389\/fimmu.2018.02012","volume":"9","author":"D Egg","year":"2018","unstructured":"Egg D, et al. Increased risk for malignancies in 131 affected CTLA4 mutation carriers. Front Immunol. 2018;9:2012.","journal-title":"Front Immunol"},{"issue":"1","key":"1810_CR600","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10875-015-0221-x","volume":"36","author":"S Hayakawa","year":"2016","unstructured":"Hayakawa S, et al. A patient with CTLA-4 haploinsufficiency presenting gastric cancer. J Clin Immunol. 2016;36(1):28\u201332.","journal-title":"J Clin Immunol"},{"key":"1810_CR601","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s10875-019-00677-6","volume":"39","author":"D Cagdas","year":"2019","unstructured":"Cagdas D, et al. A spectrum of clinical findings from ALPS to CVID: several novel LRBA defects. J Clin Immunol. 2019;39:726\u201338.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1810_CR602","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10875-015-0224-7","volume":"36","author":"OK Alkhairy","year":"2016","unstructured":"Alkhairy OK, et al. Spectrum of Phenotypes Associated with Mutations in LRBA. J Clin Immunol. 2016;36(1):33\u201345.","journal-title":"J Clin Immunol"},{"key":"1810_CR603","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-017-0682-5","volume":"12","author":"N Bratani\u010d","year":"2017","unstructured":"Bratani\u010d N, et al. Multifocal gastric adenocarcinoma in a patient with LRBA deficiency. Orphanet J Rare Dis. 2017;12:1\u20138.","journal-title":"Orphanet J Rare Dis"},{"issue":"6246","key":"1810_CR604","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.aaa1663","volume":"349","author":"B Lo","year":"2015","unstructured":"Lo B, et al. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science. 2015;349(6246):436\u201340.","journal-title":"Science"},{"key":"1810_CR605","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.3389\/fimmu.2018.02397","volume":"9","author":"P Soler-Palac\u00edn","year":"2018","unstructured":"Soler-Palac\u00edn P, et al. LRBA deficiency in a patient with a novel homozygous mutation due to chromosome 4 segmental uniparental isodisomy. Front Immunol. 2018;9:2397.","journal-title":"Front Immunol"},{"issue":"1","key":"1810_CR606","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10875-022-01358-7","volume":"43","author":"T Freund","year":"2023","unstructured":"Freund T, et al. Clinically Complex LRBA Deficiency Due to a Founder Allele in the Georgian Jewish Population. J Clin Immunol. 2023;43(1):151\u201364.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1810_CR607","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","volume":"125","author":"EM Haapaniemi","year":"2015","unstructured":"Haapaniemi EM, et al. Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. Blood. 2015;125(4):639\u201348.","journal-title":"Blood"},{"issue":"4","key":"1810_CR608","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","volume":"151","author":"JW Leiding","year":"2023","unstructured":"Leiding JW, et al. Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome. J Allergy Clin Immunol. 2023;151(4):1081\u201395.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1810_CR609","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.jaad.2009.06.061","volume":"62","author":"BC B\u00f6ckle","year":"2010","unstructured":"B\u00f6ckle BC, et al. Oral mucous squamous cell carcinoma\u2014an anticipated consequence of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Am Acad Dermatol. 2010;62(5):864\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"1810_CR610","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s40618-021-01585-6","volume":"44","author":"S Garelli","year":"2021","unstructured":"Garelli S, et al. Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients. J Endocrinol Invest. 2021;44(11):2493\u2013510.","journal-title":"J Endocrinol Invest"},{"issue":"23","key":"1810_CR611","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1182\/blood-2013-06-508267","volume":"122","author":"B Neven","year":"2013","unstructured":"Neven B, et al. A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. Blood. 2013;122(23):3713\u201322.","journal-title":"Blood"},{"issue":"7","key":"1810_CR612","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1097\/MPH.0b013e318207a37a","volume":"33","author":"MA Bautista-Quach","year":"2011","unstructured":"Bautista-Quach MA, Bedros A, Wang J. Subsequent development of diffuse large B-cell lymphomas and Hodgkin lymphoma associated with primary immune disorder in a 6-year-old female: a case report and review of the literature. J Pediatr Hematol Oncol. 2011;33(7):e320\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"1810_CR613","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/PAS.0b013e3181d5ddf8","volume":"34","author":"G Venkataraman","year":"2010","unstructured":"Venkataraman G, et al. Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. Am J Surg Pathol. 2010;34(4):589\u201394.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1810_CR614","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1182\/blood.V98.1.194","volume":"98","author":"SE Straus","year":"2001","unstructured":"Straus SE, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood. 2001;98(1):194\u2013200.","journal-title":"Blood"},{"issue":"13","key":"1810_CR615","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","volume":"123","author":"S Price","year":"2014","unstructured":"Price S, et al. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014;123(13):1989\u201399.","journal-title":"Blood"},{"issue":"7","key":"1810_CR616","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/01.pas.0000157997.61177.08","volume":"29","author":"I Maric","year":"2005","unstructured":"Maric I, et al. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol. 2005;29(7):903\u201311.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1810_CR617","first-page":"1522","volume":"117","author":"JP Schmid","year":"2011","unstructured":"Schmid JP, et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency). Blood J Am Soc Hematol. 2011;117(5):1522\u20139.","journal-title":"Blood J Am Soc Hematol"},{"issue":"4","key":"1810_CR618","first-page":"1268","volume":"98","author":"R Sumazaki","year":"2001","unstructured":"Sumazaki R, et al. SH2D1A mutations in Japanese males with severe Epstein-Barr virus\u2013associated illnesses. Blood J Am Soc Hematol. 2001;98(4):1268\u201370.","journal-title":"Blood J Am Soc Hematol"},{"issue":"9","key":"1810_CR619","doi-asserted-by":"publisher","first-page":"E85","DOI":"10.1002\/pbc.24525","volume":"60","author":"JT Sandlund","year":"2013","unstructured":"Sandlund JT, et al. Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms. Pediatr Blood Cancer. 2013;60(9):E85\u20137.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1810_CR620","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1097\/MPH.0000000000000815","volume":"39","author":"SO Sharapova","year":"2017","unstructured":"Sharapova SO, et al. Novel mutations in SH2D1A gene in X-linked lymphoproliferative syndrome, diagnosed after B-Cell non-hodgkin lymphoma. J Pediatr Hematol Oncol. 2017;39(4):e203\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"13","key":"1810_CR621","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1093\/hmg\/8.13.2407","volume":"8","author":"O Brandau","year":"1999","unstructured":"Brandau O, et al. Epstein\u2014Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). Hum Mol Genet. 1999;8(13):2407\u201313.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1810_CR622","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1046\/j.1365-2141.2000.01884.x","volume":"108","author":"B Strahm","year":"2000","unstructured":"Strahm B, et al. Recurrent B-cell non-Hodgkin\u2019s lymphoma in two brothers with X-linked lymphoproliferative disease without evidence for Epstein-Barr virus infection. Br J Haematol. 2000;108(2):377\u201382.","journal-title":"Br J Haematol"},{"issue":"3","key":"1810_CR623","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00431-005-0023-x","volume":"165","author":"A Alangari","year":"2006","unstructured":"Alangari A, et al. X-linked lymphoproliferative disease associated with hypogammaglobulinemia and growth-hormone deficiency. Eur J Pediatr. 2006;165(3):165\u20137.","journal-title":"Eur J Pediatr"},{"issue":"11_Part_1","key":"1810_CR624","first-page":"4237","volume":"41","author":"AK Saemundsen","year":"1981","unstructured":"Saemundsen AK, et al. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA\/DNA and viral DNA\/DNA hybridization. Cancer Res. 1981;41(11_Part_1):4237\u201342.","journal-title":"Cancer Res"},{"issue":"18","key":"1810_CR625","first-page":"3398","volume":"116","author":"AH Filipovich","year":"2010","unstructured":"Filipovich AH, et al. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood J Am Soc Hematol. 2010;116(18):3398\u2013408.","journal-title":"Blood J Am Soc Hematol"},{"issue":"8","key":"1810_CR626","doi-asserted-by":"publisher","first-page":"e1210","DOI":"10.1097\/MPH.0000000000002049","volume":"43","author":"FI Cardenas","year":"2021","unstructured":"Cardenas FI, et al. Two clonally distinct B-cell lymphomas reveal the diagnosis of XLP1 in a male child and his asymptomatic male relatives: case report and review of the literature. J Pediatr Hematol Oncol. 2021;43(8):e1210\u20133.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"1810_CR627","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/1097-0142(19920801)70:3<683::AID-CNCR2820700324>3.0.CO;2-C","volume":"70","author":"RM Egeler","year":"1992","unstructured":"Egeler RM, et al. Documentation of Burkitt lymphoma with t(8;14) (q24;q32) in X-linked lymphoproliferative disease. Cancer. 1992;70(3):683\u20137.","journal-title":"Cancer"},{"issue":"3","key":"1810_CR628","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ajmg.1320400309","volume":"40","author":"HL Grierson","year":"1991","unstructured":"Grierson HL, et al. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. Am J Med Genet. 1991;40(3):294\u20137.","journal-title":"Am J Med Genet"},{"issue":"8","key":"1810_CR629","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/1097-0142(19870415)59:8<1419::AID-CNCR2820590807>3.0.CO;2-P","volume":"59","author":"DS Harrington","year":"1987","unstructured":"Harrington DS, Weisenburger DD, Purtilo DT. Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer. 1987;59(8):1419\u201329.","journal-title":"Cancer"},{"issue":"6","key":"1810_CR630","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/sj.bmt.1701389","volume":"22","author":"T Hoffmann","year":"1998","unstructured":"Hoffmann T, et al. Matched unrelated allogeneic bone marrow transplantation for recurrent malignant lymphoma in a patient with X-linked lymphoproliferative disease (XLP). Bone Marrow Transplant. 1998;22(6):603\u20134.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"1810_CR631","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0165-4608(90)90026-7","volume":"47","author":"WG Sanger","year":"1990","unstructured":"Sanger WG, et al. Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP). Cancer Genet Cytogenet. 1990;47(2):163\u20139.","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"1810_CR632","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3324\/haematol.2012.068791","volume":"98","author":"E Salzer","year":"2013","unstructured":"Salzer E, et al. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica. 2013;98(3):473.","journal-title":"Haematologica"},{"issue":"3","key":"1810_CR633","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jaci.2015.02.022","volume":"136","author":"OK Alkhairy","year":"2015","unstructured":"Alkhairy OK, et al. Novel mutations in TNFRSF7\/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency. J Allergy Clin Immunol. 2015;136(3):703-712.e10.","journal-title":"J Allergy Clin Immunol"},{"issue":"23","key":"1810_CR634","first-page":"2638","volume":"136","author":"S Ghosh","year":"2020","unstructured":"Ghosh S, et al. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency. Blood J Am Soc Hematol. 2020;136(23):2638\u201355.","journal-title":"Blood J Am Soc Hematol"},{"issue":"2","key":"1810_CR635","doi-asserted-by":"publisher","first-page":"e233482","DOI":"10.1136\/bcr-2019-233482","volume":"13","author":"R Kishore","year":"2020","unstructured":"Kishore R, et al. Novel mutation in the CD27 gene in a patient presenting with hypogammaglobulinemia, bronchiectasis and EBV-driven lymphoproliferative disease. BMJ Case Rep CP. 2020;13(2):e233482.","journal-title":"BMJ Case Rep CP"},{"issue":"1","key":"1810_CR636","first-page":"110","volume":"22","author":"Z Golchehre","year":"2023","unstructured":"Golchehre Z, et al. New presentation of CD27 deficiency; coronary ectasia and COVID-19. Iran J Allergy Asthma Immunol. 2023;22(1):110\u20138.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"1","key":"1810_CR637","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20160849","volume":"214","author":"H Abolhassani","year":"2017","unstructured":"Abolhassani H, et al. Combined immunodeficiency and Epstein-Barr virus\u2013induced B cell malignancy in humans with inherited CD70 deficiency. J Exp Med. 2017;214(1):91\u2013106.","journal-title":"J Exp Med"},{"key":"1810_CR638","doi-asserted-by":"publisher","first-page":"615724","DOI":"10.3389\/fped.2021.615724","volume":"9","author":"H Abolhassani","year":"2021","unstructured":"Abolhassani H. Specific immune response and cytokine production in CD70 deficiency. Front Pediatr. 2021;9:615724.","journal-title":"Front Pediatr"},{"issue":"1","key":"1810_CR639","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.20160784","volume":"214","author":"K Izawa","year":"2017","unstructured":"Izawa K, et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70\u2013CD27 pathway in immunity to Epstein-Barr virus infection. J Exp Med. 2017;214(1):73\u201389.","journal-title":"J Exp Med"},{"issue":"6","key":"1810_CR640","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/15513815.2021.2000533","volume":"41","author":"M Vij","year":"2022","unstructured":"Vij M, et al. CARMIL2 immunodeficiency with epstein barr virus associated smooth muscle tumor (EBV-SMT). Report of a case with comprehensive review of literature. Fetal Pediatr Pathol. 2022;41(6):1023\u201334.","journal-title":"Fetal Pediatr Pathol"},{"issue":"3","key":"1810_CR641","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/all.15010","volume":"77","author":"B Kolukisa","year":"2022","unstructured":"Kolukisa B, et al. Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency. Allergy. 2022;77(3):1004\u201319.","journal-title":"Allergy"},{"issue":"1","key":"1810_CR642","doi-asserted-by":"publisher","first-page":"14209","DOI":"10.1038\/ncomms14209","volume":"8","author":"T Schober","year":"2017","unstructured":"Schober T, et al. A human immunodeficiency syndrome caused by mutations in CARMIL2. Nat Commun. 2017;8(1):14209.","journal-title":"Nat Commun"},{"key":"1810_CR643","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3389\/fimmu.2020.00884","volume":"11","author":"JR Yonkof","year":"2020","unstructured":"Yonkof JR, et al. A novel pathogenic variant in CARMIL2 (RLTPR) causing CARMIL2 deficiency and EBV-associated smooth muscle tumors. Front Immunol. 2020;11:884.","journal-title":"Front Immunol"},{"issue":"14","key":"1810_CR644","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1182\/blood-2013-11-538686","volume":"123","author":"FY Li","year":"2014","unstructured":"Li FY, et al. XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood. 2014;123(14):2148\u201352.","journal-title":"Blood"},{"issue":"1","key":"1810_CR645","first-page":"92","volume":"21","author":"S Haskologlu","year":"2022","unstructured":"Haskologlu S, et al. Scales of Magt1 gene: novel mutations, different presentations. Iran J Allergy Asthma Immunol. 2022;21(1):92.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"2","key":"1810_CR646","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0022-3476(95)70557-0","volume":"126","author":"ME Weinblatt","year":"1995","unstructured":"Weinblatt ME, et al. Transformation of congenital neutropenia into monosomy 7 and acute nonlymphoblastic leukemia in a child treated with granulocyte colony-stimulating factor. J Pediatr. 1995;126(2):263\u20135.","journal-title":"J Pediatr"},{"issue":"3","key":"1810_CR647","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0022-3476(79)80581-8","volume":"94","author":"RB Rosen","year":"1979","unstructured":"Rosen RB, Kang SJ. Congenital agranulocytosis terminating in acute myelomonocytic leukemia. J Pediatr. 1979;94(3):406\u20138.","journal-title":"J Pediatr"},{"issue":"9","key":"1810_CR648","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/leu.2008.64","volume":"22","author":"S Yetgin","year":"2008","unstructured":"Yetgin S, et al. Transformation of severe congenital neutropenia to early acute lymphoblastic leukemia in a patient with HAX1 mutation and without G-CSF administration or receptor mutation. Leukemia. 2008;22(9):1797\u20131797.","journal-title":"Leukemia"},{"issue":"3","key":"1810_CR649","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/pbc.22836","volume":"56","author":"G Carlsson","year":"2011","unstructured":"Carlsson G, et al. Hematopoietic stem cell transplantation in severe congenital neutropenia. Pediatr Blood Cancer. 2011;56(3):444\u201351.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1810_CR650","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/MPH.0b013e318249a4dc","volume":"34","author":"V Dinand","year":"2012","unstructured":"Dinand V, et al. Hepatic hemangioendothelioma in an infant with severe congenital neutropenia. J Pediatr Hematol Oncol. 2012;34(4):298\u2013300.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"22","key":"1810_CR651","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1182\/blood-2012-01-406116","volume":"119","author":"R Beekman","year":"2012","unstructured":"Beekman R, et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood. 2012;119(22):5071\u20137.","journal-title":"Blood"},{"issue":"1","key":"1810_CR652","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1365-2141.1998.00652.x","volume":"101","author":"T Bernard","year":"1998","unstructured":"Bernard T, et al. Mutations of the granulocyte-colony stimulating factor receptor in patients with severe congenital neutropenia are not required for transformation to acute myeloid leukaemia and may be a bystander phenomenon. Br J Haematol. 1998;101(1):141\u20139.","journal-title":"Br J Haematol"},{"issue":"2","key":"1810_CR653","first-page":"429","volume":"96","author":"MH Freedman","year":"2000","unstructured":"Freedman MH, et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood. 2000;96(2):429\u201336.","journal-title":"Blood"},{"issue":"1","key":"1810_CR654","first-page":"45","volume":"90","author":"J Donadieu","year":"2005","unstructured":"Donadieu J, et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French severe chronic neutropenia study group. Haematologica. 2005;90(1):45\u201353.","journal-title":"Haematologica"},{"issue":"5","key":"1810_CR655","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S0301-472X(03)00048-1","volume":"31","author":"AA Aprikyan","year":"2003","unstructured":"Aprikyan AA, et al. Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol. 2003;31(5):372\u201381.","journal-title":"Exp Hematol"},{"issue":"1","key":"1810_CR656","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1365-2141.1995.tb08928.x","volume":"89","author":"S Imashuku","year":"1995","unstructured":"Imashuku S, et al. Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia following G-CSF administration. Br J Haematol. 1995;89(1):188\u201390.","journal-title":"Br J Haematol"},{"issue":"5","key":"1810_CR657","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/sj.bmt.1704813","volume":"35","author":"S Choi","year":"2005","unstructured":"Choi S, et al. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation. Bone Marrow Transplant. 2005;35(5):473\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"1810_CR658","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0022-3476(97)70374-3","volume":"130","author":"LA Boxer","year":"1997","unstructured":"Boxer LA, Dale D. Congenital neutropenia and the risk of leukemia. J Pediatr. 1997;130(2):335.","journal-title":"J Pediatr"},{"issue":"12","key":"1810_CR659","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1182\/blood-2005-11-4370","volume":"107","author":"PS Rosenberg","year":"2006","unstructured":"Rosenberg PS, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood. 2006;107(12):4628\u201335.","journal-title":"Blood"},{"issue":"2","key":"1810_CR660","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ajh.10255","volume":"72","author":"DC Dale","year":"2003","unstructured":"Dale DC, et al. Severe chronic neutropenia: treatment and follow-up of patients in the severe chronic neutropenia international registry. Am J Hematol. 2003;72(2):82\u201393.","journal-title":"Am J Hematol"},{"issue":"6","key":"1810_CR661","first-page":"1882","volume":"97","author":"CA Tschan","year":"2001","unstructured":"Tschan CA, et al. Time course of increasing numbers of mutations in the granulocyte colony-stimulating factor receptor gene in a patient with congenital neutropenia who developed leukemia. Blood J Am Soc Hemat. 2001;97(6):1882\u20134.","journal-title":"Blood J Am Soc Hemat"},{"issue":"9","key":"1810_CR662","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/sj.bmt.1705141","volume":"36","author":"J Donadieu","year":"2005","unstructured":"Donadieu J, et al. Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry. Bone Marrow Transplant. 2005;36(9):787\u201392.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"1810_CR663","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-0609.1977.tb01473.x","volume":"18","author":"PC Huijgens","year":"1977","unstructured":"Huijgens PC, et al. Syndrome of Shwachman and leukaemia. Scand J Haematol. 1977;18(1):20\u20134.","journal-title":"Scand J Haematol"},{"issue":"3","key":"1810_CR664","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0022-3476(81)80336-8","volume":"99","author":"WG Woods","year":"1981","unstructured":"Woods WG, et al. The occurrence of leukemia in patients with the Shwachman syndrome. J Pediatr. 1981;99(3):425\u20138.","journal-title":"J Pediatr"},{"issue":"3","key":"1810_CR665","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3904\/kjim.2002.17.3.204","volume":"17","author":"SY Park","year":"2002","unstructured":"Park SY, et al. Allogeneic bone marrow transplantation in Shwachman-Diamond syndrome with malignant myeloid transformation. A case report. Korean J Intern Med. 2002;17(3):204\u20136.","journal-title":"Korean J Intern Med"},{"issue":"1","key":"1810_CR666","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1046\/j.1365-2141.1997.3673181.x","volume":"99","author":"I Dokal","year":"1997","unstructured":"Dokal I, et al. Adult onset of acute myeloid leukaemia (M6) in patients with Shwachman-Diamond syndrome. Br J Haematol. 1997;99(1):171\u20133.","journal-title":"Br J Haematol"},{"issue":"1\u20132","key":"1810_CR667","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/10428199309059581","volume":"12","author":"JF Seymour","year":"1993","unstructured":"Seymour JF, Escudier SM. Acute leukemia complicating bone marrow hypoplasia in an adult with Shwachman\u2019s syndrome. Leuk Lymphoma. 1993;12(1\u20132):131\u20135.","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"1810_CR668","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJM199508243330804","volume":"333","author":"F Dong","year":"1995","unstructured":"Dong F, et al. Mutations in the gene for the granulocyte colony-stimulating\u2013factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med. 1995;333(8):487\u201393.","journal-title":"N Engl J Med"},{"issue":"1","key":"1810_CR669","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ajh.20424","volume":"80","author":"B Wolach","year":"2005","unstructured":"Wolach B, et al. Acute lymphoblastic leukemia in a patient with chronic granulomatous disease and a novel mutation in CYBB: first report. Am J Hematol. 2005;80(1):50\u20134.","journal-title":"Am J Hematol"},{"issue":"2","key":"1810_CR670","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jaci.2010.10.049","volume":"127","author":"SOL Reyes","year":"2011","unstructured":"Reyes SOL, et al. Hodgkin lymphoma in 2 children with chronic granulomatous disease. J Allergy Clin Immunol. 2011;127(2):543\u20134.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"1810_CR671","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/MPH.0b013e3181b84751","volume":"31","author":"DG Aguilera","year":"2009","unstructured":"Aguilera DG, et al. Glioblastoma multiforme in a patient with chronic granulomatous disease treated with subtotal resection, radiation, and thalidomide: case report of a long-term survivor. J Pediatr Hematol Oncol. 2009;31(12):965\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"1810_CR672","doi-asserted-by":"publisher","first-page":"118","DOI":"10.7326\/0003-4819-109-2-118","volume":"109","author":"FS Southwick","year":"1988","unstructured":"Southwick FS, van der Meer JW. Recurrent cystitis and bladder mass in two adults with chronic granulomatous disease. Ann Intern Med. 1988;109(2):118\u201321.","journal-title":"Ann Intern Med"},{"issue":"7","key":"1810_CR673","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1086\/377608","volume":"37","author":"D Mansoory","year":"2003","unstructured":"Mansoory D, et al. Chronic fusarium infection in an adult patient with undiagnosed chronic granulomatous diseas. Clin Infect Dis. 2003;37(7):e107\u20138.","journal-title":"Clin Infect Dis"},{"key":"1810_CR674","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s10875-021-01002-w","volume":"41","author":"HT Akar","year":"2021","unstructured":"Akar HT, et al. Clinical and immunological characteristics of 63 patients with chronic granulomatous disease: hacettepe experience. J Clin Immunol. 2021;41:992\u20131003.","journal-title":"J Clin Immunol"},{"issue":"5","key":"1810_CR675","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1182\/blood-2011-08-374363","volume":"119","author":"J Kazenwadel","year":"2012","unstructured":"Kazenwadel J, et al. Loss-of-function germline GATA2 mutations in patients with MDS\/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood. 2012;119(5):1283\u201391.","journal-title":"Blood"},{"issue":"4","key":"1810_CR676","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/cam4.384","volume":"4","author":"MA Mir","year":"2015","unstructured":"Mir MA, et al. Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA 2 mutations. Cancer Med. 2015;4(4):490\u20139.","journal-title":"Cancer Med"},{"issue":"3","key":"1810_CR677","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1182\/bloodadvances.2021005065","volume":"6","author":"RR West","year":"2022","unstructured":"West RR, et al. ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome. Blood Adv. 2022;6(3):793\u2013807.","journal-title":"Blood Adv"},{"key":"1810_CR678","doi-asserted-by":"publisher","first-page":"928529","DOI":"10.3389\/fimmu.2022.928529","volume":"13","author":"E Heropolita\u0144ska-Pliszka","year":"2022","unstructured":"Heropolita\u0144ska-Pliszka E, et al. Case report: Successful allogeneic stem cell transplantation in a child with novel GATA2 defect associated B-cell acute lymphoblastic leukemia. Front Immunol. 2022;13:928529.","journal-title":"Front Immunol"},{"issue":"2","key":"1810_CR679","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s10875-021-01189-y","volume":"42","author":"SF J\u00f8rgensen","year":"2022","unstructured":"J\u00f8rgensen SF, et al. A nationwide study of GATA2 deficiency in norway\u2014the majority of patients have undergone Allo-HSCT. J Clin Immunol. 2022;42(2):404\u201320.","journal-title":"J Clin Immunol"},{"key":"1810_CR680","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cancergen.2021.04.002","volume":"256","author":"JM Ellingford","year":"2021","unstructured":"Ellingford JM, et al. High penetrance of myeloid neoplasia with diverse clinical and cytogenetic features in three siblings with a familial GATA2 deficiency. Cancer Genet. 2021;256:77\u201380.","journal-title":"Cancer Genet"},{"issue":"3","key":"1810_CR681","doi-asserted-by":"publisher","first-page":"e7075","DOI":"10.1002\/ccr3.7075","volume":"11","author":"EM Nell","year":"2023","unstructured":"Nell EM, et al. Infection and myelodysplasia: a case report of GATA2 deficiency in a South African patient. Clinical Case Reports. 2023;11(3):e7075.","journal-title":"Clinical Case Reports"},{"issue":"1","key":"1810_CR682","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1038\/s41598-018-25260-8","volume":"8","author":"M Nemoto","year":"2018","unstructured":"Nemoto M, et al. Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia. Sci Rep. 2018;8(1):6956.","journal-title":"Sci Rep"},{"issue":"1","key":"1810_CR683","doi-asserted-by":"publisher","first-page":"13992","DOI":"10.1038\/ncomms13992","volume":"7","author":"D Eletto","year":"2016","unstructured":"Eletto D, et al. Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection. Nat Commun. 2016;7(1):13992.","journal-title":"Nat Commun"},{"issue":"3","key":"1810_CR684","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/jdv.12927","volume":"30","author":"Y Yoshii","year":"2016","unstructured":"Yoshii Y, et al. Primary cutaneous follicle center lymphoma in a patient with WHIM syndrome. J Eur Acad Dermatol Venereol. 2016;30(3):529\u201330.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1810_CR685","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-7-71","volume":"7","author":"SB Cohen","year":"2012","unstructured":"Cohen SB, et al. Description and outcome of a cohort of 8 patients with WHIM syndrome from the french severe chronic neutropenia registry. Orphanet J Rare Dis. 2012;7:1\u201314.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1810_CR686","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MOH.0000000000000554","volume":"27","author":"DC Dale","year":"2020","unstructured":"Dale DC, et al. Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome. Curr Opin Hematol. 2020;27(1):11\u20137.","journal-title":"Curr Opin Hematol"},{"key":"1810_CR687","doi-asserted-by":"crossref","unstructured":"Badolato R, Donadieu J, WHIM Research Group. How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. Blood J Am Soc Hematol 2017; 130(23): 2491-2498.","DOI":"10.1182\/blood-2017-02-708552"},{"issue":"1","key":"1810_CR688","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tripleo.2009.08.011","volume":"109","author":"NA Cipriani","year":"2010","unstructured":"Cipriani NA, Blair E, Taxy JB. WHIM syndrome and oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(1):105\u20138.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"1810_CR689","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1067\/mjd.2001.111337","volume":"44","author":"KM Chae","year":"2001","unstructured":"Chae KM, Ertle JO, Tharp MD. B-cell lymphoma in a patient with WHIM syndrome. J Am Acad Dermatol. 2001;44(1):124\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"1810_CR690","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00277-002-0489-9","volume":"81","author":"S Imashuku","year":"2002","unstructured":"Imashuku S, et al. Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome. Warts, hypogammaglobulinemia, infections, and myelokathexis. Ann Hematol. 2002;81(8):470\u20133.","journal-title":"Ann Hematol"},{"issue":"5","key":"1810_CR691","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.jaip.2019.01.045","volume":"7","author":"L Dotta","year":"2019","unstructured":"Dotta L, et al. Long-term outcome of WHIM syndrome in 18 patients: high risk of lung disease and HPV-related malignancies. J Allergy Clin Immunol Pract. 2019;7(5):1568\u201377.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"1810_CR692","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9","volume":"91","author":"RJ Gorlin","year":"2000","unstructured":"Gorlin RJ, et al. WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies. Am J Med Genet. 2000;91(5):368\u201376.","journal-title":"Am J Med Genet"},{"issue":"5","key":"1810_CR693","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/2050640616684404","volume":"5","author":"S Koo","year":"2017","unstructured":"Koo S, et al. Oesophageal candidiasis and squamous cell cancer in patients with gain-of-function STAT1 gene mutation. United European Gastroenterol J. 2017;5(5):625\u201331.","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"1810_CR694","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/1097-0142(197901)43:1<101::AID-CNCR2820430116>3.0.CO;2-6","volume":"43","author":"IK Aronson","year":"1979","unstructured":"Aronson IK, et al. Late onset chronic mucocutaneous candidiasis with lymphoma and specific serum inhibitory factor. Cancer. 1979;43(1):101\u20138.","journal-title":"Cancer"},{"issue":"8223","key":"1810_CR695","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0140-6736(81)92640-4","volume":"1","author":"R Hong","year":"1981","unstructured":"Hong R, Dibbell DG. Cultured thymus fragment transplant in chronic candidiasis complicated by oral carcinoma. Lancet. 1981;1(8223):773\u20134.","journal-title":"Lancet"},{"issue":"4","key":"1810_CR696","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0030-4220(89)90138-2","volume":"68","author":"MS Rothberg","year":"1989","unstructured":"Rothberg MS, Eisenbud L, Griboff SJOS. Chronic mucocultaneous candidiasis-thymoma syndrome: a case report. Oral Surg Oral Med Oral Pathol. 1989;68(4):411\u20133.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"2","key":"1810_CR697","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/13693780802342545","volume":"47","author":"M Domingues-Ferreira","year":"2009","unstructured":"Domingues-Ferreira M, et al. Esophageal cancer associated with chronic mucocutaneous candidiasis. Could chronic candidiasis lead to esophageal cancer? Med Mycol. 2009;47(2):201\u20135.","journal-title":"Med Mycol"},{"issue":"4","key":"1810_CR698","doi-asserted-by":"publisher","first-page":"271","DOI":"10.18176\/jiaci.0261","volume":"28","author":"B Gokturk","year":"2018","unstructured":"Gokturk B, et al. A Novel Homozygous Mutation With Different Clinical Presentations in 2 IRAK-4-Deficient Siblings: First Case With Recurrent Salmonellosis and Non-Hodgkin Lymphoma. J Investig Allergol Clin Immunol. 2018;28(4):271\u20133.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"1810_CR699","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10875-021-01098-0","volume":"41","author":"H Hashem","year":"2021","unstructured":"Hashem H, et al. Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients. J Clin Immunol. 2021;41:1633\u201347.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1810_CR700","doi-asserted-by":"publisher","first-page":"e28302","DOI":"10.1002\/pbc.28302","volume":"67","author":"O Wegehaupt","year":"2020","unstructured":"Wegehaupt O, et al. TIM-3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2020;67(6):e28302.","journal-title":"Pediatr Blood Cancer"},{"issue":"20","key":"1810_CR701","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1182\/bloodadvances.2021004562","volume":"5","author":"J Koh","year":"2021","unstructured":"Koh J, et al. Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations. Blood Adv. 2021;5(20):3919\u201330.","journal-title":"Blood Adv"},{"key":"1810_CR702","unstructured":"Nir Tsur M, et al.\u00a0Characterization of fanconi anemia patients with head and neck squamous cell carcinoma: Israel fanconi registry. Isr Med Assoc J. 2022;24(8):491\u2013496."},{"key":"1810_CR703","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cancergen.2020.10.003","volume":"256","author":"E Errichiello","year":"2021","unstructured":"Errichiello E, et al. FANCA, TP53, and del (5q)\/RPS14 alterations in a patient with T-cell non-Hodgkin lymphoma and concomitant Fanconi anemia and Li-Fraumeni syndrome. Cancer Genet. 2021;256:179\u201383.","journal-title":"Cancer Genet"},{"issue":"6","key":"1810_CR704","doi-asserted-by":"publisher","first-page":"a005595","DOI":"10.1101\/mcs.a005595","volume":"6","author":"FP Lach","year":"2020","unstructured":"Lach FP, et al. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic FANCA variant. Mol Case Stud. 2020;6(6):a005595.","journal-title":"Mol Case Stud"},{"issue":"1","key":"1810_CR705","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41409-020-0994-2","volume":"56","author":"PE Debureaux","year":"2021","unstructured":"Debureaux PE, et al. FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study. Bone Marrow Transplant. 2021;56(1):285\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"1810_CR706","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/bjh.12634","volume":"164","author":"R Mitchell","year":"2014","unstructured":"Mitchell R, et al. Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in F anconi anaemia. Br J Haematol. 2014;164(3):384\u201395.","journal-title":"Br J Haematol"},{"issue":"2","key":"1810_CR707","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/jmg.2004.022673","volume":"42","author":"S Reid","year":"2005","unstructured":"Reid S, et al. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour. J Med Genet. 2005;42(2):147\u201351.","journal-title":"J Med Genet"},{"issue":"3","key":"1810_CR708","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/pbc.23168","volume":"58","author":"K Myers","year":"2012","unstructured":"Myers K, et al. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1\/BRCA2 mutations. Pediatr Blood Cancer. 2012;58(3):462\u20135.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1810_CR709","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/pbc.25303","volume":"62","author":"A Malric","year":"2015","unstructured":"Malric A, et al. Fanconi anemia and solid malignancies in childhood: a national retrospective study. Pediatr Blood Cancer. 2015;62(3):463\u201370.","journal-title":"Pediatr Blood Cancer"},{"issue":"20","key":"1810_CR710","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/jnci\/djg072","volume":"95","author":"K Offit","year":"2003","unstructured":"Offit K, et al. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. J Natl Cancer Inst. 2003;95(20):1548\u201351.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"1810_CR711","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/MPH.0000000000001090","volume":"40","author":"A Berot","year":"2018","unstructured":"Berot A, Pluchart C. Treatment With Azacitidine in the Context of Palliative Care for a Patient With Acute Myeloid Leukemia Complicating Fanconi Anemia With Biallelic FANCD1\/BRCA 2 Mutations. J Pediatr Hematol Oncol. 2018;40(3):247\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1\u20132","key":"1810_CR712","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cancergen.2015.11.005","volume":"209","author":"AJ Dodgshun","year":"2016","unstructured":"Dodgshun AJ, et al. Biallelic FANCD1\/BRCA2 mutations predisposing to glioblastoma multiforme with multiple oncogenic amplifications. Cancer Genet. 2016;209(1\u20132):53\u20136.","journal-title":"Cancer Genet"},{"issue":"1","key":"1810_CR713","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/cge.14231","volume":"103","author":"KN Maxwell","year":"2023","unstructured":"Maxwell KN, et al. Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood. Clin Genet. 2023;103(1):119\u201324.","journal-title":"Clin Genet"},{"issue":"8","key":"1810_CR714","doi-asserted-by":"publisher","first-page":"104260","DOI":"10.1016\/j.ejmg.2021.104260","volume":"64","author":"I Radulovic","year":"2021","unstructured":"Radulovic I, et al. A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia. Eur J Med Genet. 2021;64(8):104260.","journal-title":"Eur J Med Genet"},{"issue":"9","key":"1810_CR715","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1136\/jmedgenet-2021-108072","volume":"59","author":"E Ip","year":"2022","unstructured":"Ip E, et al. Catastrophic chemotherapy toxicity leading to diagnosis of Fanconi anaemia due to FANCD1\/BRCA2 during adulthood: description of an emerging phenotype. J Med Genet. 2022;59(9):912\u20135.","journal-title":"J Med Genet"},{"issue":"1","key":"1810_CR716","first-page":"105","volume":"90","author":"AP Gillio","year":"1997","unstructured":"Gillio AP, et al. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an international fanconi anemia registry study. Blood J Am Soc Hematol. 1997;90(1):105\u201310.","journal-title":"Blood J Am Soc Hematol"},{"key":"1810_CR717","doi-asserted-by":"publisher","unstructured":"Pang X, et al. Durable benefit from immunotherapy and accompanied lupus erythematosus in pancreatic adenocarcinoma with DNA repair deficiency. J Immunother Cancer. 2020;8(2). https:\/\/doi.org\/10.1136\/jitc-2019-000463.","DOI":"10.1136\/jitc-2019-000463"},{"issue":"3","key":"1810_CR718","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ajh.2830120312","volume":"12","author":"AD Auerbach","year":"1982","unstructured":"Auerbach AD, et al. Acute myeloid leukemia as the first hematologic manifestation of Fanconi anemia. Am J Hematol. 1982;12(3):289\u2013300.","journal-title":"Am J Hematol"},{"issue":"7795","key":"1810_CR719","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0140-6736(73)90212-2","volume":"1","author":"JT Guy","year":"1973","unstructured":"Guy JT, Auslander MO. Androgenic steroids and hepatocellular carcinoma. Lancet. 1973;1(7795):148.","journal-title":"Lancet"},{"issue":"7790","key":"1810_CR720","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(72)92649-9","volume":"300","author":"FL Johnson","year":"1972","unstructured":"Johnson FL, et al. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet. 1972;300(7790):1273\u20136.","journal-title":"Lancet"},{"issue":"6","key":"1810_CR721","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archpedi.1994.02170060115027","volume":"148","author":"BP Alter","year":"1994","unstructured":"Alter BP, Tenner MS. Brain tumors in patients with Fanconi\u2019s anemia. Arch Pediatr Adolesc Med. 1994;148(6):661\u20133.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"1810_CR722","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00004836-198106000-00012","volume":"3","author":"RA Kozarek","year":"1981","unstructured":"Kozarek RA, Sanowski RA. Carcinoma of the esophagus associated with Fanconi\u2019s anemia. J Clin Gastroenterol. 1981;3(2):171\u20134.","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"1810_CR723","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1182\/blood.V10.8.788.788","volume":"10","author":"RH Cowdell","year":"1955","unstructured":"Cowdell RH, Phizackerley PJR, Pyke DA. Constitutional anemia (Fanconi\u2019s syndrome) and leukemia in two brothers. Blood. 1955;10(8):788\u2013801.","journal-title":"Blood"},{"issue":"1","key":"1810_CR724","first-page":"205","volume":"48","author":"P Hersey","year":"1982","unstructured":"Hersey P, et al. Deficient natural killer cell activity in a patient with Fanconi\u2019s anaemia and squamous cell carcinoma. Association with defect in interferon release. Clin Exp Immunol. 1982;48(1):205\u201312.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1810_CR725","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/1097-0142(197703)39:3<1163::AID-CNCR2820390322>3.0.CO;2-Y","volume":"39","author":"CA Bourgeois","year":"1977","unstructured":"Bourgeois CA, Hill FG. Fanconi anemia leading to acute myelomonocytic leukemia: cytogenetic studies. Cancer. 1977;39(3):1163\u20137.","journal-title":"Cancer"},{"issue":"6","key":"1810_CR726","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/1097-0142(19800915)46:6<1401::AID-CNCR2820460619>3.0.CO;2-#","volume":"46","author":"DA Obeid","year":"1980","unstructured":"Obeid DA, et al. Fanconi anemia. Oxymetholone hepatic tumors, and chromosome aberrations associated with leukemic transition. Cancer. 1980;46(6):1401\u20134.","journal-title":"Cancer"},{"issue":"4","key":"1810_CR727","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1399-0004.1979.tb00998.x","volume":"16","author":"T Schroeder","year":"1979","unstructured":"Schroeder T, et al. Fanconi\u2019s anemia: terminal leukemia and \u201cforme fruste\u201d in one family. Clin Genet. 1979;16(4):260\u20138.","journal-title":"Clin Genet"},{"issue":"3","key":"1810_CR728","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/archderm.1973.01620180069022","volume":"107","author":"D Abels","year":"1973","unstructured":"Abels D, Reed WB. Fanconi-like syndrome. Immunologic deficiency, pancytopenia, and cutaneous malignancies. Arch Dermatol. 1973;107(3):419\u201323.","journal-title":"Arch Dermatol"},{"issue":"24","key":"1810_CR729","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1056\/NEJM197706162962414","volume":"296","author":"ST Mokrohisky","year":"1977","unstructured":"Mokrohisky ST, Ambruso DR, Hathaway WE. Fulminant hepatic neoplasia after androgen therapy. N Engl J Med. 1977;296(24):1411\u20132.","journal-title":"N Engl J Med"},{"issue":"3","key":"1810_CR730","first-page":"214","volume":"67","author":"R Rotzak","year":"1982","unstructured":"Rotzak R, et al. Giant marker chromosome in Fanconi\u2019s anemia transforming into erythroleukemia in an adult. Acta Haematol. 1982;67(3):214\u20136.","journal-title":"Acta Haematol"},{"issue":"4","key":"1810_CR731","doi-asserted-by":"publisher","first-page":"638","DOI":"10.2214\/ajr.124.4.638","volume":"124","author":"LE Holder","year":"1975","unstructured":"Holder LE, et al. Hepatoma associated with anabolic steroid therapy. Am J Roentgenol Radium Ther Nucl Med. 1975;124(4):638\u201342.","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"1","key":"1810_CR732","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1001\/archotol.129.1.106","volume":"129","author":"DI Kutler","year":"2003","unstructured":"Kutler DI, et al. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg. 2003;129(1):106\u201312.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"3","key":"1810_CR733","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00043426-199905000-00014","volume":"21","author":"RE Goldsby","year":"1999","unstructured":"Goldsby RE, et al. Lymphoblastic lymphoma and excessive toxicity from chemotherapy: an unusual presentation for Fanconi anemia. J Pediatr Hematol Oncol. 1999;21(3):240\u20133.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"10","key":"1810_CR734","first-page":"1104","volume":"131","author":"P Shapiro","year":"1977","unstructured":"Shapiro P, et al. Multiple hepatic tumors and peliosis hepatis in Fanconi\u2019s anemia treated with androgens. Am J Dis Child. 1977;131(10):1104\u20136.","journal-title":"Am J Dis Child"},{"issue":"3","key":"1810_CR735","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/1097-0142(197509)36:3<1029::AID-CNCR2820360328>3.0.CO;2-5","volume":"36","author":"G Sarna","year":"1975","unstructured":"Sarna G, et al. Multiple neoplasms in two siblings with a variant form of Fanconi\u2019s anemia. Cancer. 1975;36(3):1029\u201333.","journal-title":"Cancer"},{"issue":"4","key":"1810_CR736","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/1097-0142(19820815)50:4<811::AID-CNCR2820500432>3.0.CO;2-I","volume":"50","author":"AW Kennedy","year":"1982","unstructured":"Kennedy AW, Hart WRJC. Multiple squamous-cell carcinomas in Fanconi\u2019s anemia. Cancer. 1982;50(4):811\u20134.","journal-title":"Cancer"},{"issue":"32","key":"1810_CR737","first-page":"1233","volume":"50","author":"MC Kew","year":"1976","unstructured":"Kew MC, et al. Occurrence of primary hepatocellular cancer and peliosis hepatis after treatment with androgenic steroids. S Afr Med J. 1976;50(32):1233\u20137.","journal-title":"S Afr Med J"},{"issue":"5","key":"1810_CR738","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/00007890-198405000-00006","volume":"37","author":"E Schmidt","year":"1984","unstructured":"Schmidt E, Deeg HJ, Storb R. Regression of androgen-related hepatic tumors in patients with Fanconi\u2019s anemia following marrow transplantation. Transplantation. 1984;37(5):452\u20135.","journal-title":"Transplantation"},{"issue":"5","key":"1810_CR739","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/08880018.2013.788593","volume":"30","author":"T Rizk","year":"2013","unstructured":"Rizk T, et al. Sequential development of Wilms tumor and medulloblastoma in a child: an unusual presentation of fanconi anemia. Pediatr Hematol Oncol. 2013;30(5):400\u20132.","journal-title":"Pediatr Hematol Oncol"},{"issue":"9","key":"1810_CR740","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/ped.13648","volume":"60","author":"A Inoue","year":"2018","unstructured":"Inoue A, et al. Sequential reduced-intensity chemotherapy for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia with rare cytogenetic abnormalities transformed from Fanconi anemia. Pediatr Int. 2018;60(9):893\u20134.","journal-title":"Pediatr Int"},{"issue":"7 Pt 1","key":"1810_CR741","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1288\/00005537-198507000-00003","volume":"95","author":"MJ Kaplan","year":"1985","unstructured":"Kaplan MJ, et al. Squamous cell carcinoma in the immunosuppressed patient: Fanconi\u2019s anemia. Laryngoscope. 1985;95(7 Pt 1):771\u20135.","journal-title":"Laryngoscope"},{"issue":"4","key":"1810_CR742","first-page":"523","volume":"118","author":"TD Doerr","year":"1998","unstructured":"Doerr TD, Shibuya TY, Marks SC. Squamous cell carcinoma of the supraglottic larynx in a patient with Fanconi\u2019s anemia. Otolaryngol Head Neck Surg. 1998;118(4):523\u20135.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"1810_CR743","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/j.1879-3479.1980.tb00527.x","volume":"18","author":"WJ Arnold","year":"1980","unstructured":"Arnold WJ, et al. Squamous cell carcinoma of the vulva and Fanconi anemia. Int J Gynaecol Obstet. 1980;18(6):395\u20137.","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"1810_CR744","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/1097-0142(19830901)52:5<926::AID-CNCR2820520530>3.0.CO;2-T","volume":"52","author":"K Reed","year":"1983","unstructured":"Reed K, et al. The association of Fanconi\u2019s anemia and squamous cell carcinoma. Cancer. 1983;52(5):926\u20138.","journal-title":"Cancer"},{"issue":"6","key":"1810_CR745","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jaad.2006.02.065","volume":"54","author":"M Braun","year":"2006","unstructured":"Braun M, et al. Thrombocytopenia, multiple mucosal squamous cell carcinomas, and dyspigmentation. J Am Acad Dermatol. 2006;54(6):1056\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"1810_CR746","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/archotol.131.7.635","volume":"131","author":"BP Alter","year":"2005","unstructured":"Alter BP, et al. Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism. Arch Otolaryngol Head Neck Surg. 2005;131(7):635\u20139.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"8","key":"1810_CR747","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1182\/blood-2003-09-3138","volume":"103","author":"JE Wagner","year":"2004","unstructured":"Wagner JE, et al. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood. 2004;103(8):3226\u20139.","journal-title":"Blood"},{"issue":"3","key":"1810_CR748","first-page":"822","volume":"101","author":"PS Rosenberg","year":"2003","unstructured":"Rosenberg PS, Greene MH, Alter BPJB. Cancer incidence in persons with Fanconi anemia. Blood J Am Soc Hematol. 2003;101(3):822\u20136.","journal-title":"Blood J Am Soc Hematol"},{"issue":"4","key":"1810_CR749","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","volume":"101","author":"DI Kutler","year":"2003","unstructured":"Kutler DI, et al. A 20-year perspective on the international fanconi anemia registry (IFAR). Blood. 2003;101(4):1249\u201356.","journal-title":"Blood"},{"issue":"18","key":"1810_CR750","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.2169\/internalmedicine.6926-20","volume":"60","author":"M Fujisawa","year":"2021","unstructured":"Fujisawa M, et al. Three cases of esophageal cancer related to Fanconi anemia. Intern Med. 2021;60(18):2953\u20139.","journal-title":"Intern Med"},{"issue":"2","key":"1810_CR751","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s12094-021-02693-8","volume":"24","author":"L Murillo-Sanju\u00e1n","year":"2022","unstructured":"Murillo-Sanju\u00e1n L, et al. Post-hematopoietic stem cell transplant squamous cell carcinoma in patients with Fanconi anemia: a dreadful enemy. Clin Transl Oncol. 2022;24(2):388\u201392.","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"1810_CR752","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1097\/SCS.0000000000008317","volume":"33","author":"MA Wright","year":"2022","unstructured":"Wright MA, et al. Microsurgical head and neck reconstruction in patients with fanconi anemia. J Craniofac Surg. 2022;33(4):e414\u20136.","journal-title":"J Craniofac Surg"},{"issue":"7","key":"1810_CR753","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/ajh.25810","volume":"95","author":"S Giardino","year":"2020","unstructured":"Giardino S, et al. Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: a retrospective analysis on behalf of EBMT group. Am J Hematol. 2020;95(7):809\u201316.","journal-title":"Am J Hematol"},{"issue":"4","key":"1810_CR754","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/bjh.18091","volume":"197","author":"BP Alter","year":"2022","unstructured":"Alter BP, et al. Fanconi anaemia: a syndrome with distinct subgroups. Br J Haematol. 2022;197(4):467\u201374.","journal-title":"Br J Haematol"},{"key":"1810_CR755","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12185-020-02991-x","volume":"113","author":"M Yabe","year":"2021","unstructured":"Yabe M, et al. Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis. Int J Hematol. 2021;113:134\u201344.","journal-title":"Int J Hematol"},{"issue":"3","key":"1810_CR756","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/scd.12668","volume":"42","author":"LFSL Macedo","year":"2022","unstructured":"Macedo LFSL, et al. Fanconi anemia and hematopoietic stem cell transplant as risk factors for oral squamous cell carcinoma: a case report with a 12-year follow-up. Spec Care Dentist. 2022;42(3):299\u2013303.","journal-title":"Spec Care Dentist"},{"issue":"9","key":"1810_CR757","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.1007\/s00784-022-04554-2","volume":"26","author":"M Di Bartolomeo","year":"2022","unstructured":"Di Bartolomeo M, et al. Tongue cancer following hematopoietic cell transplantation for Fanconi anemia. Clin Oral Invest. 2022;26(9):5943\u201352.","journal-title":"Clin Oral Invest"},{"issue":"1","key":"1810_CR758","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/sj.bmt.1704340","volume":"33","author":"M Ayas","year":"2004","unstructured":"Ayas M, et al. Allogeneic stem cell transplantation in patients with Fanconi\u2019s anemia and myelodysplasia or leukemia utilizing low-dose cyclophosphamide and total body irradiation. Bone Marrow Transplant. 2004;33(1):15\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"34","key":"1810_CR759","doi-asserted-by":"publisher","first-page":"36577","DOI":"10.18632\/oncotarget.5369","volume":"6","author":"C Caperton","year":"2015","unstructured":"Caperton C, Agrawal S, Gupta S. Good syndrome presenting with CD8(+) T-cell large granular lymphocyte leukemia. Oncotarget. 2015;6(34):36577\u201386.","journal-title":"Oncotarget"},{"issue":"4","key":"1810_CR760","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1093\/rheumatology\/keaa666","volume":"60","author":"MT Koning","year":"2021","unstructured":"Koning MT, et al. Two independent hematological malignancies in a B-cell deficient good syndrome patient. Rheumatology. 2021;60(4):e126\u20138.","journal-title":"Rheumatology"},{"issue":"4","key":"1810_CR761","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jdcr.2017.04.006","volume":"3","author":"M Ilyas","year":"2017","unstructured":"Ilyas M, Costello CM, Sharma A. Exploring the relationship between natural killer cells and cutaneous squamous cell carcinoma development. JAAD Case Rep. 2017;3(4):364\u20136.","journal-title":"JAAD Case Rep"},{"key":"1810_CR762","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s00467-018-3930-6","volume":"33","author":"M Steinberg","year":"2018","unstructured":"Steinberg M, et al. The light at the end of the tunnel: an unusual case of acute kidney injury in a pediatric patient: answers. Pediatr Nephrol. 2018;33:2269\u201373.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"1810_CR763","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.jaci.2016.08.027","volume":"139","author":"V Barlogis","year":"2017","unstructured":"Barlogis V, et al. Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: a French reference center for PIDs (CEREDIH) study. J Allergy Clin Immunol. 2017;139(4):1275-1281.e7.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1810_CR764","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/ajmg.1320200410","volume":"20","author":"E Seemanov\u00e1","year":"1985","unstructured":"Seemanov\u00e1 E, et al. Familial microcephaly with normal intelligence, immunodeficiency, and risk for lymphoreticular malignancies: a new autosomal recessive disorder. Am J Med Genet. 1985;20(4):639\u201348.","journal-title":"Am J Med Genet"},{"issue":"4","key":"1810_CR765","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/MPH.0b013e318161aa3b","volume":"30","author":"A Bal","year":"2008","unstructured":"Bal A, et al. Multifocal extranodal non-Hodgkin lymphoma involving both the lungs and brain in a child with primary immunodeficiency. J Pediatr Hematol\/Oncol. 2008;30(4):317\u20139.","journal-title":"J Pediatr Hematol\/Oncol"},{"issue":"14","key":"1810_CR766","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJM197109302851410","volume":"285","author":"AT Davis","year":"1971","unstructured":"Davis AT, Brunning RD, Quie PG. Polymorphonuclear leukocyte myeloperoxidase deficiency in a patient with myelomonocytic leukemia. N Engl J Med. 1971;285(14):789\u201390.","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1007\/s10875-026-02078-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000}}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01810-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-024-01810-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01810-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:03:02Z","timestamp":1791010982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-024-01810-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":766,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1810"],"URL":"https:\/\/doi.org\/10.1007\/s10875-024-01810-w","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"28 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper has been updated because the captions for Figures 1 through 3 were inadvertently omitted.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10875-026-02078-y","URL":"https:\/\/doi.org\/10.1007\/s10875-026-02078-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"34"}}